Cirrus Logic Annual Report 2021

← All annual reports

FY2021 Annual Report · Cirrus Logic

Loading PDF…

2021

ANNUAL
REPORT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K
Í ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended March 27, 2021

‘ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from

Commission File Number 0-17795
CIRRUS LOGIC, INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or organization)

77-0024818
(I.R.S. Employer Identification No.)

800 W. 6th Street Austin, Texas
(Address of principal executive offices)

78701
(Zip Code)

Title of each class

Registrant’s telephone number, including area code: (512) 851-4000
Securities registered pursuant to Section 12(b) of the Act:
Trading Symbol

Name of each exchange on which registered

Common stock, $0.001 par value

CRUS

The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes Í No ‘
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ‘ No Í

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes Í

No ‘

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive

Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit and post such files). Yes Í

No ‘

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Í Accelerated filer ‘ Non-accelerated filer ‘ Smaller reporting company ‘ Emerging growth company ‘

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ‘

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of

its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public
accounting firm that prepared or issued its audit report. Í

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ‘

No Í

The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates was $2,238,559,321 based

upon the closing price reported on the NASDAQ Global Select Market as of September 26, 2020. Stock held by directors, officers and
stockholders owning 5 percent or more of the outstanding common stock were excluded as they may be deemed affiliates. This determination
of affiliate status is not a conclusive determination for any other purpose.

As of May 19, 2021, the number of outstanding shares of the registrant’s common stock, $0.001 par value, was 57,525,391.

Certain information contained in the registrant’s proxy statement for its annual meeting of stockholders to be held July 30, 2021 is

incorporated by reference in Part II – Item 5 and Part III of this Annual Report on Form 10-K.

DOCUMENTS INCORPORATED BY REFERENCE

CIRRUS LOGIC, INC.

FORM 10-K

For The Fiscal Year Ended March 27, 2021
INDEX

PART I

Item 1.

Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 1A.

Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 1B.

Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 2.

Item 3.

Item 4.

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 6.

Item 7.

Selected Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Management’s Discussion and Analysis of Financial Condition and Results of Operations

. . . .

Item 7A. Quantitative and Qualitative Disclosures about Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 8.

Item 9.

Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure . . . . .

Item 9A.

Controls and Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART III

Item 10.

Directors, Executive Officers and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 11.

Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder

Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Item 13.

Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . . . . . .

Item 14.

Principal Accounting Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART IV

Item 15.

Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signatures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITEM 1. Business

PART I

Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-

precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile
and consumer applications.

We were incorporated in California in 1984, became a public company in 1989 and were reincorporated in

the State of Delaware in February 1999. Our primary facility housing engineering, sales and marketing, and
administrative functions is located in Austin, Texas. We also have offices in various other locations in the
United States, United Kingdom, the People’s Republic of China, South Korea, Japan, Singapore, and Taiwan.
Our common stock, which has been publicly traded since 1989, is listed on the NASDAQ’s Global Select Market
under the symbol CRUS.

We maintain a website with the address www.cirrus.com. We are not including the information contained

on our website as a part of, or incorporating it by reference into, this Annual Report on Form 10-K. We make
available free of charge through our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q
and Current Reports on Form 8-K, and amendments to these reports, as soon as reasonably practicable after we
electronically file such material with, or furnish such material to, the Securities and Exchange Commission (the
“SEC”). We also routinely post other important information on our website, including information specifically
addressed to investors or posted on the “Ask the CEO” portion of our website. We intend for the investor
relations section of our website to be a recognized channel of distribution for disseminating information to the
securities marketplace in general. To receive a free copy of this Annual Report on Form 10-K, please forward
your written request to Cirrus Logic, Inc., Attn: Investor Relations, 800 W. 6th Street, Austin, Texas 78701, or via
email at Investor@cirrus.com. In addition, the SEC maintains a website at www.sec.gov that contains reports,
proxy and information statements filed electronically with the SEC by Cirrus Logic.

Company Strategy

Cirrus Logic targets growing markets where we can leverage our expertise in advanced mixed-signal

processing to solve complex problems. The Company has identified three growth vectors that are expected to fuel
opportunities in the coming years. First, we anticipate strengthening our position as the leading audio supplier in
smartphones. Second, we are focused on increasing sales of audio components in applications beyond
smartphones. And third, we are drawing on our extensive mixed-signal engineering expertise to develop
solutions in new, adjacent product areas that we believe will drive diversification beyond the audio domain. Our
approach has been to develop custom and general market components that embody our latest innovations, which
we use to engage key players in a particular market or application. We focus on building strong engineering
relationships with our customers’ product teams and work to develop highly differentiated components that
address their technical and price requirements across product tiers. Many of our products include programmable
aspects and are comprised of our best-in-class hardware which incorporates software algorithms from some
combination of our own intellectual property (“IP”), algorithms that have been ported to our platform by an
ecosystem of third-party partners, and our customers’ IP. When we have been successful with this approach, one
initial design win has often expanded into additional products. This strategy gives us the opportunity to increase
our content with a customer over time through the incorporation of new features, the integration of other system
components into our products and the addition of new components.

Markets and Products

In the fourth quarter of fiscal year 2021, the Company adjusted how we report product line revenue to better
represent our business and strategic focus. The revised product line categories are Audio and High-Performance
Mixed-Signal, compared to Portable and Non-Portable and Other Products in prior periods. While we continue to
see new opportunities for growth in the coming years with audio products in both smartphones and in
applications beyond smartphones, we believe our investment in high-performance mixed-signal products will
drive product diversification and fuel exciting additional avenues of growth. See Note 9 — Revenues for
disclosure of revenue associated with modified product line categories and revenue as previously reported.

The following provides a detailed discussion regarding our audio and high-performance mixed-signal

product lines.

Audio Products: Smart codecs, boosted amplifiers, analog-to-digital converters, digital-to-analog converters and
standalone digital signal processors.

High-Performance Mixed-Signal Products: Haptic driver and sensing solutions, camera controllers and power-
related components.

AUDIO PRODUCTS

Cirrus Logic is a leading supplier of low-power, low-latency, high-precision audio components that are used

in a variety of applications including smartphones, tablets, truly wireless headsets, laptops, AR/VR headsets,
home theater systems, automotive entertainment systems and professional audio systems. We have an extensive
portfolio of products, including “codecs” — chips that integrate analog-to-digital converters (“ADCs”) and
digital-to-analog converters (“DACs”) into a single integrated circuit (“IC”), “smart codecs” — codecs with
digital signal processing integrated, boosted amplifiers, as well as standalone digital signal processors (“DSPs”).
Additionally, the Company’s SoundClear® technology consists of a broad portfolio of tools, software and
algorithms that help to differentiate our customers’ products by improving the user experience with features such
as louder, high-fidelity sound, high-quality audio playback, voice capture, hearing augmentation and active noise
cancellation.

HIGH-PERFORMANCE MIXED-SIGNAL PRODUCTS

Drawing on our extensive mixed-signal design and low-power processing expertise, Cirrus Logic has

expanded beyond our traditional audio domain into new categories where we provide a range of high-
performance mixed-signal ICs, including haptic driver and sensing solutions, camera controllers and power-
related components. These products help deliver a more immersive and compelling user experience in a wide
array of applications including smartphones, tablets, wearables and laptops. This product line also includes
legacy industrial and energy applications such as digital utility meters, power supplies, energy control, energy
measurement and energy exploration.

Customers, Marketing, and Sales

We offer products worldwide through both direct and indirect sales channels. Our major customers are
among the world’s leading electronics manufacturers. We target both large existing and emerging customers that
derive value from our expertise in advanced analog and mixed-signal design processing, systems-level integrated
circuit engineering and embedded software development. We derive our revenues from both domestic and
international sales. Our domestic sales force includes direct sales offices located primarily in California and
Texas. International sales offices and staff are located in Japan, People’s Republic of China, Singapore, South
Korea, Taiwan, and the United Kingdom. We supplement our direct sales force with external sales
representatives and distributors. We have technical support centers in China, South Korea, Taiwan and the
United States. Our worldwide sales force provides geographically specific support to our customers and
specialized selling of product lines with unique customer bases. See Note 19 — Segment Information, of the
Notes to Consolidated Financial Statements contained in Item 8 for further detail and for additional disclosure
regarding sales and property, plant and equipment, net, by geographic locations.

Since the components we produce are largely proprietary and generally not available from second sources,

we generally consider our end customer to be the entity specifying the use of our component in their design.
These end customers may then purchase our products directly from us, through distributors or third party
manufacturers contracted to produce their designs. For fiscal years 2021, 2020, and 2019, our ten largest end
customers, represented approximately 93 percent, 93 percent, and 91 percent, of our sales, respectively. For fiscal
years 2021, 2020, and 2019, we had one end customer, Apple, Inc., who purchased through multiple contract
manufacturers and represented approximately 83 percent, 79 percent, and 78 percent, of the Company’s total
sales, respectively. No other customer or distributor represented more than 10 percent of net sales in fiscal years
2021, 2020, or 2019.

Manufacturing

As a fabless semiconductor company, we contract with third parties for wafer fabrication and product
assembly and test. We use a variety of foundries in the production of wafers, primarily supplied by TSMC and
GLOBALFOUNDRIES. The Company’s primary assembly and test houses include Advanced Semiconductor
Engineering, Inc., STATS ChipPAC Pte. Ltd, Amkor Technology Inc., and SFA Semicon Co., Ltd. Our
outsourced manufacturing strategy allows us to concentrate on our design strengths and minimize fixed costs and
capital expenditures while giving us access to advanced manufacturing facilities. It also provides the flexibility to
source multiple leading-edge technologies through strategic relationships. After wafer fabrication by the foundry,
third-party assembly vendors package the wafer die. The finished products are then tested before shipment to our
customers. While we do have some redundancy of fabrication processes by using multiple outside foundries, any
interruption of supply by one or more of these foundries could materially impact the Company. As a result, we
maintain some amount of business interruption insurance to help reduce the risk of wafer supply interruption, but
we are not fully insured against such risk. Our supply chain management organization is responsible for the
management of all aspects of the manufacturing, assembly, and testing of our products, including process and
package development, test program development, and production testing of products in accordance with our
ISO-certified quality management system.

Although our products are made from basic materials (principally silicon, metals and plastics), all of which

are available from a number of suppliers, capacity at wafer foundries sometimes becomes constrained. The
limited availability of certain materials may impact our suppliers’ ability to meet our demand needs or impact the
price we are charged. The prices of certain other basic materials, such as metals, gases and chemicals used in the
production of circuits can increase as demand grows for these basic commodities. In most cases, we do not
procure these materials ourselves; nevertheless, we are reliant on such materials for producing our products
because our outside foundry and package and test subcontractors must procure them. To help mitigate risks
associated with constrained capacity, we use multiple foundries, assembly and test sources.

Patents, Licenses and Trademarks

We rely on patent, copyright, trademark, and trade secret laws to protect our intellectual property, products,

and technology. As of March 27, 2021, we held approximately 3,670 pending and issued patents worldwide,
which include approximately 1,280 granted U.S. patents, 430 U.S. pending patent applications and various
international patents and applications. Our U.S. patents expire in calendar years 2021 through 2040. While our
patents are an important element of our success, our business as a whole is not dependent on any one patent or
group of patents. We do not anticipate any material effect on our business due to any patents expiring in 2021,
and we continue to obtain new patents through our ongoing research and development.

We have maintained U.S. federal trademark registrations for CIRRUS LOGIC, CIRRUS, Cirrus Logic logo
designs, and SoundClear, among others. These U.S. registrations may be renewed as long as the marks continue
to be used in interstate commerce. We have also filed or obtained foreign registration for these marks in other
countries or jurisdictions where we conduct, or anticipate conducting, international business. To complement our
own research and development efforts, we have also licensed and expect to continue to license, a variety of
intellectual property and technologies important to our business from third parties.

Segments

We determine our operating segments in accordance with Financial Accounting Standards Board (“FASB”)

guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker as
defined by these guidelines.

The Company operates and tracks its results in one reportable segment, but reports revenue performance in

two product lines: Audio and High-Performance Mixed-Signal, compared to Portable and Non-Portable and
Other in prior periods (discussed above). Our CEO receives and uses enterprise-wide financial information to
assess financial performance and allocate resources, rather than detailed information at a product line level.
Additionally, our product lines have similar characteristics and customers. They share operations support
functions such as sales, public relations, supply chain management, various research and development and

engineering support, in addition to the general and administrative functions of human resources, legal, finance
and information technology. Therefore, there is no discrete financial information maintained for these product
lines.

See Note 9 — Revenues of the Notes to Consolidated Financial Statements contained in Item 8 for further
details including sales by product line. See Note 19 — Segment Information, for details on sales and property,
plant and equipment, net, by geographic locations.

Research and Development

We concentrate our research and development efforts on the design and development of new products for

each of our principal markets. We also fund certain advanced-process technology development, as well as other
emerging product opportunities. Our future success is highly dependent upon our ability to develop complex new
products, transfer new products to volume production, introduce them into the marketplace in a timely fashion,
and have them selected for design into products of systems manufacturers. Our future success may also depend
on assisting our customers with integration of our components into their new products, including providing
support from the concept stage through design, launch and production ramp.

Competition

Markets for our products are highly competitive and we expect that competition will continue to increase.
Our ability to compete effectively and to expand our business will depend on our ability to continue to recruit
key engineering talent, execute on new product developments, partner with customers to include these new
products into their applications, and provide cost efficient versions of existing products. We compete with other
semiconductor suppliers that offer standard semiconductors, application-specific standard products and fully
customized ICs, including embedded software, chip and board-level products.

While no single company competes with us in all of our product lines, we face significant competition in all

markets where our products are available. Cirrus Logic is a leading supplier of audio and high-performance
mixed-signal processing solutions including codecs, smart codecs, boosted amplifiers, haptic and sensing
solutions, and camera controllers. We expect to face additional competition from new entrants in our markets,
which may include both large domestic and international IC manufacturers and smaller, emerging companies.
Our primary competitors include, but are not limited to AKM Semiconductor Inc., Analog Devices Inc.,
Bestechnic (Shanghai) Co., Dialog Semiconductor PLC, DSP Group, Goodix Technology, Maxim Integrated
Products Inc., Qualcomm Incorporated, Realtek Semiconductor Corporation, Shanghai Awinic Technology Co.,
Ltd., Skyworks Solutions Inc., ST Microelectronics N.V., Synaptics Incorporated and Texas Instruments, Inc.

The principal competitive factors in our markets include: time to market; quality of hardware/software
design and end-market systems expertise; price; product performance, features, quality and compatibility with
standards; access to advanced process and packaging technologies at competitive prices; and sales and technical
support, which includes assisting our customers with integration of our components into their new products and
providing support from the concept stage through design, launch and production ramp.

Product life cycles may vary greatly by product category. For example, many consumer products
have shorter design-in cycles; therefore, our competitors have increasingly frequent opportunities to achieve
design wins in next-generation systems. Conversely, this also provides us frequent opportunities to displace
competitors in products that have previously not utilized our design.

Backlog

Sales are made primarily pursuant to short-term purchase orders for delivery of products. The quantity
actually ordered by the customer, as well as the shipment schedules, are frequently revised, without significant
penalty, to reflect changes in the customer’s needs. The majority of our backlog is typically requested for
delivery within six months. In markets where the end system life cycles are relatively short, customers typically
request delivery in six to twelve weeks. We believe a backlog analysis at any given time gives little indication of
our future business except on a short-term basis, principally within the next 60 days.

We utilize backlog as an indicator to assist us in production planning. However, backlog is influenced by

several factors including market demand, pricing, and customer order patterns in reaction to product lead times.
Quantities actually purchased by customers, as well as prices, are subject to variations between booking and
delivery because of changes in customer needs or industry conditions. As a result, we believe that our backlog at
any given time is an incomplete indicator of future sales.

Governmental Regulations

Our business and operations around the world are subject to government regulation at the national, state or

local level addressing, among other matters, applicable environmental laws, health and safety laws and
regulations, and laws relating to export controls and economic sanctions.

We believe that our properties and operations comply in all material respects with applicable laws
protecting the environment and worker health and safety. As a fabless semiconductor company, we do not
manufacture our own products but do maintain research and laboratory space at certain of our facilities to
facilitate the development, evaluation and testing of our products. These laboratories may maintain small
quantities of hazardous materials. While we believe we are in material compliance with applicable law
concerning the safeguarding of these materials and with respect to other matters relating to health, safety and the
environment, the risk of liability relating to hazardous conditions or materials cannot be eliminated completely.
To date, we have not incurred significant expenditures relating to environmental compliance at our facilities nor
have we experienced any material issues relating to employee health and safety.

In addition to environmental and worker health and safety laws, our business is subject to various rules and

regulations and executive orders relating to export controls and trade sanctions. Certain of our products are
subject to the Export Administration Regulations (EAR), which are administered by the United States
Department of Commerce’s Bureau of Industry and Security (“BIS”), and we may from time to time be required
to obtain an export license before we can export certain products or technology to specified countries or
customers. In addition, the EAR imposes broad controls on entities listed on sanctioned persons lists, including
the BIS Entity List. If one of our customers is listed on the BIS Entity List or another U.S. government
sanctioned persons’ list, we may be precluded from doing business with that customer. For example, certain of
our Chinese customers, or their affiliated entities, have been added to the BIS Entity List in the last couple of
years, which limits our ability to support these customers. We cannot guarantee that export control restrictions or
sanctions imposed in the future will not prevent, or materially limit, our ability to conduct business with certain
customers or in certain countries. Any failure to comply with these laws could result in governmental
enforcement actions, including substantial monetary penalties and denial of export privileges.

For further discussion relating to the potential effects that compliance with government regulation may have

upon our business, refer to “Item 1A. Risk Factors.”

Human Capital

Our long-term success depends, in part, on our ability to continue to attract and retain highly qualified

technical, marketing, engineering, and administrative personnel. Cirrus Logic’s goal, as it pertains to our
employees, is to foster an outstanding corporate culture that encourages innovation, teamwork, and individual
growth. We do this by creating programs and practices that motivate and reward our employees while helping
their families thrive. We center everything we do around our corporate vision, mission and core values. The
Company strives to cultivate an inclusive workplace where all employees feel they belong, diverse backgrounds
and perspectives are valued, and everyone has an opportunity to succeed. We have adopted strategies to create an
even more inclusive and positive work environment.

We believe that we offer competitive compensation, training programs, and health and wellness benefits,

designed to improve the quality of our employees’ lives, build long-term employee loyalty and attract top talent.
Cirrus Logic prides itself on maintaining a world-class employee training and professional development program
to maximize our employees’ success. Our comprehensive benefits, such as health insurance coverage and
emotional well-being support are tailored for each country. Additional benefits focus on family care, including
fertility coverage, paid parental leave, discounts for childcare, backup care and programs for new mothers. The

Company also provides fitness facilities and classes at several locations, as well as other employee benefits
including health screenings, flu shots, ergonomic assessments and pet insurance. Cirrus Logic provides
retirement planning programs with matching contributions, such as a 401(k) plan in the United States and defined
contribution pension plans for our employees in other countries.

We believe that these benefits, combined with our corporate culture, contribute to low voluntary employee

turnover. In fiscal year 2021, our voluntary turnover rate was 6 percent, below the technology industry
benchmarks (2020 Radford Salary Increase and Turnover Study).

As of March 27, 2021, we had 1,481 full-time employees, of whom 69 percent were engaged in research and

product development activities, 26 percent in sales, marketing, general and administrative activities, and
5 percent in manufacturing-related activities. As of March 27, 2021, 13 percent of our employees worldwide
were foreign nationals and 63 percent of our total workforce reside in the U.S., with 37 percent residing offshore.
We also employ individuals on a temporary basis and use the services of contractors as necessary. We have never
had a work stoppage and the majority of our employees are not represented by collective bargaining agreements.

Cirrus Logic is committed to promoting a safe, secure and productive environment for our employees,
customers, and visitors. Our global health and safety policy outlines our commitment to employees. Employees
working in our research facilities receive specialized, role-specific health and safety training. The Company takes
measures to reduce employee exposure to potential health hazards in our offices and research facilities and
conducts regular inspections to maintain a safe and healthy work environment. A risk management system also
provides technicians with additional data and information on the potential hazards associated with certain
chemicals. In fiscal year 2021, we had no monetary losses as a result of legal proceedings associated with
employee health and safety violations.

In response to the COVID-19 pandemic, we implemented a response plan that we believe was in the best

interest of our employees, customers, and the communities in which we operate. This included transitioning the
majority of our global workforce to a remote work model, while establishing preventative measures to ensure
essential on-site employees could safely perform their jobs. Recognizing that the pandemic placed unanticipated
demands on all our employees, we also launched initiatives to help people feel connected, and continued to
support our local communities in a time of need.

For more information on the commitment to our employees and other Environmental, Social and

Governance (“ESG”) topics visit https://www.cirrus.com/company/esg. We are not including the information
contained on our website as a part of, or incorporating it by reference into, this Annual Report on Form 10-K.

Forward-Looking Statements

This Annual Report on Form 10-K and certain information incorporated herein by reference contain
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. All statements included or incorporated by reference in this Annual Report on Form 10-K, other
than statements that are purely historical, are forward-looking statements. In some cases, forward-looking
statements are identified by words such as “expect,” “anticipate,” “target,” “project,” “believe,” “goals,”
“estimates,” “will,” “would,” “could,” “can,” “may,” “plan,” and “intend”, and other similar types of words and
expressions. Variations of these types of words and similar expressions are intended to identify these forward-
looking statements. Any statements that refer to our plans, beliefs, expectations, strategies or other
characterizations of future events or circumstances are forward-looking statements. Readers are cautioned that
these forward-looking statements are predictions based on management’s expectations as of the date of this filing
and are subject to risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may
differ materially and adversely from those expressed in any forward-looking statements. Factors that could cause
actual results to differ materially from those indicated or implied by our forward-looking statements include, but
are not limited to, those discussed in Item 1A. Risk Factors and elsewhere in this report, as well as in the
documents filed by us with the SEC, specifically the most recent reports on Form 10-Q and 8-K, each as it may
be amended from time to time.

We caution you not to place undue reliance on these forward-looking statements, which speak only as of the

date of this Annual Report on Form 10-K, and we undertake no obligation, and expressly disclaim any duty, to
revise or update this information, whether as a result of new information, events or circumstances after the filing
of this report with the SEC, except as required by law. We urge readers to carefully review and consider the
various disclosures made in this Annual Report on Form 10–K and in other documents we file from time to time
with the SEC that disclose risks and uncertainties that may affect our business. All forward-looking statements,
expressed or implied, included in this Annual Report on Form 10-K and attributable to Cirrus Logic are expressly
qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in
connection with any subsequent written or oral forward-looking statements that we may make or persons acting
on our behalf may issue.

ITEM 1A. Risk Factors

Our business faces significant risks. The risk factors set forth below may not be the only risks that we face

and there is a risk that we may have failed to identify all possible risk factors. Additional risks that we are not
aware of yet or that currently are not material may adversely affect our business operations. You should read the
following cautionary statements in conjunction with the factors discussed elsewhere in this and other Cirrus
Logic filings with the SEC. These cautionary statements are intended to highlight certain factors that may affect
the financial condition and results of operations of Cirrus Logic and are not meant to be an exhaustive discussion
of risks that apply to companies such as ours.

Risks Related to Operating our Business

We are dependent on third-party manufacturing and supply chain relationships for all of our products. Our
reliance on third-party foundries and suppliers involves certain risks that may result in increased costs, delays
in meeting our customers’ demand, and loss of revenue.

We do not own or operate a semiconductor fabrication facility and do not have the resources to manufacture
our products internally. We use third parties to manufacture, assemble, package and test the vast majority of our
products. As a result, we are subject to risks associated with these third parties, including:

▪

insufficient capacity available to meet our demand;

inadequate manufacturing yields and excessive costs;

inability of these third parties to obtain an adequate supply of raw materials;

difficulties selecting and integrating new subcontractors;

limited warranties on products supplied to us;

potential increases in prices; and

increased exposure to potential misappropriation of our intellectual property.

Our outside foundries and assembly and test suppliers generally manufacture our products on a purchase
order basis, and we have few long-term supply arrangements with these suppliers. Therefore, our third-party
manufacturers and suppliers are not obligated to supply us with products for any specific period of time, quantity,
or price, except as may be provided in any particular purchase order or in relation to an existing supply
agreement. A manufacturing or supply disruption experienced by one or more of our outside suppliers or a
disruption of our relationship with an outside foundry could negatively impact the production of certain of our
products for a substantial period of time.

Like many others in the semiconductor industry, we have experienced the effects of industry-wide
manufacturing capacity constraints. These supply challenges are currently limiting our ability to fully satisfy
recent increases in demand for some of our general market products. We do not typically manufacture the
majority of these products at more than one foundry or more than one assembly and test subcontractor, and the
costs and effort associated with the potential transfer of any portion of our supply chain to a backup supplier
would likely be substantial. Therefore, if one or more of our third-party manufacturers and suppliers are not able

to provide us sufficient capacity to meet our current demand, we may not be able to ship our products to
customers on time and in the quantity requested, which could cause an unanticipated decline in our sales and
damage our existing customer relationships and our ability to establish new customer relationships. Capacity
constraints could further result in increased prices in our supply chain, which, if we are unable to increase our
selling price to our customers or if we have previously committed to pricing with them, could result in lower
revenues and margins that could adversely affect our financial results.

In addition, difficulties associated with adapting our technology and product design to the proprietary
process technology and design rules of outside foundries can lead to reduced yields of our products. Since low
yields may result from either design or process technology failures, yield problems may not be effectively
determined or resolved until an actual product exists that can be analyzed and tested to identify process
sensitivities relating to the design rules that are used. As a result, yield problems may not be identified until well
into the production process, and resolution of yield problems may require cooperation between our manufacturer
and us. This risk could be compounded by the offshore location of certain of our manufacturers, increasing the
effort and time required to identify, communicate and resolve manufacturing yield problems. Manufacturing
defects that we do not discover during the manufacturing or testing process may lead to costly product recalls.
These risks may lead to increased costs or delayed product delivery, which would harm our profitability and
customer relationships.

In some cases, our requirements may represent a small portion of the total production of the third-party
suppliers. As a result, we are subject to the risk that a producer will cease production of an older or lower-volume
process that it uses to produce our parts. We cannot provide any assurance that our external foundries will
continue to devote resources to the production of parts for our products or continue to advance the process design
technologies on which the manufacturing of our products are based. Each of these events could increase our
costs, lower our gross margin, and cause us to hold more inventories, or materially impact our ability to deliver
our products on time.

We depend on a limited number of customers and distributors for a substantial portion of our sales, and the
loss of, or a significant reduction in orders from, or pricing on products sold to, any key customer or
distributor could significantly reduce our sales and our profitability.

While we generate sales from a broad base of customers worldwide, the loss of any of our key customers, or
a significant reduction in sales or selling prices to any key customer, or reductions in selling prices made to retain
key customer relationships, would significantly reduce our revenue, margins and earnings and adversely affect
our business. For the twelve-month periods ending March 27, 2021, March 28, 2020, and March 30, 2019, our
ten largest end customers represented approximately 93 percent, 93 percent, and 91 percent of our sales,
respectively. For the twelve-month periods ending March 27, 2021, March 28, 2020, and March 30, 2019, we had
one end customer, Apple Inc., who purchased through multiple contract manufacturers and represented
approximately 83 percent, 79 percent and 78 percent of the Company’s total sales, respectively.

We may not be able to maintain or increase sales to certain of our key customers for a variety of reasons,

including the following:

▪ most of our customers can stop incorporating our products into their own products with limited notice to

us and suffer little or no penalty;

▪

our agreements with our customers typically do not require them to purchase a minimum quantity of our
products;

▪ many of our customers have pre-existing or concurrent relationships with our current or potential

competitors that may affect the customers’ decisions to purchase our products;

▪ many of our customers have sufficient resources to internally develop technology solutions and

semiconductor components that could replace the products that we currently supply in our customers’
end products;

▪

our customers face intense competition from other manufacturers that do not use our products; and

▪

our customers regularly evaluate alternative sources of supply in order to diversify their supplier base,
which increases their negotiating leverage with us and their ability to either obtain or dual source
components from other suppliers.

In addition, our dependence on a limited number of key customers may make it easier for them to pressure
us on price reductions. We have experienced pricing pressure from certain key customers and we expect that the
average selling prices for certain of our products will decline from time to time, potentially reducing our revenue,
our margins and our earnings.

Our key customer relationships often require us to develop new products that may involve significant

technological challenges. Our customers frequently place considerable pressure on us to meet their tight
development schedules. In addition, we have, and may again in the future, enter into customer agreements
providing for exclusivity periods during which we may only sell specified products or technology to a specific
customer. Even without exclusivity periods, the products that we develop are often specific to our customer’s
system architecture and frequently cannot be sold to other customers. Accordingly, we may have to devote a
substantial amount of resources to strategic relationships, which could detract from or delay our completion of
other important development projects or the development of next generation products and technologies.

Moreover, our reliance on certain customers may continue to increase, which could heighten the risks
associated with having key customers, including making us more vulnerable to significant reductions in revenue,
margins and earnings, pricing pressure, and other adverse effects on our business.

Our lack of diversification in our revenue and customer base increases the risk of an investment in our
company, and our consolidated financial condition, results of operations, and stock price may deteriorate if we
fail to diversify.

Although we continue to investigate, invest in, and try to develop opportunities to diversify our revenue and
customer base, our sales, marketing, and development efforts have historically been focused on a limited number
of customers and opportunities. Larger companies have the ability to manage their risk by product, market, and
customer diversification. However, we lack diversification, in terms of both the nature and scope of our business,
which increases the risk of an investment in our company. If we cannot diversify our customer and revenue
opportunities, our financial condition and results of operations could deteriorate.

Our results may be affected by fluctuation in sales in the consumer electronics and smartphone markets.

Because we sell products primarily in the consumer electronics and smartphone markets, we are likely to be

affected by any decrease in demand or unit volumes, seasonality in the sales of our products, and the cyclical
nature of these markets. We have experienced, and expect to continue to experience, slowing growth in a
maturing smartphone market, due to, among other factors, market saturation in developed countries, lengthening
replacement cycles, and a growing market for refurbished devices. Further, a decline in consumer confidence and
consumer spending relating to economic conditions, terrorist attacks, armed conflicts, oil prices, global health
conditions, natural disasters, and/or the political stability of countries in which we operate or sell products could
have a material adverse effect on our business.

We may be adversely impacted by global economic conditions. As a result, our financial results and the market
price of our common shares may decline.

Global economic conditions could make it difficult for our customers, our suppliers, and us to accurately
forecast and plan future business activities, and could cause global businesses to defer or reduce spending on our
products, or increase the costs of manufacturing our products. During challenging economic times our customers
and distributors may face issues gaining timely access to sufficient credit, which could impact their ability to
make timely payments to us. If that were to occur, we may be required to increase our allowance for doubtful
accounts and our days sales outstanding would increase. Additionally, if our own supply chain or others from
whom our customers source are financially impacted and ultimately unable to deliver their required
component(s), then our customers may delay or cancel their orders from us.

We cannot predict the timing, strength, or duration of any economic slowdown or subsequent economic

recovery. If the economy or markets in which we operate were to deteriorate, our business, financial condition,
and results of operations will likely be materially and/or adversely affected.

Changes in government trade policies, including the imposition of tariffs and export restrictions, could have
an adverse impact on our business operations and sales.

The United States or foreign governments may enact changes in government trade policies that could
adversely impact our ability to sell products in certain countries, particularly in China. For example, the U.S.
government has imposed tariffs on certain Chinese imports and, in return, the Chinese government has imposed
or proposed tariffs on certain U.S. products. Additionally, export restrictions imposed by the U.S. government,
including the addition of licensing requirements by the BIS through the addition of companies to the BIS Entity
List, may require us to suspend our business with certain international customers if we conclude or are notified
by the U.S. government that such business presents a risk of noncompliance with U.S. regulations. We cannot
predict what actions may ultimately be taken with respect to tariffs or trade relations between certain countries,
what products may be subject to such actions, or what actions may be taken by other countries in response. It also
may not be possible to anticipate the timing or duration of such tariffs, export restrictions, or other regulatory
actions. These government trade policies may materially adversely affect our sales and operations with current
customers as well as impede our ability to develop relationships with new customers.

While we have received a license from the U.S. to sell to Huawei Technologies Co., Ltd. (“Huawei”), it is

limited to specific products and end customer uses and there is no guarantee that we will be able to obtain a
license for the manufacture or sale of future products or for other entities if the U.S government adds other
companies to the BIS Entity List and/or subjects them to additional trade restrictions. Despite our receipt of
licenses, BIS Entity List restrictions may also encourage Huawei or other foreign customers to seek to obtain a
greater supply of similar or substitute products from our competitors that are not subject to these restrictions or to
develop their own solutions, especially as the Chinese government invests in developing its domestic
semiconductor industry. This decreases our long-term competitiveness as a supplier to Chinese customers.

There is a risk of further escalation and retaliatory actions between the U.S. and other foreign governments.

If significant tariffs or other restrictions are placed on goods exported from China or any related counter-
measures are taken, our revenue and results of operations may be materially harmed. These tariffs may also make
our customers’ products more expensive for consumers, which may reduce consumer demand.

There is also a risk that the U.S. government may seek to implement more protective trade measures, not
just with respect to China but with respect to other countries as well. This could include new or higher tariffs and
even more restrictive trade barriers, such as prohibiting certain types of, or all sales of certain products or
products sold by certain parties into the U.S. Any increased trade barriers or restrictions on global trade could
have a materially adverse impact on our business and financial results.

System security risks, data protection breaches, cyber-attacks and other related cyber security issues could
disrupt our internal operations and/or supply chain, and any such disruption could increase our expenses,
damage our reputation and adversely affect our stock price.

Security measures at Cirrus Logic and/or within our manufacturing and supply chain are subject to third-
party security breaches, employee error, malfeasance, faulty password management, and other irregularities. We
manage and store various proprietary information and sensitive or confidential data relating to our business. In
addition, we manage and store a significant amount of proprietary and sensitive or confidential information from
third parties, such as our customers. Unauthorized insiders and/or third-party hackers (including organized crime
and/or foreign government agents) may be able to penetrate our security controls and misappropriate or
compromise such confidential information, create system disruptions or cause shutdowns. Hackers also may be
able to develop and deploy viruses, worms, phishing attempts, ransomware and other malicious software
programs that attack our websites, computer systems, access to critical information, products or otherwise exploit
any security vulnerabilities. This risk may be heightened when our employees are working remotely.

For example, we became aware that one of our vendors providing IT infrastructure management software,

SolarWinds Corporation, had been compromised by cyberattacks. Although we have not identified any

compromise of our IT systems due to the use of SolarWinds software to date, we continue to monitor our
network for any potential impact related to the SolarWinds cyberattack. Any breach of our security measures or
the loss, inadvertent disclosure or unapproved dissemination of proprietary information or sensitive or
confidential data about us or our customers, including the potential loss or disclosure of such information or data
as a result of the SolarWinds cyberattack, could result in litigation and potential liability for us, damage our
brand and reputation or otherwise harm our business.

Any breach of our security measures or the loss, inadvertent disclosure or unapproved dissemination of
proprietary information or sensitive or confidential data about us or our customers, including the potential loss or
disclosure of such information or data as a result of ransomware, fraud, trickery or other forms of deception,
could result in litigation and potential liability for us, damage our brand and reputation or otherwise harm our
business.

Our sales could be materially impacted by the failure of other component suppliers to deliver required parts
needed in the final assembly of our customers’ end products.

The products we supply our customers are typically a portion of the many components provided from
multiple suppliers in order to complete the final assembly of an end product. If one or more of these other
component suppliers are unable to deliver their required component(s) in order for the final end product to be
assembled, our customers may delay, or ultimately cancel, their orders from us.

We face risks related to global health epidemics that could impact our sales, supply chain and operations,
resulting in significantly reduced revenue and operating results.

On March 11, 2020, the World Health Organization declared a pandemic related to a novel coronavirus,

commonly referred to as COVID-19. With the pandemic on-going, we are unable to predict the full extent and
nature of the impact that COVID-19 may have on our business, financial condition and results of operations. The
COVID-19 pandemic will likely heighten or exacerbate many of the other risks described in the risk factors listed
in our filings with the Securities and Exchange Commission.

Although we did not experience any significant disruptions to our supply chain due to COVID-19 in fiscal
year 2021, any increase in the severity of the outbreak or additional government measures restricting movement
or business operations, could cause a disruption to our supply of products to our customers – particularly with
respect to the manufacture of semiconductor wafers that would have to go through extensive qualification to
relocate manufacturing to a different fabrication facility. Even if our suppliers and service providers are
operational, other third-party suppliers may be closed or not fully operational, resulting in a shortage of some
components needed for our products or our customers’ end products. Any disruption of our suppliers or
customers and their contract manufacturers would likely impact our inventory, backlog, sales and operating
results, as customers may cancel or reschedule orders on short notice. In addition, we have seen some reductions
in commercial airline and cargo flights, and disruption to ports and other shipping infrastructure that resulted in
increased transport times and costs, which, if those disruptions were to intensify, could affect our ability to timely
deliver our products.

Although we did not experience a significant reduction in our overall productivity due to COVID-19 during

fiscal year 2021, we have experienced, and expect to continue to experience, disruptions to our business
operations, including those resulting from remote work arrangements for the majority of our employees, the
implementation of certain measures at our facilities worldwide to protect our employees’ health and safety,
government stay-at-home directives, quarantines, self-isolations, travel restrictions, or other restrictions on the
ability of our employees to perform their jobs that may impact our ability to develop and design our products in a
timely manner, meet required milestones, or win new business. Any increased or additional disruptions to our
business operations would likely impact our ability to continue to maintain current levels of productivity.

In the longer term, the COVID-19 pandemic is likely to continue to adversely affect the economies and
financial markets of many countries, leading to a global economic downturn and potentially a recession. This
would also likely continue to adversely affect the demand environment for our products and those of our
customers, particularly consumer products such as smartphones, which may, in turn, negatively affect our
revenue and operating results.

We are subject to risks relating to product concentration.

We derive a substantial portion of our revenues from a limited number of products, and we expect these
products to represent a large percentage of our revenues in the near term. Customer acceptance of these products
is critical to our future success. Our business, operating results, financial condition and cash flows could
therefore be adversely affected by:

▪

a decline in demand for any of our more significant products;

a decline in the average selling prices of our more significant products;

failure of our products to achieve continued market acceptance;

competitive products;

new technological standards or changes to existing standards that we are unable to address with our
products;

▪ manufacturing or supply issues that prevent us from meeting our customers’ demand for these products;

▪

a failure to release new products or enhanced versions of our existing products on a timely basis; and

the failure of our new products to achieve market acceptance.

In general, our customers may cancel or reschedule orders on short notice without incurring significant
penalties; therefore, our sales and operating results in any quarter are difficult to forecast.

In general, we rely on customers issuing purchase orders to buy our products rather than long-term supply
contracts. Customers may cancel or reschedule orders on short notice without incurring significant penalties. This
risk is potentially heightened for those customers with whom we have less experience regarding the reliability of
their forecasts. Therefore, cancellations, reductions, or delays of orders from any significant customer could have
a material adverse effect on our business, financial condition, and results of operations.

In addition, a significant portion of our sales and earnings in any quarter depends upon customer orders for

our products that we receive and fulfill in that quarter. Because our expense levels are based in part on our
expectations as to future revenue and to a large extent are fixed in the short term, we likely will be unable to
adjust spending on a timely basis to compensate for any unexpected shortfall in sales or reductions in average
selling prices. Accordingly, any significant shortfall of sales in relation to our expectations could hurt our
operating results.

Strong competition in the semiconductor market may harm our business.

The IC industry is intensely competitive and is frequently characterized by rapid technological change, price
erosion, technological obsolescence, and a push towards IC component integration. Because of shortened product
life cycles and even shorter design-in cycles in a number of the markets that we serve, our competitors have
increasingly frequent opportunities to achieve design wins in next-generation systems. As markets mature and
components become commoditized, competitors that can tolerate lower margins/operating income pose a risk to
our profitability and growth. In the event that competitors succeed in supplanting our products, our market share
may not be sustainable and our net sales, gross margin and operating results would be adversely affected.

We compete in a number of markets. Our principal competitors in these markets include AKM

Semiconductor Inc., Analog Devices Inc., Bestechnic (Shanghai) Co., Dialog Semiconductor PLC, DSP Group,
Goodix Technology, Maxim Integrated Products Inc., Qualcomm Incorporated, Realtek Semiconductor
Corporation, Shanghai Awinic Technology Co., Ltd., Skyworks Solutions Inc., ST Microelectronics N.V. and
Texas Instruments, Inc. Many of these competitors have greater financial, engineering, manufacturing,
marketing, technical, distribution, and other resources; broader product lines; and broader intellectual property
portfolios. We also expect intensified competition from emerging companies and from customers who develop
their own IC products or other technologies. In addition, some of our current and future competitors maintain
their own fabrication facilities, which could benefit them in connection with cost, capacity, and technical issues.

Increased competition could adversely affect our business. We cannot provide assurances that we will be
able to compete successfully in the future or that competitive pressures will not adversely affect our financial
condition and results of operations. Competitive pressures could reduce market acceptance of our products and
result in price reductions and increases in expenses that could adversely affect our business and our financial
condition.

We have significant international sales, and risks associated with these sales could harm our operating results.

International sales represented 98 percent of our net sales in each of fiscal years 2021 and 2019, and

99 percent of our net sales in fiscal year 2020. We expect international sales to continue to represent a significant
portion of product sales. This reliance on international sales subjects us to the risks of conducting business
internationally, including risks associated with political and economic instability, global health conditions,
currency controls, exchange rate fluctuations and changes in import/export regulations, and tariff and freight
rates. For example, the political or economic instability in a given region may have an adverse impact on the
financial position of end users in the region, which could affect future orders and harm our results of operations.
Our international sales operations involve a number of other risks including, but not limited to:

▪

unexpected changes in government regulatory requirements;

sales, VAT, or other indirect tax regulations and treaties and potential changes in regulations and treaties
in the United States and in and between countries in which we manufacture or sell our products;

changes to countries’ banking and credit requirements;

changes in diplomatic and trade relationships;

delays resulting from difficulties in obtaining export licenses for technology, particularly in China;

any changes in U.S. trade policy, including potential adoption and expansion of trade restrictions, higher
tariffs, or cross border taxation by the U.S. government involving other countries, particularly China,
that might impact overall customer demand for our products or affect our ability to manufacture and/or
sell our products overseas;

tariffs and other barriers and restrictions, particularly in China;

competition with non-U.S. companies or other domestic companies entering the non-U.S. markets in
which we operate;

longer sales and payment cycles;

problems in collecting accounts receivable;

changes to economic, social, or political conditions in countries such as China, where we have
significant operations; and

the burdens of complying with a variety of non-U.S. laws.

In addition, our competitive position may be affected by the exchange rate of the U.S. dollar against other
currencies. While our sales are predominately denominated in U.S. dollars, increases in the value of the dollar
would increase the price in local currencies of our products in non-U.S. markets and make our products relatively
more expensive. We cannot provide assurances that regulatory, political and other factors will not adversely
affect our operations in the future or require us to modify our current business practices.

Because we depend on subcontractors internationally to perform key manufacturing functions for us, we are
subject to political, economic, climate and natural disaster risks that could disrupt the fabrication, assembly,
packaging, or testing of our products.

We depend on third-party subcontractors, primarily in Asia, for the fabrication, assembly, packaging, and
testing of most of our products. International operations may be subject to a variety of risks, including political
instability, global health conditions, currency controls, exchange rate fluctuations, changes in import/export

regulations, tariff and freight rates, as well as the risks of natural disasters such as earthquakes, tsunamis, and
floods. The potential physical impacts of climate change, including high heat events, power or water shortages,
fires, rising sea levels, changes in storm patterns or intensities, or other extreme weather conditions, are uncertain
and could impact operations at our subcontractors. Any disruption to our manufacturing cycle could adversely
affect our operations and financial results.

Although we seek to reduce our dependence on any one subcontractor, this concentration of subcontractors

and manufacturing operations in Asia subjects us to the risks of conducting business internationally, including
associated political and economic conditions. If we experience manufacturing problems at a particular location,
or a supplier is unable to continue operating due to financial difficulties, natural disasters, or other reasons, we
would be required to transfer manufacturing to a backup supplier. The substantial majority of our semiconductor
wafers are manufactured by TSMC at fabs in Taiwan, and Global Foundries in Singapore and Germany.
Converting or transferring manufacturing from a primary supplier to a backup facility could be expensive and
time consuming. As a result, delays in our production or shipping by the parties to whom we outsource these
functions could reduce our sales, damage our customer relationships, and damage our reputation in the
marketplace, any of which could harm our business, results of operations, and financial condition.

Our international operations subject our business to additional political and economic risks that could have
an adverse impact on our business.

In addition to international sales constituting a large portion of our net sales, we maintain international
operations, sales, and technical support personnel. International expansion has required, and will continue to
require, significant management attention and resources. There are risks inherent in expanding our presence into
non-U.S. regions, including, but not limited to:

▪

difficulties in staffing and managing non-U.S. operations;

failure in non-U.S. regions to adequately protect our intellectual property, patent, trademarks,
copyrights, know-how, and other proprietary rights;

global health conditions and potential natural disasters, including those resulting from climate change;

political and economic instability in international regions;

international currency controls and exchange rate fluctuations;

vulnerability to terrorist groups targeting American interests abroad; and

legal uncertainty regarding liability and compliance with non-U.S. laws and regulatory requirements.

If we are unable to successfully manage the demands of our international operations, it may have a material

adverse effect on our business, financial condition, or results of operations.

The United Kingdom (U.K.) formally left the E.U. on January 31, 2020. During the ensuing “transition

period,” which ended on December 31, 2020, an agreement on the key terms of the U.K.’s withdrawal and its
future relationship with the E.U. (the “Trade and Cooperation Agreement”), was negotiated and agreed by the
U.K. and E.U. Council (acting on behalf of the E.U. nation governments), thus avoiding a “no-deal” outcome.
The terms of the Trade and Cooperation Agreement were provisionally in effect since January 1, 2021, and
formally entered into force on 1 May 2021 following ratification by both sides. However, the Trade and
Cooperation Agreement does not cover all aspects of the ongoing relationship between the U.K. and E.U.
member states. The ongoing nature of the separation process, coupled with the potential for new laws in the U.K.,
greater restrictions on immigration between the U.K. and E.U. countries that make it more difficult to staff our
U.K. operations, changes in tax laws that may negatively impact our effective tax rate, restrictions on imports
and exports between the U.K. and E.U. member states, and increased regulatory complexities may adversely
affect our operations and financial results.

Our products may be subject to average selling prices that decline over time. If we are unable to maintain
average selling prices for existing products, increase our volumes, introduce new or enhanced products with
higher selling prices, or reduce our costs, our business and operating results could be harmed.

Historically in the semiconductor industry, average selling prices of products have decreased over time.

Moreover, our dependence on a limited number of key customers may make it easier for key customers to
pressure us to reduce the prices of the products we sell to them. If the average selling price of any of our products
declines and we are unable to increase our unit volumes, introduce new or enhanced products with higher
margins, and/or reduce manufacturing costs to offset anticipated decreases in the prices of our existing products,
our operating results may be adversely affected. In addition, because of procurement lead times, we are limited in
our ability to reduce total costs quickly in response to any reductions in prices or sales shortfalls. Because of
these factors, we may experience material adverse fluctuations in our future operating results on a quarterly or
annual basis.

If we fail to attract, hire and retain qualified personnel, we may not be able to develop, market, or sell our
products or successfully manage our business.

Competition for highly qualified personnel in our industry, particularly for employees with technical
backgrounds, is intense. The number of technology companies in the geographic areas in which we operate is
greater than it has been historically and we expect competition for qualified personnel to intensify because there
is only a limited number of individuals in the job market with the requisite skills.

In addition, there is a risk that changes in immigration laws and regulations, or the administration or
enforcement of such laws or regulations, can also impair our ability to attract and retain qualified engineering
personnel. In the United States, where the majority of our research and development teams are located, future
tightening of immigration controls may adversely affect the employment status of non-U.S. engineers and other
key technical employees or further impact our ability to hire new non-U.S. employees. Moreover, certain
immigration policies in the United States may make it more difficult for us to recruit and retain highly skilled
foreign national graduates of universities in the United States, additionally limiting the pool of available talent. In
the U.K., where we maintain several design centers, changes to the immigration system brought about by Brexit
will likely make it more difficult to employ E.U. nationals to work in the U.K., also limiting our ability to attract
and retain qualified technical personnel.

There are significant costs to the Company associated with attracting and retaining qualified personnel in
key technology positions. The loss of the services of key personnel or our inability to hire new personnel with the
requisite skills or to assimilate talent could restrict our ability to develop new products or enhance existing
products in a timely manner, sell products to our customers, or manage our business effectively.

We may acquire other companies or technologies, which may create additional risks associated with our
ability to successfully integrate them into our business.

We continue to consider future acquisitions of other companies, or their technologies or products, to
improve our market position, broaden our technological capabilities, and expand our product offerings. If we are
able to acquire companies, products or technologies that would enhance our business, we could experience
difficulties in integrating them. Integrating acquired businesses involves a number of risks, including, but not
limited to:

▪

the potential disruption of our ongoing business;

unexpected costs or incurring unknown liabilities;

the diversion of management resources from other strategic and operational issues;

the inability to retain the employees of the acquired businesses;

difficulties relating to integrating the operations and personnel of the acquired businesses;

adverse effects on our existing customer relationships or the existing customer relationships of acquired
businesses;

▪

the potential incompatibility of the acquired business or their business customers;

adverse effects associated with entering into markets and acquiring technologies in areas in which we
have little experience; and

acquired intangible assets, including goodwill, becoming impaired as a result of technological
advancements or worse-than-expected performance of the acquired business.

If we are unable to successfully address any of these risks, our business could be harmed.

Risks Related to Research and Development and New Technologies

We have entered into joint development agreements, custom product arrangements, and strategic relationships
with some of our largest customers. These arrangements subject us to a number of risks, and any failure to
execute on any of these arrangements could have a material adverse effect on our business, results of
operations, and financial condition.

We have entered into joint development, product collaboration and technology licensing arrangements with
some of our largest customers, and we expect to enter into new strategic arrangements of these kinds from time
to time in the future. Such arrangements can magnify several risks for us, including loss of control over the
development and development timeline of jointly developed products, risks associated with the ownership of the
intellectual property that is developed pursuant to such arrangements, and increased risk that our joint
development activities may result in products that are not commercially successful or that are not available in a
timely fashion. In addition, any third party with whom we enter into a joint development, product collaboration
or technology licensing arrangement may fail to commit sufficient resources to the project, change its policies or
priorities or abandon or fail to perform its obligations related to such arrangement. In addition, we have
previously and may in the future enter into customer product arrangements that provide for exclusivity periods
during which we may only sell specified products or technologies to that particular customer. Any failure to
timely develop commercially successful products through our joint development activities as a result of any of
these and other challenges could have a material adverse effect on our business, results of operations, and
financial condition.

Our failure to develop and ramp new products into production in a timely manner could harm our operating
results.

Our success depends upon our ability to develop new products for new and existing customers, and to
introduce these products in a timely and cost-effective manner. New product introductions involve significant
investment of resources and potential risks. Delays in new product introductions or less-than-anticipated market
acceptance of our new products are possible and would have an adverse effect on our sales and earnings. The
development of new products is highly complex and, from time-to-time, we have experienced delays in
developing and introducing these new products. Successful product development and introduction depend on a
number of factors including, but not limited to:

▪

proper new product definition;

timely completion of design and testing of new products;

assisting our customers with integration of our components into their new products, including providing
support from the concept stage through design, launch and production ramp;

successfully developing and implementing the software necessary to integrate our products into our
customers’ products;

achievement of acceptable manufacturing yields;

availability of wafer fabrication, assembly, and test capacity; and

▪ market acceptance of our products and the products of our customers.

Both sales and/or margins may be materially affected if new product introductions are delayed, or if our
products are not designed into successive generations of new or existing customers’ products. Our failure to
develop and introduce new products successfully could harm our business and operating results.

We continue to invest in research and development efforts for several new markets. If we are unable to
commercialize these technologies, our future results and profits could be negatively affected.

Our investments into new markets subjects us to additional risks. We may have limited or no experience in

these markets, and our customers may not adopt our new offerings. These new offerings may present new and
difficult challenges, including risks related to technology, customers, competitors, product cycles, customer
demand, terms and conditions and other industry specific issues which could negatively affect our operating
results. These developing products and market segments may not grow as significantly as projected, or at all, and
we may not realize an adequate return on our investments or may be required to write-down the value of certain
tangible and intangible assets.

Our products are increasingly complex and could contain defects, which could result in material costs to us.

Product development in the markets we serve is becoming more focused on the integration of multiple
functions on individual devices. There is a general trend towards increasingly complex products, including
software or firmware developed by Cirrus Logic and/or third parties. The greater integration of functions and
complexity of operations of our products increases the risk that we or our customers or end users could discover
latent defects or subtle faults after volumes of product have been shipped. Quality and reliability issues could
result in material costs and other adverse consequences to us, including, but not limited to:

▪

reduced margins;

damage to our reputation;

replacement costs for product warranty and support;

payments to our customers related to recall claims, or the delivery of product replacements as part of a
recall claim, as a result of various industry or business practices, contractual requirements, or in order to
maintain good customer relationships;

an adverse impact to our customer relationships by the occurrence of significant defects;

a delay in recognition or loss of revenues, loss of market share, or failure to achieve market acceptance;

▪ writing off or reserving the value of inventory of such products; and
▪

a diversion of the attention of our engineering personnel from our product development efforts.

In addition, any defects or other problems with our products could result in financial losses or other

damages to our customers who could seek damages from us for their losses. A product liability or warranty claim
brought against us, even if unsuccessful, would likely be time consuming and costly to defend. In particular, the
sale of systems and components that are incorporated into certain applications for the automotive industry
involves a high degree of risk that such claims may be made.

While we believe that we are reasonably insured against some of these risks and that we have attempted to

contractually limit our financial exposure with many of our customers, a warranty or product liability claim
against us in excess of our available insurance coverage and established reserves, or a requirement that we
participate in a customer product recall, could have material adverse effects on our business, results of
operations, and financial condition.

Security vulnerabilities may exist in our products, which could expose us to significant costs and damage our
business.

Our hardware and software products, including software tools deployed by our customers, may be
vulnerable to cyber-attacks. An attack could disrupt the proper functioning of our products, disrupt or cause
errors in our customers’ products, allow unauthorized access to our or our customers’ proprietary information, or
cause other destructive outcomes. A failure to prevent or mitigate such an attack could harm our business
reputation, diminish our competitive position in the market, and expose us to significant expense and liability.

The costs to us to eliminate or alleviate cyber or other security problems, bugs, viruses, worms, phishing
attempts, ransomware, malicious software programs and security vulnerabilities could be significant, and our
efforts to address these problems may not be successful and could result in interruptions, delays, an inability to
access critical information, cessation of service and loss of existing or potential customers that may impede our
sales, manufacturing, distribution or other critical functions.

We frequently develop our products for the specific system architecture of our customers’ end products. If our
customers were to change system architectures, develop competing technologies and integrated circuits, or
incorporate some of the functionality of our products into other parts of the system, we risk the potential loss
of revenue and reduced average selling prices.

Our customers, particularly in the portable market, could potentially transition to different audio

architectures, develop their own competing technologies and integrated circuits, or integrate the functionality that
our integrated circuits and software have historically provided into other components in their audio systems. In
addition, some of the audio and voice functionality that we have historically provided could be performed outside
of our customers’ end product. If our customers were to transition to these different system architectures, our
results of operations could be adversely affected by the elimination of the need for our current technology and
products, resulting in reduced average selling prices for our components and loss of revenue.

We may experience difficulties developing and transitioning to advanced manufacturing process technologies,
which could materially adversely affect our results.

Our future success depends in part on our ability to transition our current development and production

efforts to advanced manufacturing process technologies. We are currently making a significant investment to
transition our products and intellectual property to next-generation circuit geometries, for example 22
nanometers. If we are unable to reliably model behaviors required for circuit design and product requirements,
then our product development may be adversely impacted. To the extent that we do not timely develop or
transition to smaller geometries, experience difficulties in shifting to smaller geometries, or have significant
quality or reliability issues at these smaller geometries, our results could be materially adversely affected.

We may be unable to protect our intellectual property rights.

Our success depends in part on our ability to obtain patents and to preserve our other intellectual property

rights covering our products. We seek patent protection for those inventions and technologies for which we
believe such protection is suitable and is likely to provide a competitive advantage to us. We also rely on trade
secrets, proprietary technology, non-disclosure and other contractual terms, and technical measures to protect our
technology and manufacturing knowledge. We actively work to foster continuing technological innovation to
maintain and protect our competitive position. We cannot provide assurances that steps taken by us to protect our
intellectual property will be adequate, that our competitors will not independently develop or design around our
patents, or that our intellectual property will not be misappropriated. In addition, the laws of some non-U.S.
countries may not protect our intellectual property as well as the laws of the United States.

Any of these events could materially and adversely affect our business, operating results, or financial
condition. Policing infringement of our technology is difficult, and litigation may be necessary in the future to
enforce our intellectual property rights. Any such litigation could be expensive, take significant time, and divert
management’s attention.

Risks Related to our Financial Performance

Shifts in industry-wide capacity and our practice of ordering and purchasing our products based on sales
forecasts may result in significant fluctuations in inventory and our quarterly and annual operating results.

We rely on independent foundries and assembly and test houses to manufacture our products. Our reliance

on these third-party suppliers involves certain risks and uncertainties. For example, shifts in industry-wide
capacity from shortages to oversupply, or from oversupply to shortages, may result in significant fluctuations in
our quarterly and annual operating results. In addition, we may order wafers and build inventory in advance of
receiving purchase orders from our customers. Because our industry is highly cyclical and is subject to
significant downturns resulting from excess capacity, overproduction, reduced demand, order cancellations, or
technological obsolescence, there is a risk that we will forecast inaccurately and produce excess inventories of
particular products. In addition, if we experience supply constraints or manufacturing problems at a particular
supplier, we could be required to switch suppliers or qualify additional suppliers. The substantial majority of our
semiconductor wafers are manufactured at a limited number of fabrication facilities and, for a given product, the
wafers are typically sourced at a single facility. Switching and/or qualifying additional suppliers could be an
expensive process and take as long as six to twelve months to complete, which could result in material adverse
fluctuations to our operating results.

We generally order our products through non-cancelable purchase orders from third-party foundries based

on our sales forecasts, and our customers can generally cancel or reschedule orders they place with us without
significant penalties. If we do not receive orders as anticipated by our forecasts, or our customers cancel orders
that are placed, we may experience increased inventory levels.

Due to the product manufacturing cycle characteristic of IC manufacturing and the inherent imprecision in

the accuracy of our customers’ forecasts, product inventories may not always correspond to product demand,
leading to shortages or surpluses of certain products. As a result of such inventory imbalances, future inventory
write-downs and charges to gross margin may occur due to lower of cost or market accounting, excess inventory,
and inventory obsolescence.

We have historically experienced fluctuations in our operating results and expect these fluctuations to
continue in future periods.

Our quarterly and annual operating results are affected by a wide variety of factors that could materially and
adversely affect our net sales, gross margin, and operating results. If our operating results fall below expectations
of market analysts or investors, the market price of our common stock could decrease significantly. We are
subject to business cycles and it is difficult to predict the timing, length, or volatility of these cycles. These
business cycles may create pressure on our sales, gross margin, and/or operating results.

Factors that could cause fluctuations and materially and adversely affect our net sales, gross margin and/or

operating results include, but are not limited to:

▪

the volume and timing of orders received;

changes in the mix of our products sold;

▪ market acceptance of our products and the products of our customers;

▪

excess or obsolete inventory;

pricing pressures from competitors and key customers;

our ability to introduce new products on a timely basis;

▪

the timing and extent of our research and development expenses;

the failure to anticipate changing customer product requirements;

disruption in the supply of wafers, assembly, or test services;

reduction of manufacturing yields;

certain production and other risks associated with using independent manufacturers, assembly houses,
and testers; and

product obsolescence, price erosion, competitive developments, and other competitive factors.

Our stock price has been and is likely to continue to be volatile.

The market price of our common stock fluctuates significantly. This fluctuation has been or may be the

result of numerous factors, including, but not limited to:

▪

actual or anticipated fluctuations in our operating results;

announcements concerning our business or those of our competitors, customers, or suppliers;

loss of a significant customer, or customers;

changes in financial estimates by securities analysts or our failure to perform as anticipated by the
analysts;

news, commentary, and rumors emanating from the media relating to our customers, the industry, or us.
These reports may be unrelated to the actual operating performance of the Company, and in some cases,
may be potentially misleading or incorrect;

announcements regarding technological innovations or new products by us or our competitors;

announcements by us of significant acquisitions, strategic partnerships, joint ventures, or capital
commitments;

announcements by us of significant divestitures or sale of certain assets or intellectual property;

litigation arising out of a wide variety of matters, including, among others, employment matters and
intellectual property matters;

departure of key personnel;

a significant stockholder selling for any reason;

general conditions in the IC industry; and

general market conditions and interest rates.

We could be subject to changes in tax laws, the adoption of new U.S. or international tax legislation or
exposure to additional tax liabilities.

We are subject to taxes in the U.S. and numerous foreign jurisdictions, including the United Kingdom,
where a number of our subsidiaries are organized. Due to economic and political conditions, tax laws in various
jurisdictions may be subject to significant change. Our future effective tax rates could be affected by changes in
the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets
and liabilities, or changes in tax laws or their interpretation, including in the U.S. and the United Kingdom. We
are also subject to the examination of our tax returns and other tax matters by the Internal Revenue Service of the
United States (the “IRS”) and other tax authorities and governmental bodies. We regularly assess the likelihood
of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes.
There can be no assurance as to the outcome of these examinations. If our effective tax rates were to increase,
particularly in the U.S. or the United Kingdom, or if the ultimate determination of taxes owed is for an amount in
excess of amounts previously accrued, our operating results, cash flows, and financial condition could be
adversely affected.

Significant judgment is required in the calculation of our tax provision and the resulting tax liabilities. Our
estimates of future taxable income and the regional mix of this income can change as new information becomes
available. Any such changes in our estimates or assumptions can significantly impact our tax provision in a given
period.

Our foreign currency exposures may change over time as the level of activity in foreign markets grows and
could have an adverse impact upon financial results.

As a global enterprise, we face exposure to adverse movements in foreign currency exchange rates. Certain

of our assets, including certain bank accounts, exist in non-U.S. dollar-denominated currencies, which are
sensitive to foreign currency exchange rate fluctuations. The non-U.S. dollar-denominated currencies are
principally the British Pound Sterling. We also have a significant number of employees that are paid in foreign
currency, the largest group being United Kingdom-based employees who are paid in British Pounds Sterling.

If the value of the U.S. dollar weakens relative to these specific currencies, the cost of doing business in
terms of U.S. dollars rises. With the growth of our international business, our foreign currency exposures may
grow and under certain circumstances, could harm our business.

If we do not hedge against these risks, or our attempts to hedge against these risks are not successful, our

financial condition and results of operations could be adversely affected.

Our debt obligations may be a burden on our future cash flows and cash resources.

On July 12, 2016, Cirrus Logic entered into an amended and restated credit agreement (the “Credit

Agreement”) which provides for a $300 million senior secured revolving credit facility (the “Credit Facility”). As
of March 27, 2021, the Company did not have an outstanding balance under the Credit Facility. The Credit
Facility matures on July 12, 2021. To the extent the Company has an outstanding balance, our ability to repay the
principal of, to pay interest on or to refinance our indebtedness, depends on our future performance, which is
subject to economic, financial, competitive, regulatory and other factors, some of which are beyond our control.
Our business may not generate cash flow from operations in the future sufficient to satisfy our obligations or to
make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt
one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, or
refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to
refinance any indebtedness will depend on the capital markets and our financial condition at such time. We may
not be able to engage in any of these activities or engage in these activities on desirable terms, which could result
in a default on the Credit Agreement.

Our Credit Agreement contains restrictions that could limit our flexibility in operating our business.

Our Credit Agreement contains various covenants that could limit our ability to engage in specified types of

transactions under certain conditions. These covenants could limit our ability to, among other things:

▪

pay dividends on, repurchase or make distributions in respect of our capital stock or make other
restricted payments;

incur additional indebtedness or issue certain preferred shares;

▪ make certain investments;

▪

sell certain assets;

create liens;

consolidate, merge, sell or otherwise dispose of all or substantially all of our assets; and

enter into certain transactions with our affiliates.

A breach of any of these covenants could result in a default under the Credit Agreement. In the event of a

default under the Credit Agreement, the lenders could elect to declare all amounts outstanding to be immediately

due and payable. If our lenders accelerate the repayment of borrowings, we may not be able to repay our debt
obligations. If we were unable to repay amounts due to the lenders under our credit facility, those lenders could
proceed against the collateral granted to them to secure that indebtedness.

Legal and Regulatory Risks

We are subject to the export control regulations of the U.S. Department of State and the Department of
Commerce. A violation of these export control regulations could have a material adverse effect on our
business or our results of operations, cash flows, or financial position.

The nature of our international business subjects us to the export control regulations of the U.S. Department

of State and the Department of Commerce. Any changes regarding such regulations or U.S. trade policy more
generally, including potential adoption and expansion of trade restrictions, particularly with respect to China,
might impact overall customer demand for our products or affect our ability to manufacture and/or sell our
products overseas. Although we currently have a license to provide certain products and support to Huawei, it is
possible that the U.S. government may view some of our efforts as outside the scope of our license, particularly
given the complex and dynamic nature of export control regulations. Violation of these export control regulations
could result in monetary penalties and denial of export privileges. The U.S. government is very strict with respect
to compliance and has served notice generally that failure to comply with these regulations may subject violators
to fines and/or imprisonment. Although we are not aware of any material violation of any export control
regulations, a failure to comply with any of these regulations could have a material adverse effect on our
business.

Potential intellectual property claims and litigation could subject us to significant liability for damages and
could invalidate our proprietary rights.

The IC industry is characterized by frequent litigation regarding patent and other intellectual property rights.
We may find it necessary to initiate lawsuits to assert our patent or other intellectual property rights. These legal
proceedings could be expensive, take significant time, and divert management’s attention. We cannot provide
assurances that we will ultimately be successful in any lawsuit, nor can we provide assurances that any patent
owned by us will not be invalidated, circumvented, or challenged. We cannot provide assurances that rights
granted under our patents will provide competitive advantages to us, or that any of our pending or future patent
applications will be issued with the scope of the claims sought by us, if at all.

As is typical in the IC industry, our customers and we have, from time to time, received and may in the
future receive, communications from third parties asserting patents, mask work rights, or copyrights. In the event
third parties were to make a valid intellectual property claim and a license was not available on commercially
reasonable terms, our operating results could be harmed. Litigation, which could result in substantial cost to us
and diversion of our management, technical and financial resources, may also be necessary to defend us against
claimed infringement of the rights of others. An unfavorable outcome in any such litigation could have an
adverse effect on our future operations and/or liquidity.

We have provisions in our Certificate of Incorporation and Bylaws, and are subject to certain provisions of
Delaware law, which could prevent, delay or impede a change of control of our company. These provisions
could affect the market price of our stock.

Certain provisions of Delaware law and of our Certificate of Incorporation and Bylaws could make it more

difficult for a third party to acquire us, even if our stockholders support the acquisition. These provisions include,
but are not limited to:

▪

the inability of stockholders to call a special meeting of stockholders;

a prohibition on stockholder action by written consent; and

a requirement that stockholders provide advance notice of any stockholder nominations of directors or
any proposal of new business to be considered at any meeting of stockholders.

We are also subject to the anti-takeover laws of Delaware that may prevent, delay or impede a third party

from acquiring or merging with us, which may adversely affect the market price of our common stock.

Our Bylaws provide, to the fullest extent permitted by applicable law, that the Court of Chancery of the State
of Delaware or, if the Court of Chancery does not have jurisdiction, a state court located within the State of
Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal district court
for the District of Delaware, will be the exclusive forum for certain legal actions between the Company and its
stockholders, which could increase costs to bring a claim, discourage claims, or limit the ability of the
Company’s stockholders to bring a claim in a judicial forum viewed by the stockholders as more favorable for
disputes with the Company or the Company’s directors, officers, or other employees.

Our Bylaws provide, to the fullest extent permitted by law, that, unless the Company consents in writing to
the selection of an alternative forum, the Court of Chancery of the State of Delaware or, if the Court of Chancery
does not have jurisdiction, a state court located within the State of Delaware or, if no state court located within
the State of Delaware has jurisdiction, the federal district court for the District of Delaware, will, to the fullest
extent permitted by applicable law, be the sole and exclusive forum for (a) any derivative action or proceeding
brought on behalf of the Company; (b) any action asserting a claim of breach of a fiduciary duty owed by any
director, officer, or other employee of the Company to the Company or the Company’s stockholders; (c) any
action asserting a claim against the Company or any director, officer, or other employee of the Company
pursuant to any provision of the Company’s Certificate of Incorporation or Bylaws (as either may be amended
from time to time) or the Delaware General Corporation Law; and (d) any action asserting a claim against the
Company or any director, officer, or other employee of the Company governed by the internal affairs doctrine.

The forum selection provision may increase costs to bring a claim, discourage claims, or limit a

stockholder’s ability to bring a claim in a judicial forum that such stockholder finds favorable for disputes with
the Company or the Company’s directors, officers, or other employees, which may discourage such lawsuits
against the Company or the Company’s directors, officers, and other employees. Alternatively, if a court were to
find the forum selection provision contained in the Company’s Bylaws to be inapplicable or unenforceable in an
action, the Company could incur additional costs associated with resolving such action in other jurisdictions. The
exclusive forum provision in the Bylaws will not preclude or decrease the scope of exclusive federal or
concurrent jurisdiction for actions brought under the federal securities laws including the Securities Exchange
Act of 1934 or the Securities Act of 1933, or the respective rules and regulations promulgated thereunder.

General Risk Factors

Corporate social responsibility initiatives, specifically related to environmental, social and governance
(“ESG”) matters, may impose additional costs and expose us to emerging areas of risk.

Providing public disclosures regarding ESG matters, for example sustainability reporting, is becoming more

broadly expected by investors, shareholders and other third parties. Certain organizations currently, and other
organizations may in the future, use such disclosures to evaluate companies regarding ESG activities and publish
scores or ratings based upon ESG or “sustainability” metrics. Potential and current investors may use the
Company’s ESG ratings to guide their investment strategies and may decrease or withdraw investment, or
alternatively increase investment in our competitors, if our ESG performance is perceived to be lagging. The
qualitative and quantitative criteria regarding ESG may continue to evolve and we may incur additional costs to
satisfy these expectations. We may communicate certain goals or initiatives regarding our ESG activities from
time to time, and if we are unable to meet those goals or they are perceived to be inadequate, we could be
exposed to reputational damage and other emerging areas of risk.

As we carry only limited insurance coverage, uninsured or under-insured losses could adversely affect our
financial condition and results of operations.

Our insurance policies may not be adequate to fully offset losses from covered incidents, and we do not
have coverage for certain losses. For example, there is limited coverage available with respect to the services

provided by our third-party foundries and assembly and test subcontractors. Although we believe that our
existing insurance coverage is consistent with common practices of companies in our industry, our insurance
coverage may be inadequate to protect us against product recalls, natural disasters, cybersecurity and/or
information security breaches, and other unforeseen catastrophes that could adversely affect our financial
condition and results of operations.

We are subject to the risks of owning real property.

We currently own our U.S. headquarters and research facility in Austin, Texas. The ownership of our U.S.

properties subjects us to the risks of owning real property, which may include:

▪

the possibility of environmental contamination and the costs associated with correcting any
environmental problems;

adverse changes in the value of these properties, due to interest rate changes, changes in the
neighborhood in which the property is located, or other factors; and

the risk of financial loss in excess of amounts covered by insurance, or uninsured risks, such as the loss
caused by damage to the buildings as a result of fire, floods, or other natural disasters.

ITEM 1B. Unresolved Staff Comments

None.

ITEM 2. Properties

As of March 27, 2021, our principal facilities are located in Austin, Texas and Edinburgh, Scotland,
United Kingdom. The Austin facilities, which we own, consist of approximately 155,000 square feet of office
space and are primarily occupied by research and development personnel and testing equipment. In addition, our
failure analysis and reliability facility occupies approximately 27,000 square feet.

Additionally, we have various leased facilities in Austin, Texas, consisting of approximately 157,000 square

feet. This includes approximately 151,000 square feet of leased space that houses a mixture of administrative
personnel as well as research and development personnel.

In connection with a previous acquisition, we acquired a building located in Edinburgh, Scotland,
United Kingdom. This building consisted of approximately 50,000 square feet of office space. We sold the
building in the fourth quarter of fiscal year 2019 and recorded a $4.9 million gain on the sale. The gain is
presented as a separate line item in the Consolidated Statements of Income as “Gain on sale of assets”.
Additionally, we lease approximately 110,000 square feet of office space and 27,000 square feet of high quality
lab space in Edinburgh. See further details below in Results of Operation.

Below is a detailed schedule that identifies our principal locations of occupied leased and owned property as

of March 27, 2021, with various lease terms through calendar year 2028. We believe that these facilities are
suitable and adequate to meet our current operating needs.

Design Centers

Sales Support Offices – International

Austin, Texas
Mesa, Arizona
Salt Lake City, Utah
Edinburgh, Scotland, United Kingdom
Newbury, England, United Kingdom
London, England, United Kingdom

Hong Kong, China
Shanghai, China
Shenzhen, China
Tokyo, Japan
Singapore
Seoul, South Korea
Taipei, Taiwan

See Note 14 — Commitments and Contingencies of the Notes to Consolidated Financial Statements

contained in Item 8 for further detail.

ITEM 3. Legal Proceedings

From time to time, we are involved in legal proceedings concerning matters arising in connection with the

Based on current knowledge, management does not believe that there are any pending matters that could

potentially have a material adverse effect on our business, financial condition, results of operations or cash
flows. However, we are engaged in various legal actions in the normal course of business. While there can be no
assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are
beyond our control, an adverse outcome in any legal proceeding could be material to our results of operations or
cash flows for any particular reporting period.

ITEM 4. Mine Safety Disclosures

Not applicable.

PART II

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Equity Securities

Our common stock is traded on the NASDAQ’s Global Select Market under the symbol CRUS.

As of May 19, 2021, there were approximately 366 holders of record of our common stock.

The information under the caption “Equity Compensation Plan Information” in the proxy statement to be
delivered to stockholders in connection with our Annual Meeting of Stockholders to be held on July 30, 2021
(the “Proxy Statement”) is incorporated herein by reference.

Dividend Policy

We have not paid any dividends on our capital stock. We do not anticipate declaring or paying in the
foreseeable future any dividends on our capital stock. Any future determination to pay dividends will be made at
the discretion of our board of directors, subject to applicable laws, and will depend upon our results of
operations, financial condition, contractual restrictions, capital requirements, and other factors. Our future ability
to pay dividends on our capital stock may be limited by the terms of any future debt that we may incur or any
preferred securities that we may issue in the future.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table provides information about purchases of equity securities that are registered by us
pursuant to Section 12 of the Exchange Act during the three months ended March 27, 2021 (in thousands, except
per share amounts):

Monthly Period

Total Number
of Shares
Purchased

Average Price Paid
Per Share

December 27, 2020 - January 23, 2021 . . . . . .
January 24, 2021 - February 20, 2021 . . . . . . .
February 21, 2021 - March 27, 2021 . . . . . . . .

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . .

—
283
235

518

$ —
88.29
85.26

$86.92

Total Number of
Shares
Purchased as
Part of Publicly
Announced
Plans
or Programs

Approximate
Dollar Value of
Shares That
May Yet Be
Purchased
Under the Plans
or Programs (1)

—
283
235

518

$
—
380,015
360,015

$360,015

(1) The Company currently has two active share repurchase programs: the 2019 share repurchase program
with a remaining $10.0 million available for repurchase as of March 27, 2021, and the $350 million
share repurchase program authorized by the Board of Directors in January 2021. The Company
repurchased 0.5 million shares of its common stock for $45.0 million during the fourth quarter of fiscal
year 2021. All of these shares were repurchased in the open market and were funded from existing
cash. All shares of our common stock that were repurchased were retired as of March 27, 2021. The
repurchases are to be funded from existing cash and intended to be effected from time to time in
accordance with applicable securities laws through the open market or in privately negotiated
transactions. The timing of the repurchases and the actual amount purchased depend on a variety of
factors including general market and economic conditions and other corporate considerations. The
programs do not have an expiration date, do not obligate the Company to repurchase any particular
amount of common stock, and may be modified or suspended at any time at the Company’s discretion.

Stock Price Performance Graph

The following graph and table show a comparison of the five-year cumulative total stockholder return,
calculated on a dividend reinvestment basis, for Cirrus Logic, the Standard & Poor’s 500 Composite Index (the

“S&P 500 Index”), and the Semiconductor Subgroup of the Standard & Poor’s Electronics Index (the “S&P 500
Semiconductors Index”).

Comparison of 5 Year Cumulative Total Return
Assumes Initial Investment of $100
March 2021

400.00

300.00

200.00

100.00

0.00

3/26/2016

3/25/2017

3/31/2018

3/30/2019

3/28/2020

3/27/2021

Cirrus Logic, Inc.

S&P 500 Index - Total Returns

S&P 500 Semiconductors Index

Cirrus Logic, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .
S&P 500 Index . . . . . . . . . . . . . . . . . . . . . . . . . . .
S&P 500 Semiconductors Index . . . . . . . . . . . . . .

100.00
100.00
100.00

174.24
117.61
138.09

117.87
135.17
190.71

122.05
148.01
199.92

179.63
135.35
209.31

240.81
215.31
375.65

3/26/2016

3/25/2017

3/31/2018

3/30/2019

3/28/2020

3/27/2021

(1) The graph assumes that $100 was invested in our common stock and in each index at the market close
on March 26, 2016, and that all dividends were reinvested. No cash dividends were declared on our
common stock during the periods presented.

(2) Stockholder returns over the indicated period should not be considered indicative of future stockholder

returns.

The information in this Annual Report on Form 10-K appearing under the heading “Stock Price

Performance Graph” is being “furnished” pursuant to Item 201(e) of Regulation S-K under the Securities Act of
1933, as amended, and shall not be deemed to be “soliciting material” or “filed” with the Securities and
Exchange Commission or subject to Regulation 14A or 14C, other than as provided in Item 201(e) of
Regulation S-K, or to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended.

ITEM 6. Selected Financial Data

This item is no longer required as the Company has elected to early adopt the amendment to Regulation S-K

that eliminates Item 301.

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Please read the following discussion in conjunction with our audited historical consolidated financial
statements and notes thereto, which are included elsewhere in this Form 10-K. Management’s Discussion and
Analysis of Financial Condition and Results of Operations contains statements that are forward-looking. These
statements are based on current expectations and assumptions that are subject to risk, uncertainties and other
factors. Actual results could differ materially because of the factors discussed in Part I, Item 1A. “Risk Factors”
of this Form 10-K and elsewhere in this report, as well as in the documents filed by us with the SEC, specifically
the most recent reports on Forms 10-Q and 8-K, each as it may be amended from time to time.

Critical Accounting Policies

Our discussion and analysis of the Company’s financial condition and results of operations are based upon
the consolidated financial statements included in this report, which have been prepared in accordance with U.S.
generally accepted accounting principles. The preparation of these financial statements requires us to make
estimates and judgments that affect the reported amounts. We evaluate the estimates on an on-going basis. We
base these estimates on historical experience and on various other assumptions that we believe to be reasonable
under the circumstances, the results of which form the basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions and conditions.

We believe the following critical accounting policies involve significant judgments and estimates that are

used in the preparation of the consolidated financial statements:

▪ We recognize revenue upon the transfer of promised goods or services to customers, in an amount that
reflects the consideration the Company expects to be entitled in exchange for those goods or services.
See Note 2 — Summary of Significant Accounting Policies — Revenue Recognition of the Notes to
Consolidated Financial Statements contained in Item 8 for discussion on the identification of the
Company’s performance obligations and determination of transaction price, including treatment of
rebates, right of returns, warranties, price protection and stock rotation.

▪

Inventories are recorded at the lower of cost or net realizable value, with cost being determined on a
first-in, first-out basis. We write down inventories to net realizable value based on forecasted demand
while taking into account product release schedules and product life cycles. We also review and write
down inventory, as appropriate, based on the age and condition of the inventory. Actual demand and
market conditions may be different from those projected by management, which could have a material
effect on our operating results and financial position. See Note 2 — Summary of Significant
Accounting Policies of the Notes to Consolidated Financial Statements contained in Item 8.

▪ We evaluate the recoverability of property, plant, and equipment and intangible assets by testing for

impairment losses on long-lived assets used in operations when indicators of impairment are present and
the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying
amounts. An impairment loss is recognized in the event the carrying value of these assets exceeds the
fair value of the applicable assets. Impairment evaluations involve management estimates of asset useful
lives and future cash flows. Actual useful lives and cash flows could be different from those estimated
by management, which could have a material effect on our operating results and financial position. See
Note 2 — Summary of Significant Accounting Policies and Note 7 — Intangibles, net and Goodwill of
the Notes to Consolidated Financial Statements contained in Item 8. See also Note 11 — Restructuring
Costs for discussion of fiscal year 2021 and 2020 asset disposals related to the microelectromechanical
systems (“MEMS”) restructuring.

▪ We evaluate goodwill and other intangible assets for impairment. The Company tests goodwill and other

intangible assets for impairment on an annual basis or more frequently if the Company believes

indicators of impairment exist. Impairment evaluations involve management’s assessment of qualitative
factors to determine whether it is more likely than not that goodwill and other intangible assets are
impaired. If management concludes from its assessment of qualitative factors that it is more likely than
not that impairment exists, then a quantitative impairment test will be performed involving management
estimates of asset useful lives and future cash flows. Significant management judgment is required in the
forecasts of future operating results that are used in these evaluations. Following the quantitative test, an
impairment charge would be recorded for the amount the carrying value exceeds the calculated fair
value. If our actual results, or the plans and estimates used in future impairment analyses, are lower than
the original estimates used to assess the recoverability of these assets, we could incur additional
impairment charges in a future period. The Company has recorded no goodwill impairments in fiscal
years 2021, 2020, and 2019. There were no material other intangible asset impairments in fiscal years
2021, 2020, and 2019.

▪ We are subject to the possibility of loss contingencies for various legal matters. See Note 15 — Legal
Matters of the Notes to Consolidated Financial Statements contained in Item 8. We regularly evaluate
current information available to us to determine whether any accruals should be made based on the
status of the case, the results of the discovery process and other factors. If we ultimately determine that
an accrual should be made for a legal matter, this accrual could have a material effect on our operating
results and financial position and the ultimate outcome may be materially different than our estimate.

▪ We report income taxes under the asset and liability method. Deferred tax assets and liabilities are

recognized for the expected tax consequences of temporary differences between the financial reporting
basis and tax basis of assets and liabilities, which are measured using the enacted tax laws and tax rates
that will be in effect when the differences are expected to reverse. We assess the likelihood that the
deferred tax assets will be realized. A valuation allowance is established against deferred tax assets to
the extent the Company believes that it is more likely than not that the deferred tax assets will not be
realized, taking into consideration the level of historical taxable income and projections for future
taxable income over the periods in which the temporary differences are deductible.

Although we believe our assumptions, judgments and estimates are reasonable, the provision for income
taxes in our consolidated financial statements could be significantly impacted by changes in tax laws,
interpretations of tax laws, and the resolution of any tax audits. The calculation of our tax liabilities
involves assessing uncertainties with respect to the application of complex tax rules. Uncertain tax
positions must meet a more likely than not threshold to be recognized in the financial statements and the
tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood
of being realized upon final settlement. The ultimate settlement of uncertain tax positions may differ
from our estimates, which could result in the recognition of a tax benefit or an additional charge to the
income tax provision in the relevant period. See Note 18 — Income Taxes of the Notes to Consolidated
Financial Statements contained in Item 8 for additional details.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326):

Measurement of Credit Losses on Financial Instruments. This ASU requires credit losses on available-for-sale
debt securities to be presented as an allowance rather than a write-down. Unlike current U.S. GAAP, the credit
losses could be reversed with changes in estimates, and recognized in current year earnings. This ASU is
effective for annual periods beginning after December 15, 2019, and interim periods within those annual
periods. The Company adopted this ASU in the first quarter of fiscal year 2021, with no material impact to the
financial statements.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles — Goodwill and Other (Topic 350):
Simplifying the Test for Goodwill Impairment. This ASU eliminates step two of the goodwill impairment test. An
impairment charge is to be recognized for the amount by which the recorded book value exceeds the fair value.
This ASU is effective for annual periods beginning after December 15, 2019, including interim periods. The
Company adopted this ASU in the first quarter of fiscal year 2021, with no material impact to the financial
statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure
Framework-Changes to the Disclosure Requirements for Fair Value Measurement. This ASU adjusts current
required disclosures related to fair value measurements. This ASU is effective for fiscal years beginning after
December 15, 2019, including interim periods within that fiscal year. The Company adopted this ASU in the first
quarter of fiscal year 2021, with no material impact to the financial statements.

In August 2018, the FASB issued ASU No. 2018-15, Intangibles — Goodwill and Other — Internal-Use
Software (Subtopic 350-40), Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing
Arrangement That Is a Service Contract. This ASU provides guidance on the accounting for implementation
costs related to a cloud computing arrangement that is a service contract. This ASU is effective for fiscal years
beginning after December 15, 2019, including interim periods within that fiscal year. The Company adopted this
ASU in the first quarter of fiscal year 2021, with prospective application and no material impact to the financial
statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the
Accounting for Income Taxes. The ASU removes certain exceptions to the general principles in Topic 740 and
also clarifies and amends existing guidance to improve consistent application. This ASU is effective for fiscal
years beginning after December 15, 2020, including interim periods within that fiscal year. The Company is
currently evaluating the impact of this ASU, but does not expect a material impact to the financial statements
upon adoption in the first quarter of fiscal year 2022.

In January 2020, the FASB issued ASU No. 2020-01, Investments — Equity Securities (Topic 321) —
Investments — Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) —
Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the FASB Emerging
Issues Task Force). This ASU clarifies the interaction of the accounting for equity securities, investments
accounted for under the equity method of accounting, and the accounting for certain forward contracts and
purchased options. This ASU is effective for fiscal years beginning after December 15, 2020, including interim
periods within that fiscal year. The Company is currently evaluating the impact of this ASU, but does not expect
a material impact to the financial statements upon adoption in the first quarter of fiscal year 2022.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the
Effects of Reference Rate Reform on Financial Reporting. The ASU, effective immediately for reporting periods
through December 31, 2022, provides accounting relief for contract modifications that replace an interest rate
impacted by reference rate reform (e.g., LIBOR) with a new alternative reference rate. The guidance is applicable
to investment securities, receivables, debt, leases, hedging relationships and other contractual arrangements. The
Company adopted this ASU in the first quarter of fiscal year 2021, with no material impact to the financial
statements.

Overview

Cirrus Logic develops low-power, high-precision mixed-signal processing solutions for a broad range of
customers. We track operating results in one reportable segment, but report revenue performance by product line,
currently audio and high-performance mixed-signal products. See Item 1. Business for discussion of our change
to product line classifications in the current fiscal year. In fiscal year 2021, the Company made excellent progress
executing on the growth vectors and strategic initiatives that we believe will contribute to our continued success.
In the past year, we expanded our position in audio in Android smartphones, gained traction in applications
beyond smartphones and further diversified our product portfolio with the introduction of our first camera
controller. Design activity and development were robust across our product lines and we made substantial R&D
investment in critical technologies and intellectual property that are important to our roadmap.

Fiscal Year 2021

Fiscal year 2021 net sales of $1.37 billion represented an increase over fiscal year 2020 net sales of
$1.28 billion. High-performance mixed-signal product line sales of $265.2 million represented a 54.9 percent
increase from fiscal year 2020 sales of $171.2 million, primarily attributable to content gains in smartphones.
Audio product line sales of $1.10 billion in fiscal year 2021 decreased from fiscal year 2020 sales of

$1.11 billion, attributable to headwinds in wired headset codecs and decreased smart codec sales in Android. The
decrease was partially offset by higher unit volumes in smartphones as well as content gains in smartphones,
tablets and wearables.

Overall, gross margin for fiscal year 2021 was 51.7 percent. The decrease in gross margin for fiscal year
2021 was primarily due to a shift in product mix and typical pricing reductions on certain products, partially
offset by cost reductions associated with exiting the MEMS product line. The Company’s number of employees
increased to 1,481 as of March 27, 2021. The Company achieved net income of $217.3 million in fiscal year
2021, which included an income tax provision in the amount of $27.9 million.

Fiscal Year 2020

Fiscal year 2020 net sales of $1.28 billion represented an increase over fiscal year 2019 net sales of
$1.19 billion. Audio product line sales of $1.11 billion in fiscal year 2020 increased from fiscal year 2019 sales
of $1.04 billion, attributable to strong demand for components shipping in smartphones. High-performance
mixed signal product line sales of $171.2 million represented a 18.3% increase from fiscal year 2019 sales of
$144.7 million attributable to increased content and sales of haptic drivers.

Overall, gross margin for fiscal year 2020 was 52.6 percent. The increase in gross margin for fiscal year
2020 was primarily due to favorable product mix and cost reductions on certain products, and, to a lesser extent,
the benefit of lower reserves and supply chain efficiencies versus fiscal year 2019. The Company’s number of
employees decreased to 1,443 as of March 28, 2020. The Company achieved net income of $159.5 million in
fiscal year 2020, which included an income tax provision in the amount of $21.8 million.

Results of Operations

The following table summarizes the results of our operations for each of the past three fiscal years as a

percentage of net sales. All percentage amounts were calculated using the underlying data, in thousands:

Fiscal Years Ended
March 28,
2020

March 27,
2021

March 30,
2019

Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross margin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.K. pension settlement
Other expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Income before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

100%
52%
25%
10%
—%
—%

17%

1%
—%
—%
—%

18%
2%

16%

100%
53%
27%
10%
2%
—%

14%

—%
—%
—%
—%

14%
2%

12%

100%
50%
32%
11%
—%
(1)%

1%
—%
(1)%
—%

8%
—%

Net Sales

We report sales in two product categories: audio products and high-performance mixed-signal products. Our

sales by product line are shown in the table below (in thousands). Prior periods were retrospectively adjusted to
conform to the fiscal year 2021 product line categories. See Note 9 — Revenues for disclosure of revenue

associated with modified product line categories and revenue as previously reported under the previous product
line groupings.

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

Audio Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
High-Performance Mixed-Signal Products . . . . . . . . . . . . . . . . . . . . . . . .

$1,104,060
265,170

$1,109,958
171,166

$1,040,866
144,658

$1,369,230

$1,281,124

$1,185,524

Net sales for fiscal year 2021 increased by 6.9 percent, to $1.37 billion from $1.28 billion in fiscal year
2020. The increase in net sales reflects a $94.0 million increase in high-performance mixed-signal product sales,
or 54.9 percent, from fiscal year 2020 sales of $171.2 million, which was primarily attributable to content gains
in smartphones. This increase was offset by a $5.9 million decrease in audio product sales. The audio product
line experienced a decrease in net sales attributable to headwinds in wired headset codecs and decreased smart
codec sales in Android. The decrease was partially offset by higher unit volumes in smartphones as well as
content gains in smartphones, tablets and wearables.

Net sales for fiscal year 2020 increased by 8.1%, to $1.28 billion from $1.19 billion in fiscal year 2019. The
increase in net sales reflects a $69.1 million increase in audio product sales and a $26.5 million increase in high-
performance mixed-signal product sales. The audio product line experienced an increase in net sales attributable
to content gains, primarily in smartphones and, to a lesser extent, higher unit volumes. In Android, increased
sales of boosted amplifiers were offset somewhat by a reduction in smart codec revenue. High-performance
mixed-signal product line sales of $171.2 million represented an 18.3% increase from fiscal year 2019 sales of
$144.7 million, which was primarily attributable to increased content and sales of haptic drivers.

International sales, including sales to U.S.-based end customers that manufacture products through contract

manufacturers or plants located overseas, were approximately $1.3 billion in fiscal years 2021 and 2020 and
$1.2 billion in fiscal year 2019, representing 98 percent of net sales in fiscal years 2021 and 2019, and 99 percent
in fiscal year 2020. Our sales are denominated primarily in U.S. dollars.

Gross Margin

Overall gross margin of 51.7 percent for fiscal year 2021 reflects a decrease from fiscal year 2020 gross
margin of 52.6 percent. The decrease was primarily attributable to a shift in product mix and typical pricing
reductions on certain products. This was partially offset by cost reductions associated with exiting the MEMS
product line. Changes in excess and obsolete inventory charges, including scrapped inventory, and sales of
product written down in prior periods did not have a material impact on margin in fiscal year 2021.

Overall gross margin of 52.6 percent for fiscal year 2020 reflects an increase from fiscal year 2019 gross

margin of 50.4 percent. The increase was primarily attributable to favorable product mix and cost reductions on
certain products, and, to a lesser extent, the benefit of lower reserves and supply chain efficiencies versus fiscal
year 2019. Changes in excess and obsolete inventory charges, including scrapped inventory, and sales of product
written down in prior periods did not have a material impact on margin in fiscal year 2020.

Research and Development Expenses

Fiscal year 2021 research and development expenses of $342.8 million reflect a decrease of $4.9 million, or

1 percent, from fiscal year 2020. The overall decrease was attributable to reduced amortization of acquisition
intangibles, travel and employee events expenses, depreciation and amortization costs on non-acquisition-related
intangibles, and product development costs after exiting the MEMS product line, offset by increases in
employee-related expenses, primarily salaries, variable compensation and stock-based compensation.

Fiscal year 2020 research and development expenses of $347.6 million reflect a decrease of $27.5 million,

or 7 percent, from fiscal year 2019. The decrease was attributable to reduced amortization of intangibles and
increased R&D incentives, offset by increases in employee-related expenses, primarily variable compensation
and stock-based compensation.

Selling, General and Administrative Expenses

Fiscal year 2021 selling, general and administrative expenses of $127.0 million reflect a decrease of
$4.1 million, or 3 percent, compared to fiscal year 2020. The decrease was primarily attributable to reduced
travel and employee events expenses in fiscal year 2021.

Fiscal year 2020 selling, general and administrative expenses of $131.1 million reflect an increase of
$4.6 million, or 4 percent, compared to fiscal year 2019. The primary drivers were employee-related expenses,
primarily variable compensation, in fiscal year 2020.

Restructuring Costs

During the fourth quarter of fiscal year 2020, the Company approved a restructuring plan (the “MEMS
Restructuring”), including discontinuing efforts relating to the MEMS microphone product line. The Company
recorded charges of approximately $0.4 million in the first quarter of fiscal year 2021 and $21.9 million in fiscal
year 2020, as part of the MEMS Restructuring, which included equipment disposal costs, asset impairment and
write-off of intangible assets, and other nonrecurring costs. No additional restructuring charges were incurred for
the remainder of fiscal year 2021. See Note 11 — Restructuring Costs for additional details.

Gain on Sale of Assets

In the fourth quarter of fiscal year 2019, the Company sold the previously-acquired Edinburgh, Scotland

property, for a gain of $4.9 million, presented as “Gain on sale of assets” in the Consolidated Statements of
Income. See Item 2. Properties for additional information.

Interest Income

Interest income in fiscal years 2021, 2020, and 2019, was $6.3 million, $10.5 million, and $8.0 million,
respectively. The fluctuations in interest income in fiscal year 2021 and 2020 versus prior years were a function
of earnings on average cash, cash equivalent, and marketable securities balances throughout the year.

Interest Expense

The Company reported interest expense of $1.1 million, $1.1 million and $1.1 million for fiscal years 2021,

2020, and 2019, respectively, primarily as a result of the revolving credit facility, described in Note 8.

U.K. Pension Settlement

The Company settled its defined benefit pension scheme in the third quarter of fiscal year 2019. A

settlement loss of $13.8 million was recognized, which was the amount of the previously recorded unamortized
actuarial pension loss in Accumulated Other Comprehensive Income (“AOCI”). The loss is presented as a
separate line item in the Consolidated Statements of Income under the caption “U.K. pension settlement”. The
Company has no further contribution obligations going forward.

Other Income (Expense)

In fiscal years 2021, 2020, and 2019 the Company reported $2.8 million, $(1.6) million, and $(0.2) million

respectively, in other income (expense), primarily related to remeasurement on foreign currency denominated
monetary assets and liabilities.

Provision for Income Taxes

We recorded income tax expense of $27.9 million in fiscal year 2021 on a pre-tax income of $245.2 million,

yielding an effective tax rate of 11.4 percent. Our effective tax rate was lower than the U.S. statutory rate of
21.0 percent, primarily due to the effect of income earned in certain foreign jurisdictions that is taxed below the
federal statutory rate, the release of prior year unrecognized tax benefits during fiscal year 2021, and excess tax
benefits from stock-based compensation.

We recorded income tax expense of $21.8 million in fiscal year 2020 on a pre-tax income of $181.3 million,

yielding an effective tax rate of 12.0 percent. Our effective tax rate was lower than the U.S. statutory rate of
21.0 percent, primarily due to the effect of income earned in certain foreign jurisdictions that is taxed below the
federal statutory rate, excess tax benefits from stock-based compensation, and the release of prior year
unrecognized tax benefits during fiscal year 2020.

We recorded income tax expense of $3.8 million in fiscal year 2019 on pre-tax income of $93.7 million,
yielding an effective tax provision rate of 4.0 percent. Our effective tax rate was lower than the U.S. statutory
rate of 21.0 percent, primarily due to a decrease in the provisional enactment-date effects of the legislation
commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”), as well as the U.S. federal research and
development tax credit and the effect of income earned in certain foreign jurisdictions that is taxed below the
federal statutory rate. This overall decrease was partially offset by an increase in valuation allowance related to
certain U.S. federal deferred tax assets and state tax attributes due to the likelihood that they will expire or go
unutilized.

For additional discussion about our income taxes, see Note 18 — Income Taxes.

Outlook

Given the wide array of uncertainties surrounding the implications of the COVID-19 pandemic, industry-
wide supply constraints and the timing of when these challenges will be alleviated, it is difficult to predict our
revenue, gross margin and operating expense outlook for fiscal year 2022. Cirrus Logic made meaningful
progress in fiscal year 2021 however, with numerous strategic initiatives that we believe position the Company
for growth in the coming years. In fiscal year 2022, we expect gross margins to be impacted by capacity
constraints driving an increase in third-party manufacturing costs. Additionally, with strong customer
engagements and content gains in new products coming to market, we expect revenue growth to accelerate.

Liquidity and Capital Resources

In fiscal year 2021, cash flow from operations was $348.9 million. Operating cash flow during fiscal year

2021 was related to the cash components of our net income and a $33.2 million favorable change in working
capital. The favorable change in working capital was driven primarily by a decrease in accounts receivable and
increase in accounts payable, partially offset by an increase in inventories. In fiscal year 2020, cash flow from
operations was $295.8 million. Operating cash flow during fiscal year 2020 was related to the cash components
of our net income, offset by a $2.8 million unfavorable change in working capital. The unfavorable change in
working capital was driven primarily by an increase in accounts receivable, partially offset by an increase in
payables. In fiscal year 2019, cash flow from operations was $206.7 million. Operating cash flow during fiscal
year 2019 was related to the cash components of our net income, offset by a $23.4 million unfavorable change in
working capital. The unfavorable change in working capital was driven primarily by a decrease in payables and
an increase in accounts receivable, partially offset by a decrease in inventories during the period.

In fiscal year 2021, the Company used $77.7 million in cash for investing activities primarily related to
$57.2 million in net purchases of marketable securities, and capital expenditures and technology investments of
$20.5 million. In fiscal year 2020, the Company used approximately $100.2 million in cash for investing
activities principally related to $78.6 million in net purchases of marketable securities, and capital expenditures
and technology investments of $21.6 million. In fiscal year 2019, the Company used approximately $54.7 million
in cash for investing activities primarily related to $28.0 million in net purchases of marketable securities, and
capital expenditures and technology investments of $35.8 million.

In fiscal year 2021, the Company used $121.2 million related to financing activities. In fiscal year 2020, the

Company used $119.6 million in financing activities. In fiscal year 2019, the Company used $171.5 million in
financing activities. In fiscal years 2021, 2020, and 2019, the Company utilized approximately $110.0 million,
$120.0 million, and $160.0 million, respectively, in cash to repurchase and retire portions of its outstanding
common stock. See Note 16 for a description of our share repurchase programs.

Our future capital requirements will depend on many factors, including the rate of sales growth, market
acceptance of our products, the timing and extent of research and development projects, potential acquisitions of

companies or technologies and the expansion of our sales and marketing activities. We believe our expected
future cash earnings, existing cash, cash equivalents, investment balances, and available borrowings under our
Credit Facility will be sufficient to meet our capital requirements both domestically and internationally, through
at least the next 12 months, although we could be required, or could elect, to seek additional funding prior to that
time.

Revolving Credit Facility

On July 12, 2016, Cirrus Logic entered into an amended and restated credit agreement (the “Credit
Agreement”) with Wells Fargo Bank, National Association, as Administrative Agent, and the Lenders party
thereto, for the purpose of refinancing an existing credit facility and providing ongoing working capital. The
Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Credit Facility”). The
Credit Facility matures on July 12, 2021. Cirrus Logic must repay the outstanding principal amount of all
borrowings, together with all accrued but unpaid interest thereon, on the maturity date. The Credit Facility is
required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the “Subsidiary Guarantors”).
The Credit Facility is secured by substantially all of the assets of Cirrus Logic and any Subsidiary Guarantors,
except for certain excluded assets.

Borrowings under the Credit Facility may, at our election, bear interest at either (a) a base rate plus the
applicable margin (“Base Rate Loans”) or (b) a LIBOR rate plus the applicable margin (“LIBOR Rate Loans”).
The applicable margin ranges from 0% to 0.50% per annum for Base Rate Loans and 1.25% to 2.00% per annum
for LIBOR Rate Loans based on the Leverage Ratio (as defined below). A commitment fee accrues at a rate per
annum ranging from 0.20% to 0.30% (based on the Leverage Ratio) on the average daily unused portion of the
commitment of the lenders. The Credit Agreement contains certain financial covenants providing that (a) the
ratio of consolidated funded indebtedness to consolidated EBITDA for the prior four fiscal quarters must not be
greater than 3.00 to 1.00 (the “Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four
consecutive fiscal quarters to consolidated fixed charges (including amounts paid in cash for consolidated interest
expenses, capital expenditures, scheduled principal payments of indebtedness, and income taxes) for the prior
four consecutive fiscal quarters must not be less than 1.25 to 1.00 as of the end of each fiscal quarter. The Credit
Agreement also contains negative covenants limiting the Company’s or any Subsidiary’s ability to, among other
things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset
dispositions, and make certain restricted payments.

As of March 27, 2021, the Company had no amounts outstanding under the Credit Facility and was in

compliance with all covenants under the Credit Agreement.

See also Note 8 — Revolving Credit Facility.

Off Balance Sheet Arrangements

As of March 27, 2021, the Company did not have any off-balance-sheet arrangements, as defined in
Item 303(a)(4)(ii) of SEC Regulation S-K, that were reasonably likely to have a material effect on our financial
condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Contractual Obligations

In our business activities, we incur certain commitments to make future payments under contracts such as

debt agreements, purchase orders, operating leases and other long-term contracts. Maturities under these
contracts are set forth in the following table as of March 27, 2021:

Payment due by period (in thousands)

< 1 year

1-3 years 3-5 years

> 5 years

Total

Facilities leases, net . . . . . . . . . . . . . . . . . . . . . . . . . . $ 13,747 $28,265 $25,386 $139,915 $207,313
— 220,170
Wafer purchase commitments . . . . . . . . . . . . . . . . . .
4,009
—
Assembly purchase commitments . . . . . . . . . . . . . . .
—
Outside test purchase commitments . . . . . . . . . . . . . .
8,137
— 70,121
Other purchase commitments . . . . . . . . . . . . . . . . . . .
323
—
Interest on revolving line of credit (1) . . . . . . . . . . . .

220,170
4,009
8,137
34,025
323

—
—
—
36,096
—

—
—
—
—
—

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $280,411 $64,361 $25,386 $139,915 $510,073

(1) Our debt is subject to a variable interest rate based on LIBOR. The interest included in the table above

is based on forecasted commitment fees.

Certain of our operating lease obligations include escalation clauses. These escalating payment requirements

are reflected in the table.

We are unable to make a reasonably reliable estimate as to when or if a cash settlement with taxing

authorities will occur related to our unrecognized tax benefits. Therefore, our liability of $32.9 million for
unrecognized tax benefits is not included in the table above. See Note 18 — Income Taxes, to the Consolidated
Financial Statements for additional information.

ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks associated with interest rates on drawn balances of our Revolving Credit

Facility and marketable securities, and to currency movements on non-functional currency assets and liabilities.
We assess these risks on a regular basis and have established policies that are designed to protect against the
adverse effects of these and other potential exposures. All of the potential changes noted below are based on
sensitivity analyses as of March 27, 2021. Actual results may differ materially.

Interest Rate Risk

Our primary financial instruments include cash equivalents, marketable securities, accounts receivable,
accounts payable, and accrued liabilities. The Company’s investments are managed by outside professional
managers within investment guidelines set by the Company. These guidelines include security type, credit
quality, and maturity, and are intended to limit market risk by restricting the Company’s investments to high
quality debt instruments with relatively short-term maturities. The Company does not currently use derivative
financial instruments in its investment portfolio. Due to the short-term nature of our investment portfolio and the
current low interest rate environment, our downside exposure to interest rate risk is minimal.

To provide a meaningful assessment of the interest rate risk associated with our investment portfolio, the
Company performed a sensitivity analysis to determine the impact a change in interest rates would have on the
value of the investment portfolio assuming a 100 basis point parallel shift in the yield curve. Based on investment
positions as of March 27, 2021 and March 28, 2020, a hypothetical 100 basis point increase in interest rates
across all maturities would result in a $6.2 million and $5.3 million decline in the fair market value of the
portfolio, respectively. Such losses would only be realized if the Company sold the investments prior to maturity.

Foreign Currency Exchange Risk

Our revenue and spending is transacted primarily in U.S. dollars; however, in fiscal years 2021, 2020, and

2019, we entered into routine transactions in other currencies to fund the operating needs of certain legal entities

outside of the U.S. Our balance sheet also reflects monetary assets and liabilities in certain entities which are
remeasured to each entity’s functional currency. Beginning in the first quarter of fiscal year 2020, we began
using forward contracts to manage exposure to foreign currency exchange risk attributable to certain
non-functional currency balance sheet exposures. Gains and losses from these foreign currency forward contracts
are recognized currently in earnings along with the gains and losses resulting from remeasuring the underlying
exposures. Because most of the aggregate balance sheet exposure is hedged by forward currency exchange
contracts, at the end of any fiscal period a hypothetical 10% plus or minus fluctuation in exchange rates relative
to the U.S. dollar would result in an immaterial pretax currency exchange gain or loss. See Note 5 — Derivative
Financial Instruments for additional information related to our hedging activities.

ITEM 8. Financial Statements and Supplementary Data

Index to Consolidated Financial Statements

Reports of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Balance Sheets as of March 27, 2021 and March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Income for the Fiscal Years Ended March 27, 2021, March 28, 2020, and

41
44

March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Consolidated Statements of Comprehensive Income for the Fiscal Years Ended March 27, 2021, March 28,

2020, and March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Consolidated Statements of Cash Flows for the Fiscal Years Ended March 27, 2021, March 28, 2020, and

March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Consolidated Statements of Stockholders’ Equity for the Fiscal Years Ended March 27, 2021, March 28,

2020, and March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

48
49

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Cirrus Logic, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Cirrus Logic, Inc. (the Company) as of
March 27, 2021 and March 28, 2020, the related consolidated statements of income, comprehensive income,
stockholders’ equity, and cash flows for each of the three fiscal years in the period ended March 27, 2021, and
the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at
March 27, 2021 and March 28, 2020, and the results of its operations and its cash flows for each of the three
fiscal years in the period ended March 27, 2021, in conformity with U.S. generally accepted accounting
principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the Company’s internal control over financial reporting as of March 27, 2021, based
on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (2013 framework) and our report dated May 21, 2021 expressed an
unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express
an opinion on the Company’s financial statements based on our audits. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with
the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial statements are free of material
misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the financial statements. Our audits also included evaluating the accounting principles used and
significant estimates made by management, as well as evaluating the overall presentation of the financial
statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial
statements that were communicated or required to be communicated to the audit committee and that: (1) relate to
accounts or disclosures that are material to the financial statements and (2) involved our especially challenging,
subjective or complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical
audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to
which they relate.

Description of
the Matter

How We
Addressed the
Matter in Our
Audit

Description of
the Matter

How We
Addressed the
Matter in Our
Audit

Inventory valuation
At March 27, 2021, the Company’s net inventory balance was $173.3 million. As discussed in
Note 2 of the financial statements, inventories are stated at the lower of cost or net realizable value,
which includes considerations for inventory becoming obsolete or in excess of management’s
forecasted customer unit demand. The Company writes down inventories to net realizable value
based on forecasted customer unit demand while taking into account product release schedules and
product life cycles. The Company also writes down inventory, as appropriate, based on the age and
condition of the inventory.
Auditing management’s estimate of excess and obsolete inventory involved subjective auditor
judgment because management’s determination of whether a write down is warranted is
judgmental and the estimate is sensitive to changes in assumptions, including management’s
assumptions over forecasted demand which may be impacted by, among other things, future market
and economic conditions outside of the Company’s control.

We obtained an understanding, evaluated the design and tested the operating effectiveness of controls
that address the risks of material misstatement relating to the valuation of inventory. For example, we
tested controls over management’s review of forecasted demand, the significant assumptions, and the
data underlying the excess and obsolete inventory valuation estimate.
Among other audit procedures performed, we evaluated the significant assumptions discussed
above, including the forecasted customer unit demand utilized in the estimate, and tested the
completeness and accuracy of the underlying data used in management’s calculation. We evaluated
adjustments to forecasted demand for specific product considerations, assessed the historical
accuracy of management’s estimates by performing a retrospective analysis comparing prior period
forecasted demand to actual historical sales and inspected historical gross margins to assess
whether any items were being sold at a loss.

Uncertain tax positions
As described in Note 18 to the consolidated financial statements, the Company has recorded
accrued liabilities relating to unrecognized tax benefits resulting from uncertain tax positions of
$32.9 million as of March 27, 2021. The Company and its subsidiaries are subject to U.S. federal
income tax as well as income tax in multiple state and foreign jurisdictions. Furthermore, the
Company’s fiscal years 2017 to 2021 remain open to examination by the major taxing jurisdictions.
Auditing management’s analysis of the uncertainties in its tax positions was complex and
judgmental because the Company’s evaluation and measurement of each tax position involves
assessing uncertainties with respect to the application of complex tax rules, which are subject to
interpretation. The Company uses significant judgment in determining whether a tax position is
more likely than not to be sustained and measuring the amount of tax benefit that qualifies for
recognition.

We obtained an understanding, evaluated the design and tested the operating effectiveness of controls
that address the risks of material misstatement relating to the existence of uncertain tax positions and
measurement of the benefit of those positions. For example, we tested controls over management’s
review of the technical merits of tax positions, the events and information that impacted tax positions,
the estimate of the most likely outcome, and the data utilized in the estimate.
To test the valuation of uncertain tax positions, our audit procedures included, among others,
analyzing the Company’s assumptions and data used to determine the amount of tax benefit to
recognize and testing the accuracy of the calculations. In considering the measurement criteria, we
involved our tax professionals to assess the technical merits of the Company’s tax positions. This
included assessing the Company’s correspondence with the relevant tax authorities and evaluating
income tax opinions or other third-party advice obtained by the Company. We also used our
knowledge of, and experience with, the application of international and local income tax laws by
the relevant income tax authorities to evaluate the Company’s accounting for those tax positions.
We also evaluated the Company’s income tax disclosures included in Note 18 to the consolidated
financial statements in relation to these matters.

/s/ Ernst & Young LLP

We have served as the Company’s auditor since 1984.

Austin, Texas
May 21, 2021

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Cirrus Logic, Inc.

Opinion on Internal Control over Financial Reporting

We have audited Cirrus Logic, Inc.’s internal control over financial reporting as of March 27, 2021, based on
criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Cirrus Logic,
Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of
March 27, 2021, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the consolidated balance sheets of the Company as of March 27, 2021 and March 28,
2020, and related consolidated statements of income, comprehensive income, stockholders’ equity and cash
flows for each of the three fiscal years in the period ended March 27, 2021, and the related notes and our report
dated May 21, 2021 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and
for its assessment of the effectiveness of internal control over financial reporting included in the accompanying
Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an
opinion on the Company’s internal control over financial reporting based on our audit. We are a public
accounting firm registered with the PCAOB and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and
Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether effective internal control over financial
reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that
a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based
on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We
believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. A company’s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the
company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.

/s/ Ernst & Young LLP

Austin, Texas
May 21, 2021

CIRRUS LOGIC, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)

March 27,
2021

March 28,
2020

Current assets:

Assets

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Marketable securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 442,164
55,697
108,712
173,263
37,576
25,107

$ 292,119
22,008
153,998
146,725
23,594
11,752

Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term marketable securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Right-of-use lease assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property and equipment, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Intangibles, net
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill
Deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

842,519
312,759
133,548
154,942
22,031
287,518
9,977
67,320

650,196
283,573
141,274
158,244
34,430
287,088
10,052
27,820

Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,830,614

$1,592,677

Current liabilities:

Liabilities and Stockholders’ Equity

Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued salaries and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Software license agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 102,744
54,849
28,006
14,573
13,438

78,412
42,439
10,888
13,580
13,318

Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

213,610

158,637

Long-term liabilities:

Software license agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-current income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-current lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Stockholders’ equity:

Preferred stock, 5.0 million shares authorized but unissued . . . . . . . . . . . . . . . . . . . .
Common stock, $0.001 par value, 280,000 shares authorized, 57,652 shares and
58,242 shares issued and outstanding at March 27, 2021 and March 28, 2020,
respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . .

Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)

36,096
64,020
127,883

227,999

3,806
71,143
129,312

204,261

—

58
1,498,761
(112,689)
2,875

58
1,434,871
(201,681)
(3,469)

Total stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,389,005

1,229,779

Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,830,614

$1,592,677

The accompanying notes are an integral part of these financial statements.

CIRRUS LOGIC, INC.
CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,369,230
661,929

$1,281,124
606,957

$1,185,524
588,027

Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

707,301

674,167

597,497

Operating expenses

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development
Selling, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Restructuring costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain on sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

342,759
127,008
352
—

347,647
131,115
21,925
—

375,139
126,502
—
(4,913)

Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

470,119

500,687

496,728

Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
U.K. pension settlement
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other income (expense)

Income before income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

237,182
6,281
(1,057)
—
2,840

245,246
27,902

173,480
10,458
(1,057)
—
(1,615)

181,266
21,768

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

217,344

159,498

Basic earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Basic weighted average common shares outstanding . . . . . . . . . . . . . . . .
Diluted weighted average common shares outstanding . . . . . . . . . . . . . .

$
$

3.74
3.62
58,106
60,060

$
$

2.74
2.64
58,317
60,462

100,769
8,017
(1,057)
(13,768)
(217)

93,744
3,753

89,991

1.50
1.46
60,116
61,583

The accompanying notes are an integral part of these financial statements.

CIRRUS LOGIC, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)

Fiscal Years Ended
March 28,
2020

March 27,
2021

March 30,
2019

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$217,344

$159,498

$ 89,991

Other comprehensive income (loss), before tax

Foreign currency translation gain (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Unrealized gain (loss) on marketable securities . . . . . . . . . . . . . . . . . . . . . . .
U.K. pension settlement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cumulative effect of adoption of ASU 2018-02 . . . . . . . . . . . . . . . . . . . . . .

1,862
5,673
—
—

68
(2,803)
—
(257)

(3,125)
2,823
13,814
—

Benefit (provision) for income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(1,191)

589

(3,217)

Comprehensive income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$223,688

$157,095

$100,286

The accompanying notes are an integral part of these financial statements.

CIRRUS LOGIC, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

Fiscal Years Ended
March 28,
2020

March 27,
2021

March 30,
2019

Cash flows from operating activities:

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to net cash provided by operating activities:

$ 217,344

$ 159,498

$ 89,991

Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(Gain) loss on retirement or write-off of long-lived assets . . . . . . . . . . . . . . . . . . . .
Charges for defined benefit pension plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other non-cash (gains) / charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MEMS restructuring charges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net change in operating assets and liabilities:

Accounts receivable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued salaries and benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other accrued liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

47,083
56,762
(5,581)
371
—
(622)
352

45,286
(26,538)
843
21,104
12,410
(18,185)
(1,684)

68,237
53,757
(5,888)
379
—
697
21,925

(33,082)
17,765
1,379
27,626
11,470
(9,809)
(18,139)

79,826
49,689
1,717
(2,713)
11,189
429
—

(14,316)
40,636
965
(21,965)
(6,432)
(7,974)
(14,348)

Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

348,945

295,815

206,694

Cash flows from investing activities:

Maturities and sales of available-for-sale marketable securities . . . . . . . . . . . . . . . .
Purchases of available-for-sale marketable securities . . . . . . . . . . . . . . . . . . . . . . . .
Purchases of property, equipment and software . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investments in technology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from the sale of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

168,328
(225,528)
(18,253)
(2,222)
—

170,818
(249,463)
(15,656)
(5,920)
—

70,840
(98,864)
(31,615)
(4,143)
9,120

Net cash used in investing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(77,675)

(100,221)

(54,662)

Cash flows from financing activities:

Issuance of common stock, net of shares withheld for taxes . . . . . . . . . . . . . . . . . .
Repurchase of stock to satisfy employee tax withholding obligations . . . . . . . . . . .
Repurchase and retirement of common stock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7,128
(18,367)
(109,986)

18,635
(18,280)
(120,002)

1,616
(13,083)
(159,997)

Net cash used in financing activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(121,225)

(119,647)

(171,464)

Net increase (decrease) in cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and cash equivalents at beginning of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

150,045
292,119

75,947
216,172

(19,432)
235,604

Cash and cash equivalents at end of period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 442,164

$ 292,119

$ 216,172

Supplemental disclosures of cash flow information
Cash payments during the year for:

Income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 28,988
610

$ 22,321
457

$ 20,617
612

The accompanying notes are an integral part of these financial statements.

CIRRUS LOGIC, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

Common Stock
Shares Amount

Additional
Paid-In
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive
Income / (Loss)

Total

Balance, March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . 61,960
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in unrealized gain (loss) on marketable

$62
— —

securities, net of tax . . . . . . . . . . . . . . . . . . . . . . . .
Change in defined benefit pension plan liability, net
of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Change in foreign currency translation

adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issuance of stock under stock option plans and other,
net of shares withheld for employee taxes . . . . . . .
Repurchase and retirement of common stock . . . . . .
Amortization of deferred stock compensation . . . . . .

— —

964
(3,970)

1
(4)
— —

Balance, March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . 58,954
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in unrealized gain (loss) on marketable

$59
— —

securities, net of tax . . . . . . . . . . . . . . . . . . . . . . . .

— —

$1,312,372
—

$(139,345)
89,991

$(11,361)
—

$1,161,728
89,991

—

2,231

11,189

(3,125)

1,616

(13,083)
— (159,993)
—

49,689

—
—
—

(11,466)
(159,997)
49,689

$1,363,677

$(222,430)
— 159,498

$ (1,066)
—

$1,140,240
159,498

Change in foreign currency translation

adjustments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issuance of stock under stock option plans and other,
net of shares withheld for employee taxes . . . . . . .

Cumulative effect of adoption of ASU 2016-02, net

of tax . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cumulative effect of adoption of ASU 2018-02 . . . .
Repurchase and retirement of common stock . . . . . .
Amortization of deferred stock compensation . . . . . .

— —

—

1,418

18,634

(18,280)

— —
— —
(2)
— —

(2,130)

—
(726)
257
—
— (120,000)
—

52,560

(2,214)

—

—
(257)
—
—

355

(726)
—
(120,002)
52,560

Balance, March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . 58,242
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Change in unrealized gain (loss) on marketable

$58
— —

securities, net of tax . . . . . . . . . . . . . . . . . . . . . . . .

— —

Change in foreign currency translation

— —

862
(1,452)

1
(1)
— —

$1,434,871

$(201,681)
— 217,344

$ (3,469)
—

$1,229,779
217,344

—

7,128

(18,367)
— (109,985)
—

56,762

4,482

1,862

—
—
—

4,482

1,862

(11,238)
(109,986)
56,762

Balance, March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . 57,652

$58

$1,498,761

$(112,689)

$ 2,875

$1,389,005

The accompanying notes are an integral part of these financial statements.

CIRRUS LOGIC, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Description of Business

Description of Business

Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) is a leader in low-power, high-

precision mixed-signal processing solutions that create innovative user experiences for the world’s top mobile
and consumer applications.

We were incorporated in California in 1984, became a public company in 1989, and were reincorporated in

the State of Delaware in February 1999. Our primary facility housing engineering, sales and marketing, and
administration functions is located in Austin, Texas. We also have offices in various other locations in the
United States, United Kingdom, and Asia, including the People’s Republic of China, Hong Kong, South Korea,
Japan, Singapore, and Taiwan. Our common stock, which has been publicly traded since 1989, is listed on the
NASDAQ’s Global Select Market under the symbol CRUS.

Basis of Presentation

We prepare financial statements on a 52- or 53-week year that ends on the last Saturday in March. Fiscal

years 2021, 2020 and 2019 were 52-week years.

Principles of Consolidation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally

accepted accounting principles (U.S. GAAP) and include the accounts of the Company and its wholly-owned
subsidiaries. All significant intercompany balances and transactions have been eliminated.

Reclassifications

Certain reclassifications have been made to prior year balances in order to conform to the current year’s

presentation of financial information.

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires the use of management
estimates. These estimates are subjective in nature and involve judgments that affect the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities at fiscal year-end and the reported amounts
of revenue and expenses during the reporting period. Actual results could differ from these estimates.

Summary of Significant Accounting Policies

Cash and Cash Equivalents

Cash and cash equivalents consist primarily of money market funds, commercial paper, and U.S.
Government Treasury and Agency instruments with original maturities of three months or less at the date of
purchase.

Inventories

We use the lower of cost or net realizable value to value our inventories, with cost being determined on a

first-in, first-out basis. One of the factors we consistently evaluate in the application of this method is the extent
to which products are accepted into the marketplace. By policy, we evaluate market acceptance based on known
business factors and conditions by comparing forecasted customer unit demand for our products over a specific
future period, or demand horizon, to quantities on hand at the end of each accounting period.

On a quarterly and annual basis, we analyze inventories on a part-by-part basis. Product life cycles and the
competitive nature of the industry are factors considered in the evaluation of customer unit demand at the end of
each quarterly accounting period. Inventory on-hand in excess of forecasted demand is considered to have
reduced market value and, therefore, the cost basis is adjusted to the lower of cost or net realizable value.
Typically, market values for excess or obsolete inventories are considered to be zero. Inventory charges recorded
for excess and obsolete inventory, including scrapped inventory, were $1.2 million and $2.8 million, in fiscal
year 2021 and 2020, respectively. Inventory charges in fiscal year 2021 and 2020 related to a combination of
quality issues and inventory exceeding demand.

Inventories were comprised of the following (in thousands):

Work in process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Finished goods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 92,073
81,190

$ 82,494
64,231

$173,263

$146,725

March 27,
2021

March 28,
2020

Property, Plant and Equipment, net

Property, plant and equipment is recorded at cost, net of depreciation and amortization. Depreciation and

amortization is calculated on a straight-line basis over estimated economic lives, ranging from 3 to 39 years.
Leasehold improvements are depreciated over the shorter of the term of the lease or the estimated useful life.
Furniture, fixtures, machinery, and equipment are all depreciated over a useful life of 3 to 10 years, while
buildings are depreciated over a period of up to 39 years. In general, our capitalized software is amortized over a
useful life of 3 years, with capitalized enterprise resource planning software being amortized over a useful life of
10 years. Gains or losses related to retirements or dispositions of fixed assets are recognized in the period
incurred. Additionally, if impairment indicators exist, the Company will assess the carrying value of the
associated asset. In the fourth quarter of fiscal year 2019, the Company sold the Edinburgh, Scotland property for
a $4.9 million gain presented separately in the Consolidated Statements of Income as “Gain on sale of assets”.
The Company recorded $0.1 million and $9.6 million of equipment disposal charges, during fiscal year 2021 and
the fourth quarter of fiscal year 2020, respectively, related to the MEMS restructuring. See Note 11 —
Restructuring Costs for further detail.

Property, plant and equipment was comprised of the following (in thousands):

March 27,
2021

March 28,
2020

Land . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Buildings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Leasehold improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Machinery and equipment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Capitalized software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Construction in progress and other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 23,853
63,803
23,733
52,041
160,400
26,152
950

$ 23,853
63,803
23,059
51,525
159,201
25,942
892

Total property, plant and equipment
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: Accumulated depreciation and amortization . . . . . . . . . . . . . . . . . . . . .

350,932
(195,990)

348,275
(190,031)

Property, plant and equipment, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 154,942

$ 158,244

Depreciation and amortization expense on property, plant, and equipment for fiscal years 2021, 2020, and

2019 was $24.9 million, $31.9 million, and $32.0 million, respectively.

Goodwill and Intangibles, net

Intangible assets include purchased technology licenses and patents that are reported at cost and are
amortized on a straight-line basis over their useful lives, generally ranging from 1 to 10 years. Acquired
intangibles include existing technology, core technology or patents, license agreements, in-process research &
development, trademarks, tradenames, customer relationships, non-compete agreements, and backlog. These
assets are amortized on a straight-line basis over lives ranging from 1 to 15 years.

Goodwill is recorded at the time of an acquisition and is calculated as the difference between the aggregate

consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired.
Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual
impairment tests. The Company tests goodwill and indefinite lived intangibles for impairment on an annual basis
or more frequently if the Company believes indicators of impairment exist. Impairment evaluations involve
management’s assessment of qualitative factors to determine whether it is more likely than not that goodwill and
other intangible assets are impaired. If management concludes from its assessment of qualitative factors that it is
more likely than not that impairment exists, then a quantitative impairment test will be performed involving
management estimates of asset useful lives and future cash flows. Significant management judgment is required
in the forecasts of future operating results that are used in these evaluations. If our actual results, or the plans and
estimates used in future impairment analyses, are lower than the original estimates used to assess the
recoverability of these assets, we could incur additional impairment charges in a future period. The Company has
recorded no goodwill impairments in fiscal years 2021, 2020, and 2019. During the fourth quarter of fiscal year
2020, the Company recorded $10.0 million of intangible asset impairment charges related to the MEMS
restructuring. See Note 11 — Restructuring Costs for further detail. There were no material intangible asset
impairments in fiscal years 2021 or 2019.

Long-Lived Assets

We test for impairment losses on long-lived assets and definite-lived intangibles used in operations when
indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets
are less than the assets’ carrying amounts. We measure any impairment loss by comparing the fair value of the
asset to its carrying amount. We estimate fair value based on discounted future cash flows, quoted market prices,
or independent appraisals.

Foreign Currency Translation

Some of the Company’s subsidiaries utilize the local currency as the functional currency. The Company’s

main entities, including the entities that generate the majority of sales and employ the majority of employees, are
U.S. dollar functional.

Concentration of Credit Risk

Financial instruments that potentially subject us to material concentrations of credit risk consist primarily of

cash equivalents, marketable securities, long-term marketable securities, and trade accounts receivable. We are
exposed to credit risk to the extent of the amounts recorded on the balance sheet. By policy, our cash equivalents,
marketable securities, and long-term marketable securities are subject to certain nationally recognized credit
standards, issuer concentrations, sovereign risk, and marketability or liquidity considerations.

In evaluating our trade receivables, we perform credit evaluations of our major customers’ financial

condition and monitor closely all of our receivables to limit our financial exposure by limiting the length of time
and amount of credit extended. In certain situations, we may require payment in advance or utilize letters of
credit to reduce credit risk. By policy, we establish a reserve for trade accounts receivable based on the type of
business in which a customer is engaged, the length of time a trade account receivable is outstanding, and other
knowledge that we may possess relating to the probability that a trade receivable is at risk for non-payment.

We had one contract manufacturer, Henan Fuchi, who represented 25 percent of our consolidated gross

trade accounts receivable as of the end of fiscal year 2021. Hongfujin Precision and Pegatron represented

29 percent and 20 percent, respectively of our consolidated gross trade accounts receivable as of the end of fiscal
year 2020. No other distributor or customer had receivable balances that represented more than 10 percent of
consolidated gross trade accounts receivable as of the end of fiscal year 2021 and 2020.

Since the components we produce are largely proprietary and generally not available from second sources,

we consider our end customer to be the entity specifying the use of our component in their design. These end
customers may then purchase our products directly from us, from a distributor, or through a third-party
manufacturer contracted to produce their end product. For fiscal years 2021, 2020, and 2019, our ten largest end
customers represented approximately 93 percent, 93 percent, and 91 percent, of our sales, respectively. For fiscal
years 2021, 2020, and 2019, we had one end customer, Apple Inc., who purchased through multiple contract
manufacturers and represented approximately 83 percent, 79 percent, and 78 percent, of the Company’s total
sales, respectively. No other customer or distributor represented more than 10 percent of net sales in fiscal years
2021, 2020, or 2019.

Revenue Recognition

We recognize revenue upon the transfer of promised goods or services to customers, in an amount that

reflects the consideration the Company expects to be entitled in exchange for those goods or services.

Performance Obligations

The Company’s single performance obligation is the delivery of promised goods to the customer. The
promised goods are explicitly stated in the customer contract and are comprised of either a single type of good or
a series of goods that are substantially the same, have the same pattern of transfer to the customer, and are neither
capable of being distinct nor separable from the other promised goods in the contract. This performance
obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping
terms within the customer’s contract. The vast majority of the Company’s contracts with customers have an
original expected term of one year or less. As allowed by ASC 606, the Company has not disclosed of the value
of any unsatisfied performance obligations related to these contracts.

The Company’s products typically include a warranty period of one to three years. These warranties qualify

as assurance-type warranties, as goods can be returned for product non-conformance and defect only. As such,
these warranties are accounted for under ASC 460, Guarantees, and are not considered a separate performance
obligation.

Contract balances

Payments are typically due within 30 to 60 days of invoicing and terms do not include a significant
financing component or noncash consideration. There have been no material impairment losses on accounts
receivable. There are no material contract assets or contract liabilities recorded on the consolidated balance
sheets.

Transaction price

The transaction price is the amount of consideration to which the Company expects to be entitled in
exchange for transferring the promised goods to the customer. Fixed pricing is the consideration that is agreed
upon in the customer contract. Variable pricing includes rebates, rights of return, warranties, price protection and
stock rotation. Rebates are granted as a customer account credit, based on agreed-upon sales thresholds. Rights of
return and warranty costs are estimated using the “most likely amount” method by reviewing historical returns to
determine the most likely customer return rate and applying materiality thresholds. Price protection includes
price adjustments available to certain distributors based upon established book price and a stated adjustment
period. Stock rotation is also available to certain distributors based on a stated maximum of prior billings.

The Company estimates all variable consideration at the most likely amount which it expects to be entitled.

The estimate is based on current and historical information available to the Company, including recent sales
activity and pricing. Variable consideration is only included in the transaction price to the extent that it is

probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the
uncertainty associated with the variable consideration is resolved. The Company defers all variable consideration
that does not meet the revenue recognition criteria.

Warranty Expense

We warrant our products and maintain a provision for warranty repair or replacement of shipped products.
The accrual represents management’s estimate of probable returns. Our estimate is based on an analysis of our
overall sales volume and historical claims experience. The estimate is re-evaluated periodically for accuracy.

Shipping Costs

Our shipping and handling costs are included in cost of sales for all periods presented in the Consolidated

Statements of Income.

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs were $0.9 million, $0.9 million, and

$1.0 million, in fiscal years 2021, 2020, and 2019, respectively.

Stock-Based Compensation

Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards and
is recognized as an expense, on a ratable basis, over the vesting period, which is generally between 0 and 4 years.
Determining the amount of stock-based compensation to be recorded requires the Company to develop estimates
used in calculating the grant-date fair value of stock options and performance awards (also called market stock
units). The Company calculates the grant-date fair value for stock options and market stock units using the
Black-Scholes valuation model and the Monte Carlo simulation, respectively. The use of valuation models
requires the Company to make estimates of assumptions such as expected volatility, expected term, risk-free
interest rate, expected dividend yield, and forfeiture rates. The grant-date fair value of restricted stock units is the
market value at grant date multiplied by the number of units.

Income Taxes

We are required to calculate income taxes in each of the jurisdictions in which we operate. This process
involves calculating the actual current tax liability as well as assessing temporary differences in the recognition
of income or loss for tax and accounting purposes. These differences result in deferred tax assets and liabilities,
which are included in our Consolidated Balance Sheet. We record a valuation allowance when it is more likely
than not that some portion or all of the deferred tax assets will not be realized. The Company evaluates the ability
to realize its deferred tax assets based on all the facts and circumstances, including projections of future taxable
income and expiration dates of carryover tax attributes.

The calculation of our tax liabilities involves assessing uncertainties with respect to the application of
complex tax rules and the potential for future adjustment of our uncertain tax positions by the Internal Revenue
Service or other taxing jurisdiction. We recognize liabilities for uncertain tax positions based on the required
two-step process. The first step requires us to determine if the weight of available evidence indicates that the tax
position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that
the position will be sustained on audit, including resolution of any related appeals or litigation processes. The
second step requires us to measure the tax benefit of the tax position taken, or expected to be taken, in an income
tax return as the largest amount that is more than 50 percent likely of being realized upon ultimate settlement. We
reevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts
or circumstances, changes in tax law, expirations of statutes of limitation, effectively settled issues under audit,
and new audit activity. A change in the recognition step or measurement step would result in the recognition of a
tax benefit or an additional charge to the tax provision in the period.

Although we believe the measurement of our liabilities for uncertain tax positions is reasonable, we cannot
assure that the final outcome of these matters will not be different than what is reflected in the historical income

tax provisions and accruals. If additional taxes are assessed as a result of an audit or litigation, it could have a
material effect on our income tax provision and net income in the period or periods for which that determination
is made. We operate within multiple taxing jurisdictions and are subject to audit in these jurisdictions. These
audits can involve complex issues which may require an extended period of time to resolve and could result in
additional assessments of income tax. We believe adequate provisions for income taxes have been made for all
periods.

Net Income Per Share

Basic net income per share is based on the weighted effect of common shares issued and outstanding and is

calculated by dividing net income by the basic weighted average shares outstanding during the period. Diluted
net income per share is calculated by dividing net income by the weighted average number of common shares
used in the basic net income per share calculation, plus the equivalent number of common shares that would be
issued assuming exercise or conversion of all potentially dilutive common shares outstanding. These potentially
dilutive items consist primarily of outstanding stock options and restricted stock grants.

The following table details the calculation of basic and diluted earnings per share for fiscal years 2021,

2020, and 2019, (in thousands, except per share amounts):

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

Numerator:

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$217,344

$159,498

$89,991

Denominator:

Weighted average shares outstanding . . . . . . . . . . . . . . . . . . . .
Effect of dilutive securities . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Weighted average diluted shares . . . . . . . . . . . . . . . . . . . . . . . .

58,106
1,954

60,060

58,317
2,145

60,462

60,116
1,467

61,583

Basic earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted earnings per share . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$
$

3.74
3.62

$
$

2.74
2.64

$
$

1.50
1.46

The weighted outstanding shares excluded from our diluted calculation for the years ended March 27,
2021, March 28, 2020, and March 30, 2019 were 187 thousand, 543 thousand, and 872 thousand, respectively, as
the exercise price of certain outstanding stock options exceeded the average market price during the period.

Accumulated Other Comprehensive Loss

Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments,
unrealized gains and losses on investments classified as available-for-sale and, in fiscal year 2019, the settlement
of our defined benefit pension plan assets. See Note 17 — Accumulated Other Comprehensive Income (Loss) for
additional discussion.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326):

impairment charge is to be recognized for the amount by which the recorded book value exceeds the fair value.
This ASU is effective for annual periods beginning after December 15, 2019, including interim periods. The
Company adopted this ASU in the first quarter of fiscal year 2021, with no material impact to the financial
statements.

3. Marketable Securities

The Company’s investments have been classified as available-for-sale securities in accordance with U.S.

GAAP. Marketable securities are categorized on the Consolidated Balance Sheet as “Marketable securities”
within the short-term or long-term classification, as appropriate.

The following table is a summary of available-for-sale securities (in thousands):

As of March 27, 2021

Amortized
Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Estimated Fair Value
(Net Carrying Amount)

Corporate debt securities . . . . . . . . . . . . . . .
Non-U.S. government securities . . . . . . . . . .
Agency discount notes . . . . . . . . . . . . . . . . .

$348,971
13,462
2,759

Total securities . . . . . . . . . . . . . . . . . . . . . . . $365,192

$3,403
172
4

$3,579

$(313)
(1)
(1)

$(315)

$352,061
13,633
2,762

$368,456

The Company typically invests in highly-rated securities with original maturities generally ranging from one

to three years. The Company’s specifically identified gross unrealized losses of $0.3 million related to securities
with total amortized costs of approximately $92.0 million at March 27, 2021. There were no securities that have
been in a continuous unrealized loss position for more than 12 months as of March 27, 2021. The Company may
sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not
limited to, anticipated or actual changes in credit rating and duration management. The Company records an
allowance for credit loss when a decline in investment market value is due to credit-related factors. When
evaluating an investment for impairment, the Company reviews factors including the length of time and extent to
which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates
and whether it is more likely than not the Company will be required to sell the investment before recovery of the
investment’s cost basis. As of March 27, 2021, the Company does not consider any of its investments to be
impaired.

As of March 28, 2020

Amortized
Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Estimated Fair Value
(Net Carrying Amount)

Corporate debt securities . . . . . . . . . . . . . . .
Non-U.S. government securities . . . . . . . . . .
U.S. Treasury securities . . . . . . . . . . . . . . . .

$286,668
12,483
8,839

Total securities . . . . . . . . . . . . . . . . . . . . . . . $307,990

$1,157
260
167

$1,584

$(3,993)
—
—

$(3,993)

$283,832
12,743
9,006

$305,581

The Company’s specifically identified gross unrealized losses of $4.0 million related to securities with total
amortized costs of approximately $172.9 million at March 28, 2020. There were no securities that had been in a
continuous unrealized loss position for more than 12 months as of March 28, 2020. As of March 28, 2020, the
Company did not consider any of its investments to be impaired.

The cost and estimated fair value of available-for-sale investments by contractual maturity were as follows:

March 27, 2021

March 28, 2020

Amortized
Cost

Estimated
Fair Value

Amortized
Cost

Estimated
Fair Value

Within 1 year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
After 1 year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 54,895
310,297

$ 55,698
312,758

$ 22,012
285,978

$ 22,008
283,573

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$365,192

$368,456

$307,990

$305,581

Fair Value of Financial Instruments

The Company has determined that the assets and liabilities in the Company’s financial statements that are

required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable
securities portfolio. The Company defines fair value as the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between market participants at the measurement date. The Company
applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels
and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to
the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets

for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3
measurements).

▪

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted
prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are
observable or can be corroborated by observable market data for substantially the full term of the assets
or liabilities.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant
to the fair value of the assets or liabilities.

The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt

securities, non-U.S government securities, U.S Treasury securities, and securities of U.S. government-sponsored
enterprises, and are reflected on our Consolidated Balance Sheet under the headings cash and cash equivalents,
marketable securities, and long-term marketable securities. The Company determines the fair value of its
marketable securities portfolio by obtaining non-binding market prices from its third-party pricing providers on
the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1
inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in
determining fair value.

The Company’s long-term revolving facility, described in Note 8, bears interest at a base rate plus

applicable margin or LIBOR plus applicable margin. As of March 27, 2021, there are no amounts drawn under
the facility and the fair value is zero.

As of March 27, 2021 and March 28, 2020, the Company has no material Level 3 assets or liabilities. There

were no transfers between Level 1, Level 2, or Level 3 measurements for the years ending March 27, 2021 and
March 28, 2020.

The following summarizes the fair value of our financial instruments at March 27, 2021 (in thousands):

Quoted Prices
in Active
Markets for
Identical
Assets
Level 1

Significant
Other
Observable
Inputs
Level 2

Significant
Unobservable
Inputs
Level 3

Total

Assets:
Cash equivalents

Money market funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$405,819

—

$—

$405,819

Available-for-sale securities

Corporate debt securities . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. government securities . . . . . . . . . . . . . . . . . . . . .
Agency discount notes . . . . . . . . . . . . . . . . . . . . . . . . . . . .

— $352,061
13,633
—
2,762
—

— $368,456

$—
—
—

$—

$352,061
13,633
2,762

$368,456

The following summarizes the fair value of our financial instruments at March 28, 2020 (in thousands):

Quoted Prices
in Active
Markets for
Identical
Assets
Level 1

Significant
Other
Observable
Inputs
Level 2

Significant
Unobservable
Inputs
Level 3

Total

Assets:
Cash equivalents

Money market funds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$237,714

—

$—

$237,714

Available-for-sale securities

Corporate debt securities . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. government securities . . . . . . . . . . . . . . . . . . . . .
U.S. Treasury securities . . . . . . . . . . . . . . . . . . . . . . . . . . .

— $283,832
12,743
—
—
9,006

9,006

$296,575

$—
—
—

$—

$283,832
12,743
9,006

$305,581

5. Derivative Financial Instruments

Foreign Currency Forward Contracts

Beginning in fiscal year 2020, the Company began using foreign currency forward contracts to reduce the
earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The
Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on
the remeasurement of non-functional currency assets and liabilities within “Other income (expense)” in the
consolidated statements of income. The Company does not apply hedge accounting to these foreign currency
derivative instruments.

As of March 27, 2021, the Company held one foreign currency forward contract denominated in British

Pound Sterling with a notional value of $13.6 million. The fair value of this contract was not material as of
March 27, 2021.

The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in

thousands):

Fiscal Years Ended
March 28,
2020

March 27,
2021

March 30,
2019

Location

Gain (loss) recognized in income

Foreign currency forward contracts . . . . . . . . . . . .

$3,212

$(4,226)

$—

Other income (expense)

6. Accounts Receivable, net

The following are the components of accounts receivable, net (in thousands):

Gross accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$108,712
—

$153,998
—

Accounts receivable, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$108,712

$153,998

March 27,
2021

March 28,
2020

The Company regularly evaluates the collectability of accounts receivable based on age, historical customer

payment trends and ongoing customer relations. The following table summarizes the changes in the allowance
for doubtful accounts (in thousands):

Balance, March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bad debt expense, net of recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bad debt expense, net of recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bad debt expense, net of recoveries . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$(203)
(67)

(270)
270

—
—

Balance, March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ —

Recoveries on bad debt were immaterial for the three years presented above.

Intangibles, net and Goodwill

The intangibles, net balance included on the Consolidated Balance Sheet was $22.0 million and

$34.4 million at March 27, 2021 and March 28, 2020, respectively.

The following information details the gross carrying amount and accumulated amortization of our intangible

assets (in thousands):

Intangible Category / Weighted-Average Amortization
period (in years)

Gross
Amount

Accumulated
Amortization

Gross
Amount

Accumulated
Amortization

March 27, 2021

March 28, 2020

Core technology (a)
. . . . . . . . . . . . . . . . . . . . .
License agreement (a) . . . . . . . . . . . . . . . . . . . .
Existing technology (7.0) . . . . . . . . . . . . . . . . .
In-process research & development

(“IPR&D”) (7.5) . . . . . . . . . . . . . . . . . . . . . .
Trademarks and tradename (10.0) . . . . . . . . . .
Customer relationships (10.0) . . . . . . . . . . . . . .
Backlog (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-compete agreements (a) . . . . . . . . . . . . . .
Technology licenses (3.0) . . . . . . . . . . . . . . . . .

1,390
440
111,005

(1,390)
(440)
(105,870)

1,390
440
111,005

(1,390)
(440)
(100,145)

70,936
3,037
15,381
220
470
25,945

(62,885)
(2,717)
(10,346)
(220)
(470)
(22,455)

70,936
3,037
15,381
220
470
23,820

(58,284)
(2,589)
(8,808)
(220)
(470)
(19,923)

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$228,824

$(206,793)

$226,699

$(192,269)

(a)

Intangible assets are fully amortized.

Amortization expense for intangibles in fiscal years 2021, 2020, and 2019 was $14.5 million, $28.3 million,
and $47.8 million, respectively. The following table details the estimated aggregate amortization expense for all
intangibles owned as of March 27, 2021, for each of the five succeeding fiscal years and in the aggregate
thereafter (in thousands):

For the year ended March 26, 2022 . . . . . . . . . . . . . . . . . . . . .
For the year ended March 25, 2023 . . . . . . . . . . . . . . . . . . . . .
For the year ended March 30, 2024 . . . . . . . . . . . . . . . . . . . . .
For the year ended March 29, 2025 . . . . . . . . . . . . . . . . . . . . .
For the year ended March 28, 2026 . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,533
$ 6,726
$ 2,231
541
$
$ —
$ —

The goodwill balance included on the Consolidated Balance Sheet is $287.5 million and $287.1 million at

March 27, 2021 and March 28, 2020, respectively.

8. Revolving Credit Facility

On July 12, 2016, Cirrus Logic entered into an amended and restated credit agreement (the “Credit
Agreement”) with Wells Fargo Bank, National Association, as Administrative Agent, and the Lenders party
thereto, for the purpose of refinancing an existing credit facility and providing ongoing working capital. The
Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Credit Facility”). The
Credit Facility matures on July 12, 2021. The Credit Facility is required to be guaranteed by all of Cirrus Logic’s
material domestic subsidiaries (the “Subsidiary Guarantors”). The Credit Facility is secured by substantially all
of the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets.

Borrowings under the Credit Facility may, at Cirrus Logic’s election, bear interest at either (a) a base rate
plus the applicable margin (“Base Rate Loans”) or (b) a LIBOR Rate plus the applicable margin (“LIBOR Rate
Loans”). The applicable margin ranges from 0% to 0.50% per annum for Base Rate Loans and 1.25% to
2.00% per annum for LIBOR Rate Loans based on the Leverage Ratio (as defined below). A commitment fee
accrues at a rate per annum ranging from 0.20% to 0.30% (based on the Leverage Ratio) on the average daily
unused portion of the commitment of the lenders. The Credit Agreement contains certain financial covenants
providing that (a) the ratio of consolidated funded indebtedness to consolidated EBITDA for the prior four
consecutive quarters must not be greater than 3.00 to 1.00 (the “Leverage Ratio”) and (b) the ratio of
consolidated EBITDA for the prior four consecutive fiscal quarters to consolidated fixed charges (including
amounts paid in cash for consolidated interest expenses, capital expenditures, scheduled principal payments of
indebtedness, and income taxes) for the prior four consecutive fiscal quarters must not be less than 1.25 to 1.00
as of the end of each fiscal quarter. The Credit Agreement also contains negative covenants limiting the
Company’s or any Subsidiary’s ability to, among other things, incur debt, grant liens, make investments, effect
certain fundamental changes, make certain asset dispositions, and make certain restricted payments.

As of March 27, 2021, the Company had no amounts outstanding under the Credit Facility and was in

compliance with all covenants under the Credit Agreement.

9. Revenues

Disaggregation of revenue

We disaggregate revenue from contracts with customers by product line and ship to location of the

customer. During the fourth quarter of fiscal year 2021, we adjusted how we report product line revenue to better
represent our business and strategic focus. Sales will be designated in the product line categories of Audio and
High-Performance Mixed-Signal.

Total net sales based on the product line disaggregation criteria described above are shown in the table
below (in thousands). Prior periods were retrospectively adjusted to conform to the fiscal year 2021 product line
categories.

Fiscal Year 2021

Portable
Products

Non-Portable
and Other
Products

Total

Audio Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
High-Performance Mixed-Signal Products . . . . . . . . . . . . .

$ 998,445
236,053

$105,615
29,117

$1,104,060
265,170

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,234,498

$134,732

$1,369,230

Fiscal Year 2020

Portable
Products

Non-Portable
and Other
Products

Total

Audio Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
High-Performance Mixed-Signal Products . . . . . . . . . . . . .

$1,009,933
136,985

$100,025
34,181

$1,109,958
171,166

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,146,918

$134,206

$1,281,124

Fiscal Year 2019

Portable
Products

Non-Portable
and Other
Products

Total

Audio Products . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
High-Performance Mixed-Signal Products . . . . . . . . . . . . .

$ 922,608
109,441

$118,258
35,217

$1,040,866
144,658

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,032,049

$153,475

$1,185,524

The geographic regions that are reviewed are China, the United States, and the rest of the world.

Total net sales based on the geographic disaggregation criteria described are as follows (in thousands):

China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of World . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

March 27,
2021

$1,024,178
21,708
323,344

Fiscal Years Ended
March 28,
2020

$ 975,090
17,099
288,935

March 30,
2019

$ 922,202
26,182
237,140

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$1,369,230

$1,281,124

$1,185,524

See Note 2 — Summary of Significant Accounting Policies for additional discussion surrounding revenue

recognition considerations.

10. Leases

The Company has operating leases for corporate offices and certain office equipment. Our leases have

remaining lease terms of 1 year to 28 years, some of which include options to extend the leases that are
considered reasonably certain to be exercised. Our leases generally contain fixed rental payments, with additional
variable payments linked to actual common area maintenance costs incurred by the landlord. These variable
payments are therefore not included within the lease liability and ROU asset, but are recognized as an expense
when incurred. As our leases typically do not provide an implicit rate, the Company determined the Incremental
Borrowing Rate (“IBR”) for each lease based on the information available at the commencement date, taking into
consideration necessary adjustments for collateral, currency, and lease term. There are no residual value
guarantees in any of our leases. No restrictions or covenants have been imposed on the Company as a result of
the lease agreements in place.

The Company also leases a small portion of our office space to tenants under operating leases, receiving
monthly rental payments. Payments are generally fixed, with variable payments linked to actual common area
maintenance costs incurred. Total fixed lease payments to be received over the life of the lease are recognized on
a straight-line basis over the lease term.

All of the Company’s leases have been classified as operating leases. Operating leases in excess of 12

months are recognized on the balance sheet, with future lease payments recognized as a liability, measured at
present value, and the right-of-use asset recognized for the lease term. A single lease cost is recognized in the
income statement over the lease term.

The components of net operating lease expense were as follows (in thousands):

Operating lease — in excess of 12 months . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Variable lease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Short-term lease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating lease income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Fiscal Years Ended

March 27,
2021

March 28,
2020

$14,050
4,981
151
(1,416)

$13,518
4,721
119
(1,296)

Total net operating lease expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$17,766

$17,062

Other information related to operating leases was as follows:

Cash paid for amounts included in the measurement of lease liabilities (in

thousands) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating cash flows from operating leases . . . . . . . . . . . . . . . . . . . . . . . . . .
Right-of-use assets obtained in exchange for new operating lease liabilities (in
thousands) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Weighted-average remaining lease term — operating leases (in years) . . . . . . .
Weighted-average discount rate — operating leases . . . . . . . . . . . . . . . . . . . . .

Fiscal Years Ended

March 27,
2021

March 28,
2020

$14,954

$13,955

805
19
4%

1,107
20
4%

As of March 27, 2021, there are no leases that have not yet commenced that would create significant rights

and obligations on the Company.

Future lease commitments under non-cancellable leases, including extension options reasonably anticipated

to be exercised as of March 27, 2021, are as follows (in thousands):

Fiscal Year

Operating Lease Expense

Operating Lease Income

2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2025 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . .

Less imputed interest

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 14,852
14,492
14,051
13,514
11,872
139,915

$208,696
(66,240)

$142,456

$1,105
278
—
—
—
—

$1,383
—

$1,383

Operating lease liabilities consisted of the following (in thousands):

March 27,
2021

March 28,
2020

Current lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-current lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 14,573
127,883

$ 13,580
129,312

Total operating lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$142,456

$142,892

11. Restructuring Costs

In the fourth quarter of fiscal year 2020, the Company approved a restructuring plan (the “MEMS
Restructuring”), including discontinuing efforts relating to the microelectromechanical systems (“MEMS”)
microphone product line, which allowed the Company to concentrate our resources on projects with an
anticipated larger return on investment. The Company recorded charges of $21.9 million as part of the MEMS
Restructuring in fiscal year 2020. The MEMS Restructuring was substantially complete as of the first quarter of
fiscal year 2021 with a $0.4 million “Restructuring Costs” charge to the income statement. No additional
restructuring charges were incurred during fiscal year 2021.

The following table details the total restructuring charges presented in the Consolidated Statements of

Income within the “Restructuring Costs” line item (in thousands):

Fiscal Years Ended
March 27, 2021 March 28, 2020

Disposal of equipment, net of recovery from sales (a) . . . . . . . . . . . . .
Impairment and write-off of intangible assets . . . . . . . . . . . . . . . . . . .
Other exit costs (b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Personnel-related charges, net of equity cancellations (c) . . . . . . . . . .

Total

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$130
—
222
—

$352

$ 9,578
9,961
1,903
483

$21,925

Fiscal year ended March 28, 2020 includes accelerated depreciation of equipment of $11.5 million, net
of $1.9 million of recovery from equipment sold during the fourth quarter of fiscal 2020.
Fiscal year ended March 28, 2020 includes $0.6 million of accrued exit costs as of March 28, 2020
which are presented in the “Other accrued liabilities” line item of our Consolidated Balance Sheet.
Personnel-related charges consist of severance costs of $1.7 million, net of $1.2 million of equity
cancellation benefits and includes $0.4 million of accrued severance as of March 28, 2020 which is
presented in the “Other accrued liabilities” line item of our Consolidated Balance Sheet.

Restructuring liabilities are presented in the “Other accrued liabilities” line item of our Consolidated

Balance Sheet. The activity related to restructuring liabilities is detailed below (in thousands):

Beginning balance as of March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other exit costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash payments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ending balance as of March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

982
222
(1,204)

$ —

Restructuring Liability

12.

Postretirement Benefit Plans

Defined Benefit Pension Plan

The Company had a defined benefit pension scheme (the “Scheme”), for some individuals in the United
Kingdom. On November 30, 2018, the Scheme buy-out was completed and individual policies were established
for each member. Completion of the buy-out confirmed full and final settlement of the Scheme, and the

unamortized loss previously recorded within AOCI of $13.8 million was recognized within other non-operating
expense as “U.K. pension settlement” in the third quarter of fiscal year 2019, with the corresponding tax benefit
of $2.6 million being recognized within “Provision for income taxes” in the Consolidated Statements of Income.
As the buy-out transaction fully settled, there were no further contributions to the Scheme.

Defined Contribution Plans

We have Defined Contribution Plans (“the Plans”) covering all of our qualifying employees. Under the

Plans, employees may elect to contribute any percentage of their annual compensation up to the annual
regulatory limits. The Company made matching employee contributions of $7.9 million, $7.5 million, and
$7.7 million during fiscal years 2021, 2020, and 2019, respectively.

13. Equity Compensation

The Company is currently granting equity awards from the 2018 Long Term Incentive Plan (the “Plan”),

which was approved by stockholders in August 2018 and subsequently amended on July 31, 2020. The Plan
provides for granting of stock options, restricted stock awards, performance awards, phantom stock awards, and
bonus stock awards, or any combination of the foregoing. To date, the Company has granted stock options,
restricted stock awards, phantom stock awards (also called restricted stock units), and performance awards (also
called market stock units). Each stock option granted reduces the total shares available for grant under the Plan
by one share. Each full value award granted (including restricted stock awards, restricted stock units and market
stock units) reduces the total shares available for grant under the Plan by 1.5 shares. Stock options generally vest
between one and four years, and are exercisable for a period of ten years from the date of grant. Restricted stock
units are generally subject to vesting from zero to three years, depending upon the terms of the grant. Market
stock units are subject to a vesting schedule of three years.

The following table summarizes the activity in total shares available for grant (in thousands):

Balance, March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shares added . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shares added . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shares added . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Shares
Available for
Grant

3,065
2,509
(2,371)
120

3,323
248
(1,686)
210

2,095
3,223
(1,491)
198

4,025

Stock-based Compensation Expense

The following table summarizes the effects of stock-based compensation on cost of goods sold, research and

development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted
under the Plan (in thousands, except per share amounts):

Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sales, general and administrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2021

900
37,483
18,379

Fiscal Year
2020

908
33,859
18,990

2019

877
29,115
19,697

Effect on pre-tax income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Income Tax Benefit

56,762
(9,558)

53,757
(9,336)

49,689
(5,748)

Total stock-based compensation expense (net of taxes)

. . . . . . . . . . . . . . . . . . .

47,204

44,421

43,941

Stock-based compensation effects on basic earnings per share . . . . . . . . . . . . . . . .
Stock-based compensation effects on diluted earnings per share . . . . . . . . . . . . . .

0.81
0.79

0.76
0.73

0.73
0.71

The total stock-based compensation expense included in the table above and which is attributable to
restricted stock units and market stock units was $53.6 million, $50.0 million, $45.5 million, for fiscal years
2021, 2020, and 2019, respectively. Stock-based compensation expense is presented within operating activities in
the Consolidated Statement of Cash Flows.

As of March 27, 2021, there was $105.8 million of compensation costs related to non-vested stock options,

restricted stock units, and market stock units granted under the Company’s equity incentive plans not yet
recognized in the Company’s financial statements. The unrecognized compensation cost is expected to be
recognized over a weighted average period of 1.28 years for stock options, 1.57 years for restricted stock units,
and 1.33 years for market stock units.

In addition to the income tax benefit of stock-based compensation expense shown in the table above, the
Company recognized excess tax benefits of $2.2 million, $4.9 million and $0.9 million in fiscal years 2021, 2020,
and 2019 respectively.

Stock Options

We estimate the fair value of each stock option on the date of grant using the Black-Scholes option-pricing

model using a dividend yield of zero and the following additional assumptions:

March 27, 2021

March 28, 2020

March 30, 2019

Expected stock price volatility . . . .
Risk-free interest rate . . . . . . . . . . .
Expected term (in years) . . . . . . . . .

43.85% - 43.99%
0.35% - 0.72%
4.32 - 4.43

37.17% - 41.61% 38.00% - 38.14%
2.57% - 2.94%
3.12 - 3.73

1.54% - 2.29%
3.81 - 4.55

The Black-Scholes valuation calculation requires us to estimate key assumptions such as stock price
volatility, expected term, risk-free interest rate and dividend yield. The expected stock price volatility is based
upon implied volatility from traded options on our stock in the marketplace. The expected term of options
granted is derived from an analysis of historical exercises and remaining contractual life of stock options, and
represents the period of time that options granted are expected to be outstanding after becoming vested. The risk-
free interest rate reflects the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with
the expected term assumption. Finally, we have never paid cash dividends, do not currently intend to pay cash
dividends, and thus have assumed a zero percent dividend yield.

Using the Black-Scholes option valuation model, the weighted average estimated fair values of employee

stock options granted in fiscal years 2021, 2020, and 2019, were $33.81, $29.25, and $16.27, respectively.

During fiscal years 2021, 2020, and 2019, we received a net $7.1 million, $18.6 million, and $1.6 million,
respectively, from the exercise of 0.2 million, 0.8 million, and 0.1 million, respectively, stock options granted
under the Company’s Stock Plan.

The total intrinsic value of stock options exercised during fiscal year 2021, 2020, and 2019, was

$10.2 million, $34.0 million, and $2.6 million, respectively. Intrinsic value represents the difference between the
market value of the Company’s common stock at the time of exercise and the strike price of the stock option.

Additional information with respect to stock option activity is as follows (in thousands, except per share

amounts):

Outstanding Options
Weighted
Average
Exercise Price

Number

Balance, March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Balance, March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options exercised . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Options expired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,740
280
(108)
(38)
(9)

1,865
169
(780)
(27)
(11)

1,216
96
(236)
(17)
—

Balance, March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,059

$31.91
40.41
15.03
49.62
55.01

$33.68
66.93
23.90
50.75
55.03

$44.01
77.23
30.26
56.27
—

$49.87

Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable

as of March 27, 2021 is as follows (in thousands, except years and per share amounts):

Number of
Options

Weighted
Average
Exercise price

Weighted Average
Remaining Contractual
Term (years)

Aggregate
Intrinsic Value

Vested and expected to vest . . . . . . . . . . . . . . . . .
Exercisable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,048
737

$49.68
$44.91

6.22
5.27

$34,926
$28,062

In accordance with U.S. GAAP, stock options outstanding that are expected to vest are presented net of
estimated future option forfeitures, which are estimated as compensation costs are recognized. Options with a fair
value of $4.8 million, $4.7 million, and $4.1 million, became vested during fiscal years 2021, 2020, and 2019,
respectively.

The following table summarizes information regarding outstanding and exercisable options as of March 27,

2021 (in thousands, except per share amounts):

Range of Exercise Prices

Number

$15.31 - $38.15 . . . . . . .
$38.34 - $38.99 . . . . . . .
$41.49 - $54.65 . . . . . . .
$55.72 - $68.43 . . . . . . .
$68.56 - $68.56 . . . . . . .
$78.00 - $78.00 . . . . . . .

177
183
308
156
148
88

1,060

Options Outstanding

Options Exercisable

Weighted Average
Remaining
Contractual Life
(years)

Weighted
Average Exercise
Price

Number
Exercisable

Weighted
Average
Exercise Price

4.51
3.04
6.72
6.72
8.61
9.93

6.25

$30.06
38.81
47.51
56.35
68.56
78.00

$49.87

162
169
234
123
49
—

737

$29.36
38.85
49.39
55.72
68.56
—

$44.91

As of March 27, 2021, March 28, 2020, and March 30, 2019, the number of options exercisable was

0.7 million, 0.8 million, and 1.3 million respectively.

Restricted Stock Units

Commencing in fiscal year 2011, the Company began granting restricted stock units (“RSUs”) to select

employees. These awards are valued as of the grant date and amortized over the requisite vesting period.
Generally, RSUs vest 100 percent on the first to third anniversary of the grant date depending on the vesting
specifications. A summary of the activity for RSUs in fiscal year 2021, 2020, and 2019 is presented below
(in thousands, except year and per share amounts):

March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,769
1,416
(1,176)
(175)

2,834
1,014
(897)
(271)

2,680
945
(881)
(131)

March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,613

Weighted
Average
Fair Value

$45.70
40.57
33.65
48.15

$47.99
66.76
51.20
50.82

$53.74
71.44
52.97
55.36

$60.31

The aggregate intrinsic value of RSUs outstanding as of March 27, 2021, March 28, 2020, and March 30,

2019 was $216.9 million, $165.9 million, and $119.2 million, respectively. Additional information with regards
to outstanding RSUs that are expected to vest as of March 27, 2021, is as follows (in thousands, except year and
per share amounts):

Weighted
Average
Fair Value

Weighted Average
Remaining Contractual
Term (years)

Expected to vest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2,460

$59.95

1.54

RSUs outstanding that are expected to vest are presented net of estimated future forfeitures, which are
estimated as compensation costs are recognized. RSUs with a fair value of $46.7 million, $45.9 million, and
$39.6 million became vested during fiscal years 2021, 2020, and 2019, respectively. The majority of RSUs that
vested in 2021, 2020 and 2019 were net settled such that the Company withheld a portion of the shares to satisfy
tax withholding requirements. In fiscal years 2021, 2020, and 2019 the vesting of RSUs reduced the authorized
and unissued share balance by approximately 0.9 million and 0.9 million, 1.2 million, respectively. Total shares
withheld and subsequently retired out of the Plan were approximately 0.3 million, 0.3 million, and 0.3 million
and total payments for the employees’ tax obligations to taxing authorities were $18.4 million, $18.3 million, and
$13.1 million for fiscal years 2021, 2020, and 2019, respectively.

Market Stock Units

In fiscal year 2015, the Company began granting market stock units (“MSUs”) to select employees. MSUs

vest based upon the relative total shareholder return (“TSR”) of the Company as compared to that of the
Philadelphia Semiconductor Index (“the Index”). The requisite service period for these MSUs is also the vesting
period, which is three years. The fair value of each MSU granted was determined on the date of grant using the
Monte Carlo simulation, which calculates the present value of the potential outcomes of future stock prices of the
Company and the Index over the requisite service period. The fair value is based on the risk-free rate of return,
the volatilities of the stock price of the Company and the Index, the correlation of the stock price of the Company
with the Index, and the dividend yield.

The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero

and the following additional assumptions:

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

43.85% 37.17% - 41.61% 38.00% - 38.14%
2.62% - 3.01%
3.00

1.59% - 2.28%
3.00

0.29%
3.00

Expected stock price volatility . . . . . . .
Risk-free interest rate . . . . . . . . . . . . . .
Expected term (in years) . . . . . . . . . . . .

Using the Monte Carlo simulation, the weighted average estimated fair value of the MSUs granted in fiscal

year 2021 was $83.96. A summary of the activity for MSUs in fiscal year 2021, 2020, and 2019 is presented
below (in thousands, except year and per share amounts):

March 31, 2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

199
68
—
(101)

March 30, 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

166

Granted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vested . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Forfeited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

45
—
(58)

Weighted
Average
Fair Value

$56.16
53.13
—
43.41

$62.77

95.89
—
73.25

March 28, 2020 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

153

$68.71

28
—
(48)

83.96
—
64.92

March 27, 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

133

$73.29

The aggregate intrinsic value of MSUs outstanding as of March 27, 2021, March 28, 2020, and March 30,

2019 was $11.0 million, $9.5 million, and $7.0 million, respectively. Additional information with regard to
outstanding MSUs that are expected to vest as of March 27, 2021 is as follows (in thousands, except year and per
share amounts):

Expected to vest

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

126

$72.71

1.29

Weighted
Average
Fair Value

Weighted Average
Remaining Contractual
Term (years)

No MSUs became vested in fiscal years 2021, 2020 or 2019.

14. Commitments and Contingencies

Facilities and Equipment Under Operating Lease Agreements

We currently own our corporate headquarters and select surrounding properties. We lease certain of our
other facilities and certain equipment under operating lease agreements, some of which have renewal options.
Certain of these arrangements provide for lease payment increases based upon future fair market rates. As of
March 27, 2021, our principal facilities are located in Austin, Texas and Edinburgh, Scotland, United Kingdom.

Total rent expense under operating leases was approximately $19.2 million, $18.4 million, and

$12.7 million, for fiscal years 2021, 2020, and 2019, respectively. Rental income was $1.4 million, $1.3 million,
and $0.2 million, for fiscal years 2021, 2020, and 2019, respectively.

See Note 10 — Leases for minimum future rental commitments and income under all operating leases as of

March 27, 2021.

Wafer, Assembly, Test and Other Purchase Commitments

We rely primarily on third-party foundries for our wafer manufacturing needs. Generally, our foundry
agreements do not have volume purchase commitments and primarily provide for purchase commitments based

on purchase orders. Cancellation fees or other charges may apply and are generally dependent upon whether
wafers have been started or the stage of the manufacturing process at which the notice of cancellation is given.
As of March 27, 2021, we had foundry commitments of $220.2 million.

In addition to our wafer supply arrangements, we contract with third-party assembly vendors to package the

wafer die into finished products. Assembly vendors provide fixed-cost-per-unit pricing, as is common in the
semiconductor industry. We had non-cancelable assembly purchase orders with numerous vendors totaling
$4.0 million at March 27, 2021.

Test vendors provide fixed-cost-per-unit pricing, as is common in the semiconductor industry. Our total

non-cancelable commitment for outside test services as of March 27, 2021 was $8.1 million.

Other purchase commitments primarily relate to multi-year tool commitments, and were $70.1 million at

March 27, 2021.

15. Legal Matters

From time to time, we are involved in legal proceedings concerning matters arising in connection with the

conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved
to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have
been incurred and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess
whether an estimate of possible loss or range of loss can be made. Based on current knowledge, management
does not believe that there are any pending matters that could potentially have a material adverse effect on our
business, financial condition, results of operations or cash flows.

16.

Stockholders’ Equity

Share Repurchase Program

In January 2019, the Company announced that the Board of Directors authorized a share repurchase

program of up to $200 million of the Company’s common stock. As of March 27, 2021, the Company had
repurchased 2.7 million shares at a cost of $190.0 million, or an average cost of $70.50 per share. All of these
shares were repurchased in the open market and were funded from existing cash. All shares of our common stock
that were repurchased were retired as of March 27, 2021. Approximately $10.0 million remains available for
repurchase under this plan. In January 2021, the Board of Directors authorized the repurchase of up to an
additional $350 million of the Company’s common stock. As of March 27, 2021, no shares have been
repurchased under the new plan.

Preferred Stock

We have 5.0 million shares of Preferred Stock authorized. As of March 27, 2021, we have not issued any of

the authorized shares.

17. Accumulated Other Comprehensive Income (Loss)

Our accumulated other comprehensive income (loss) is comprised of foreign currency translation

adjustments, unrealized gains and losses on investments classified as available-for-sale, and cumulative effects of
adopting new accounting standards.

The following table summarizes the changes in the components of accumulated other comprehensive

income (loss), net of tax (in thousands):

Balance, March 30, 2019 . . . . . . . . . . . . . . .

Current period foreign exchange

translation . . . . . . . . . . . . . . . . . . . . . . .

Current period marketable securities

activity . . . . . . . . . . . . . . . . . . . . . . . . .

Foreign
Currency
$(1,636)

—

Cumulative effect of adoption of ASU

2018-02 . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
Balance, March 28, 2020 . . . . . . . . . . . . . . .

Tax effect

—
—
$(1,568)

Current period foreign exchange

Unrealized Gains
(Losses) on Securities

570

—

(2,803)

—
589
$(1,644)

Cumulative
Effect of
Adoption
of ASU
2018-02
$ —

—

(257)
—
$(257)

Total
$(1,066)

(2,803)

(257)
589
$(3,469)

translation . . . . . . . . . . . . . . . . . . . . . . .

1,862

—

1,862

Current period marketable securities

activity . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . .
Balance, March 27, 2021 . . . . . . . . . . . . . . .

Tax effect

—
—
294

5,673
(1,191)
$ 2,838

—
—
$(257)

5,673
(1,191)
$ 2,875

18.

Income Taxes

Income before income taxes consisted of (in thousands):

U.S.
Non-U.S.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 19,189
226,057

$ 44,154
137,112

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

$41,980
51,764

$245,246

$181,266

$93,744

The provision (benefit) for income taxes consists of (in thousands):

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

Current:
U.S.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$
981
32,428

$ 5,241
21,634

$ (7,109)
12,428

Total current tax provision . . . . . . . . . . . . . . . . . . . . . . . . . . .

$33,409

$26,875

$ 5,319

Deferred:
U.S.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-U.S. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(192)
(5,315)

(561)
(4,546)

5,441
(7,007)

Total deferred tax provision . . . . . . . . . . . . . . . . . . . . . . . . . .
Total tax provision . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(5,507)
$27,902

(5,107)
$21,768

(1,566)
$ 3,753

The effective income tax rates differ from the rates computed by applying the statutory federal rate to pretax

income as follows (in percentages):

March 27,
2021

Fiscal Years Ended
March 28,
2020

March 30,
2019

U.S. federal statutory rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign income taxed at different rates . . . . . . . . . . . . . . . . . . . . . .
Transition tax on deferred foreign income . . . . . . . . . . . . . . . . . . .
Remeasurement of U.S. deferred tax balance . . . . . . . . . . . . . . . . .
Research and development tax credits . . . . . . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign-derived intangible income deduction . . . . . . . . . . . . . . . .
Current U.S. tax on foreign earnings . . . . . . . . . . . . . . . . . . . . . . .
Change in valuation allowance . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Release of prior year unrecognized tax benefits . . . . . . . . . . . . . . .
Interest related to unrecognized tax benefits . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effective tax rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

21.0
(8.4)
—
—
—
(0.8)
(0.3)
0.4
—
(1.4)
0.3
0.6
11.4

21.0
(5.5)
—
—
—
(2.7)
(0.8)
1.1
(0.1)
(2.3)
0.5
0.8
12.0

21.0
(2.9)
(11.8)
(0.1)
(6.7)
(1.0)
(2.8)
2.2
4.4
—
1.6
0.1
4.0

The Tax Act was enacted on December 22, 2017 and required companies to pay a one-time transition tax on

earnings of certain foreign subsidiaries that were previously tax-deferred. We elected to pay the transition tax
over the eight-year period provided in the Tax Act. As of March 27, 2021, the remaining balance of our transition
tax obligation is $27.0 million, which will be paid over the next five years.

On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which
concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany
cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the
U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On July 24, 2018, the Ninth Circuit issued a
decision that was subsequently withdrawn and a reconstituted panel conferred on the appeal. On June 7, 2019,
the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On
February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United
States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved within the
Ninth Circuit, the Ninth Circuit’s opinion is not binding in other circuits. The potential impact of this issue on the
Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will
continue to monitor developments related to this issue and the potential impact of those developments on the
Company’s current and prior fiscal years.

Significant components of our deferred tax assets and liabilities as of March 27, 2021 and March 28, 2020

are (in thousands):

Deferred tax assets:

March 27,
2021

March 28,
2020

Accrued expenses and allowances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net operating loss carryforwards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Research and development tax credit carryforwards . . . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Lease liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 4,354
1,781
12,753
10,995
17,672
—

$ 2,750
2,093
13,066
8,380
18,095
1,260

Total deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Valuation allowance for deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 47,555
(12,782)

$ 45,644
(12,596)

Net deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 34,773

$ 33,048

Deferred tax liabilities:

Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Right of use asset
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total deferred tax liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total net deferred tax assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 4,059
16,987
3,100
650

$ 24,796
$ 9,977

$ 5,425
17,391
4,645
—

$ 27,461
$ 5,587

Deferred tax assets and liabilities are recorded for the estimated tax impact of temporary differences

between the tax basis and book basis of assets and liabilities. A valuation allowance is established against a
deferred tax asset when it is more likely than not that the deferred tax asset will not be realized. Our valuation
allowance increased by $0.2 million in fiscal year 2021 due to current year operations. The Company maintains a
valuation allowance for certain deferred tax assets primarily relating to certain state net operating loss and state
tax credit carryforwards due to the likelihood that they will expire or go unutilized. Management believes that the
Company’s results from future operations will generate sufficient taxable income in the appropriate jurisdictions
and of the appropriate character such that it is more likely than not that the remaining deferred tax assets will be
realized.

At March 27, 2021, the Company had gross federal net operating loss carryforwards of $4.4 million, all of

which related to acquired companies and are, therefore, subject to certain limitations under Section 382 of the
Internal Revenue Code. The federal net operating loss carryforwards expire in fiscal years 2022 through 2031. In
addition, at March 27, 2021 the Company had gross foreign net operating loss carryforwards of $0.3 million that
do not expire and gross state net operating loss carryforwards of $12.2 million that expire in fiscal years 2022
through 2029. In addition, the Company had $12.9 million of state business tax, minimum tax, and research and
development tax credit carryforwards. Certain of these state tax credits will expire in fiscal years 2022 through
2034, and others do not expire.

At March 27, 2021, unremitted earnings of our foreign subsidiaries that can be distributed without tax

consequence, other than withholding taxes that may apply based on the jurisdiction of the subsidiary, are not
expected to be indefinitely reinvested. No taxes have been accrued for foreign withholding taxes on these
earnings as these amounts are not material. We have not provided additional income taxes for other outside basis
differences inherent in our foreign entities, as these amounts continue to be indefinitely reinvested in foreign
operations. Determining the amount of unrecognized deferred tax liability related to all other outside basis
differences in these entities is not practicable at this time.

The following table summarizes the changes in the unrecognized tax benefits (in thousands):

Beginning balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additions based on tax positions related to the current year
. . . . . . . . . . . . . . .
Reductions based on tax positions related to the prior years . . . . . . . . . . . . . . .

$36,208
—
(3,329)

$39,746
615
(4,153)

Ending balance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$32,879

$36,208

March 27,
2021

March 28,
2020

At March 27, 2021, the Company had gross unrecognized tax benefits of $32.9 million, all of which would

impact the effective tax rate if recognized. During fiscal year 2021, the Company recorded a decrease of
$3.3 million related to prior year unrecognized tax positions. The Company’s unrecognized tax benefits are
classified as “Non-current income taxes” in the Consolidated Balance Sheet.

The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for

income taxes. During fiscal years 2021 and 2020 we recognized interest expense, net of tax, of approximately
$0.7 million and $0.9 million, respectively. The total amount of interest accrued as of March 27, 2021 was
$4.1 million.

The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple
state and foreign jurisdictions. Fiscal years 2017 through 2021 remain open to examination by the major taxing
jurisdictions to which the Company is subject, although carry forward attributes that were generated in tax years
prior to fiscal year 2017 may be adjusted upon examination by the tax authorities if they have been, or will be,
used in a future period. The Company’s fiscal year 2017, 2018, and 2019 federal income tax returns are under
examination by the U.S. Internal Revenue Service. The Company believes it has accrued adequate reserves
related to the matters under examination. The Company is not under an income tax audit in any other major
taxing jurisdiction.

19.

Segment Information

We determine our operating segments in accordance with Financial Accounting Standards Board (“FASB”)
guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under
these guidelines.

The Company operates and tracks its results in one reportable segment, but reports revenue performance in

two product lines: Audio and High-Performance Mixed-Signal. Our CEO receives and uses enterprise-wide
financial information to assess financial performance and allocate resources, rather than detailed information at a
product line level. Additionally, our product lines have similar characteristics and customers. They share
operations support functions such as sales, public relations, supply chain management, various research and
development and engineering support, in addition to the general and administrative functions of human
resources, legal, finance and information technology. Therefore, there is no complete, discrete financial
information maintained for these product lines. Revenue by product line is disclosed in Note 9 — Revenues.
Geographic details of revenue and property, plant and equipment are included below.

Geographic Area

The following illustrates sales by ship to location of the customer (in thousands):

China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hong Kong . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
South Korea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Japan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of World . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

March 27,
2021

$1,024,178
170,605
42,403
32,124
21,708
78,212

Fiscal Years Ended
March 28,
2020

$ 975,090
205,314
12,218
8,149
17,099
63,254

March 30,
2019

$ 922,202
166,460
856
9,210
26,182
60,614

Total consolidated sales . . . . . . . . . . . . . . . . . . . . . . . . .

$1,369,230

$1,281,124

$1,185,524

The following illustrates property, plant and equipment, net, by geographic locations, based on physical

location (in thousands):

United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
United Kingdom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rest of World . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Fiscal Years Ended

March 27,
2021

$116,649
29,895
8,398

March 28,
2020

$117,690
36,049
4,505

Total consolidated property, plant and equipment, net . . . . . . . . . . . . . . . . .

$154,942

$158,244

20. Quarterly Results (Unaudited)

The following quarterly results have been derived from our audited annual consolidated financial

statements. In the opinion of management, this unaudited quarterly information has been prepared on the same
basis as the annual consolidated financial statements and includes all adjustments, including normal recurring
adjustments, necessary for a fair presentation of this quarterly information. This information should be read along
with the financial statements and related notes. The operating results for any quarter are not necessarily
indicative of results to be expected for any future period.

The unaudited quarterly statement of operations data for each quarter of fiscal years 2021 and 2020 were as

follows (in thousands, except per share data):

Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Basic income per share . . . . . . . . . . . . . . . . . . . . . .
Diluted income per share . . . . . . . . . . . . . . . . . . . . .

1st
Quarter

$242,573
127,472
18,209
0.31
0.30

1st
Quarter

$238,253
122,494
4,618
0.08
0.08

Fiscal Year 2021
3rd
Quarter

2nd
Quarter

$347,325
180,210
59,486
1.02
0.99

$485,795
251,500
114,368
1.97
1.91

Fiscal Year 2020
3rd
Quarter

2nd
Quarter

$388,912
207,933
76,210
1.31
1.27

$374,668
197,505
68,512
1.18
1.13

4th
Quarter

$293,537
148,119
25,281
0.44
0.42

4th
Quarter

$279,291
146,235
10,158
0.17
0.17

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

ITEM 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(e) of the Exchange Act, we have evaluated, under the supervision and with the
participation of our management, including our chief executive officer (CEO) and chief financial officer (CFO),
the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules
13a-15(b) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Form 10-K. Our
disclosure controls and procedures are designed to provide reasonable assurance that the information required to
be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed,
summarized and reported within the time periods specified in the Securities and Exchange Commission rules and
forms and (ii) accumulated and communicated to our management, including our CEO and CFO, as appropriate,
to allow timely decisions regarding required disclosure. Based upon the evaluation, our management, including
our CEO and CFO, has concluded that our disclosure controls and procedures were effective as of March 27,
2021.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial

reporting, as such term is defined under Rule 13a-15(f). Under the supervision and with the participation of our
management, including our CEO and CFO, we assessed the effectiveness of our internal control over financial
reporting as of the end of the period covered by this report based on the criteria set forth in Internal Control-
Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013
framework).

Because of its inherent limitation, internal control over financial reporting may not prevent or detect all
errors and all fraud. In addition, projections of any evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in conditions and that the degree of compliance
with the policies or procedures may deteriorate.

Based on its assessment of internal control over financial reporting, management has concluded that our
internal control over financial reporting was effective as of March 27, 2021, to provide reasonable assurance
regarding the reliability of our financial reporting and the preparation of our financial statements for external
purposes in accordance with U.S. generally accepted accounting principles. Our independent registered public
accounting firm, Ernst & Young LLP, has issued an attestation report on management’s assessment of our
internal control over financial reporting as of March 27, 2021, included in Item 8 of this report.

Changes in Internal Control Over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the quarter

ended March 27, 2021, that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.

ITEM 10. Directors, Executive Officers and Corporate Governance

PART III

The information set forth in the proxy statement to be delivered to stockholders in connection with our

Annual Meeting of Stockholders to be held on July 30, 2021 (the “Proxy Statement”) under the headings
Corporate Governance, Proposals to be Voted on — Proposal No. 1 — Election of Directors, and Delinquent
Section 16(a) Reports, if applicable, is incorporated herein by reference. The Company has adopted a Code of
Conduct (“the Code”) that applies to all of its directors, officers, and employees. A copy of the Code can be
found within the Corporate Governance section of our “Investors” page on our website at investor.cirrus.com.
We intend to satisfy the disclosure requirements of the SEC regarding amendments to, or waivers from, the Code
by posting such information on the same website.

ITEM 11. Executive Compensation

The information set forth in the Proxy Statement under the headings Director Compensation Arrangements,

Compensation Discussion and Analysis, Compensation Committee Report, Consideration of Risk Related to
Compensation Programs, Executive Compensation Tables, Pay Ratio Disclosure, and Proposals to be Voted on
— Proposal No. 3 — Advisory Vote to Approve Executive Compensation is incorporated herein by reference.

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters

The information set forth in the Proxy Statement under the headings Equity Compensation Plan Information

and Security Ownership of Certain Beneficial Owners and Management is incorporated herein by reference.

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

The information set forth in the Proxy Statement under the headings Certain Relationships and Related

Transactions and Corporate Governance is incorporated herein by reference.

ITEM 14. Principal Accountant Fees and Services

The information set forth in the Proxy Statement under the headings Audit and Non-Audit Fees and Services

and Proposal No. 2 — Ratification of Appointment of Independent Registered Public Accounting Firm is
incorporated herein by reference.

ITEM 15. Exhibits and Financial Statement Schedules

(a) The following documents are filed as part of this Report:

1. Consolidated Financial Statements

PART IV

▪ Reports of Ernst & Young LLP, Independent Registered Public Accounting Firm.
▪ Consolidated Balance Sheets as of March 27, 2021 and March 28, 2020.
▪ Consolidated Statements of Income for the fiscal years ended March 27, 2021, March 28, 2020,

and March 30, 2019.

▪ Consolidated Statements of Comprehensive Income for the fiscal years ended March 27, 2021,

March 28, 2020, and March 30, 2019.

▪ Consolidated Statements of Cash Flows for the fiscal years ended March 27, 2021, March 28,

2020, and March 30, 2019.

▪ Consolidated Statements of Stockholders’ Equity for the fiscal years ended March 27, 2021,

March 28, 2020, and March 30, 2019.
▪ Notes to Consolidated Financial Statements.

2. Financial Statement Schedules

All schedules have been omitted since the required information is not present or not present in amounts

sufficient to require submission of the schedule, or because the information required is included in the
consolidated financial statements or notes thereto.

3. Exhibits

The following exhibits are files as part of or incorporated by reference into this Annual Report on Form

10-K.

Number

Description

3.1

3.2

4.1

10.1+

10.2+

10.3+

10.4+

10.5+

10.6+

10.7+

10.8+

Certificate of Incorporation of Registrant, filed with the Delaware Secretary of State on August 26,
1998. (1)

Amended and Restated Bylaws of Registrant. (2)

Description of Securities. (13)

Cirrus Logic, Inc. 2006 Stock Incentive Plan, amended and restated as of May 26, 2015. (6)

Form of Stock Option Agreement for options granted under the Cirrus Logic, Inc. 2006 Stock
Incentive Plan. (3)

Form of Stock Option Agreement for options for U.K. Employees under the Cirrus Logic, Inc. 2006
Stock Incentive Plan. (9)

Form of Notice of Grant of Stock Option for options granted under the Cirrus Logic, Inc. 2006 Stock
Incentive Plan. (3)

Form of Stock Option Agreement for Outside Directors under the Cirrus Logic, Inc. 2006 Stock
Incentive Plan. (5)

Form of Restricted Stock Unit Agreement for U.S. Employees under the Cirrus Logic, Inc. 2006
Stock Incentive Plan. (4)

Form of Restricted Stock Unit Agreement for U.K. Employees under the Cirrus Logic, Inc. 2006
Stock Incentive Plan. (8)

Form of Notice of Grant of Restricted Stock Units granted under the Cirrus Logic, Inc. 2006 Stock
Incentive Plan. (4)

Number
10.9+

10.10+

10.11+

10.12+

10.13+

10.14+

10.15+

10.16+

10.17+

10.18+

10.19+

10.20+

10.21+

10.22+

10.23+

10.24

21.1

23.1

24.1

31.1

31.2

32.1

32.2

101.INS

101.SCH

101.CAL

101.LAB

101.PRE

Description

Form of Performance Award Agreement for U.S. Employees under the Cirrus Logic, Inc. 2006
Stock Incentive Plan. (7)

Form of Notice of Performance Award Agreement for U.S. Employees under the Cirrus Logic Inc.
2006 Stock Incentive Plan. (8)

Form of Performance Award Agreement for U.K. Employees under the Cirrus Logic, Inc. 2006
Stock Incentive Plan. (9)

Executive Severance and Change of Control Plan, effective as of October 1, 2007, as amended and
restated on April 1, 2018. (11)

2007 Management and Key Individual Contributor Incentive Plan, as amended on May 20,
2016. (9)

Cirrus Logic, Inc. 2018 Long Term Incentive Plan. (12)

First Amendment to the Cirrus Logic, Inc. 2018 Long Term Incentive Plan (15)

Form of Restricted Stock Unit Agreement. (12)

Form of Notice of Grant of Restricted Stock Units. (12)

Form of Performance Award Agreement. (12)

Form of Notice of Grant of Performance Award. (12)

Form of Stock Option Agreement. (12)

Form of Notice of Grant of Stock Option. (12)

Form of Notice of Grant of Stock Award. (12)

Transition Agreement, dated October 30, 2020. (14)

Amended and Restated Credit Agreement among the Company, Wells Fargo Bank, National
Association, as Administrative Agent and Initial Issuing Lender, and Bank of America, N.A., as
Syndication Agent. (10)

List of Subsidiaries.

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.

Power of Attorney (see signature page).

Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.

Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.

Certification of Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.

Certification of Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.

XBRL Instance Document — the instance document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Label Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Number
101.DEF

104

Description

XBRL Taxonomy Extension Definition Linkbase Document

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

+ Indicates a management contract or compensatory plan or arrangement.

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

Incorporated by reference from Registrant’s Report on Form 10-K for the fiscal year ended March 31,
2001, filed with the SEC on June 22, 2001 (Registration No. 000-17795).
Incorporated by reference from Registrant’s Report on Form 8-K filed with the Commission on
March 26, 2021 (Registration No. 000-17795).
Incorporated by reference from Registration’s Statement on Form S-8 filed with the SEC on August 1,
2006 (Registration No. 000-17795).
Incorporated by reference from Registrant’s Report on Form 8-K filed with the SEC on October 7,
2010.
Incorporated by reference from Registrant’s Report on Form 8-K filed with the SEC on August 1,
2007.
Incorporated by reference to Exhibit A of the Registrant’s Definitive Proxy Statement on Schedule 14A
filed with the SEC on June 2, 2015.
Incorporated by reference from Registrant’s Report on Form 8-K filed with the SEC on September 22,
2014.
Incorporated by reference from Registrant’s Report on Form 10-K filed with the SEC on May 27, 2015
(Registration No. 000-17795).
Incorporated by reference from Registrant’s Report on Form 10-K filed with the SEC on May 25, 2016
(Registration No. 000-17795).

(10) Incorporated by reference from Registrant’s Report on Form 8-K filed with the SEC on July 15, 2016

(Registration No. 000-17795).

(11) Incorporated by reference from Registrant’s Report on Form 10-K filed with the SEC on May 30, 2018

(Registration No. 000-17795).

(12) Incorporated by reference from Registrant’s Statement on Form S-8 filed with the SEC on August 3,

2018 (Registration No. 333-226578).

(13) Incorporated by reference from Registrant’s Report on Form 10-Q filed with the SEC on August 3,

2020 (Registration No. 000-17795).

(14) Incorporated by reference from Registrant’s Report on Form 8-K filed with the SEC on November 2,

2020 (Registration No. 000-17795).

(15) Incorporated by reference to Exhibit 1 to the Registrant’s Definitive Proxy Statement filed with the

SEC on June 3, 2020 (Registration No. 000-17795).

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant

has duly caused this report to be signed on its behalf by the undersigned; thereunto duly authorized.

Signatures

CIRRUS LOGIC, INC.

By: /S/ THURMAN K. CASE

Thurman K. Case
Vice President, Chief Financial Officer and
Principal Accounting Officer
May 21, 2021

KNOW BY THESE PRESENT, that each person whose signature appears below constitutes and appoints
Thurman K. Case, his attorney-in-fact, with the power of substitution, for him in any and all capacities, to sign
any amendments to this report on Form 10-K and to file the same, with exhibits thereto and other documents in
connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that
each of the attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, the following persons on behalf of the

Registrant, in the capacities and on the dates indicated have signed this report below:

Signature

Title

Date

/S/ JOHN M. FORSYTH
John M. Forsyth

/S/ THURMAN K. CASE
Thurman K. Case

/S/ JOHN C. CARTER
John C. Carter

/S/ ALEXANDER M. DAVERN
Alexander M. Davern

/S/ TIMOTHY R. DEHNE
Timothy R. Dehne

/S/ DEIRDRE R. HANFORD
Deirdre R. Hanford

/S/ CATHERINE P. LEGO
Catherine P. Lego

/S/ ALAN R. SCHUELE
Alan R. Schuele

/S/ DAVID J. TUPMAN
David J. Tupman

President and Chief Executive Officer

May 21, 2021

Vice President, Chief Financial Officer
and Principal Accounting Officer

May 21, 2021

Director

[THIS PAGE INTENTIONALLY LEFT BLANK]

JOHN FORSYTH
President and Chief Executive Officer

June 3, 2021

To our Stockholders:

I would like to invite you to participate in the Annual Meeting of Stockholders of Cirrus
Logic, Inc. to be held on Friday, July 30, 2021, at 11:00 a.m. Central Time. This year’s Annual
Meeting will once again be a virtual-only stockholder meeting, which, due to the public health
impact of COVID-19, allows us to support the well-being of our employees and stockholders
while also allowing a broader group of stockholders to participate. You will be able to participate,
vote,
at
www.virtualshareholdermeeting.com/CRUS2021. To access this website and enter the meeting,
you should have available your control number, which is included with the proxy materials. We
intend to hold the virtual-only meeting in a manner that affords you the same rights and
opportunities to participate as you would have at an in-person meeting.

live webcast

the meeting

questions

submit

during

your

and

We are providing the proxy materials electronically via the internet, which will allow our
stockholders to have immediate access to those materials at their discretion. Paper copies may
also be requested.

Even if you plan to participate in the Annual Meeting by live webcast, I hope you will vote
as soon as possible. Although you may vote the day of the Annual Meeting, you may also vote in
advance via the internet, as well as by telephone, or by mailing a proxy card. Voting in advance
over the internet, by telephone, or by written proxy will ensure your representation at the Annual
Meeting if you do not participate in the virtual meeting. Please review the instructions on the
Notice of Internet Availability or the proxy card regarding each of these voting options.

Cirrus Logic values the participation of its stockholders. Your vote is an important part of

our system of corporate governance, and I strongly encourage you to participate.

Sincerely,

John Forsyth
President and Chief Executive Officer

[THIS PAGE INTENTIONALLY LEFT BLANK]

TABLE OF CONTENTS

Notice of Annual Meeting of Stockholders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Questions and Answers About the Proxy Materials, the Annual Meeting, and Voting

Procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Proposals To Be Voted On . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Proposal No. 1: Election of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Proposal No. 2: Ratification of Appointment of Independent Registered Public

Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Proposal No. 3: Advisory Vote To Approve Executive Compensation . . . . . . . . . . . . . .

Other Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Security Ownership of Certain Beneficial Owners and Management . . . . . . . . . . . . . . . . . . . . . . .

Executive Officers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Compensation Discussion and Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Compensation Committee Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Consideration of Risk Related to Compensation Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Executive Compensation Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Equity Compensation Plan Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Pay Ratio Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Report of the Audit Committee of the Board . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Audit and Non-Audit Fees and Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Certain Relationships and Related Transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Householding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Communicating with Us . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annual Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page
1

Important Notice Regarding the Availability of Proxy Materials for the 2021 Annual
Meeting of Stockholders to be held July 30, 2021

Copies of the Notice of the 2021 Annual Meeting of Stockholders, this proxy statement, and our
Annual Report on Form 10-K are also available on our website at www.cirrus.com. You also may
receive copies of these documents at no charge upon request directed to:

Cirrus Logic, Inc. Investor Relations
800 W. 6th Street, Austin, Texas 78701
telephone: (512) 851-4125; email: investor@cirrus.com

Cirrus Logic, Inc.
800 W. 6th Street
Austin, Texas 78701

2021 Annual Meeting of Stockholders

July 30, 2021
YOUR VOTE IS IMPORTANT

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

Cirrus Logic, Inc. (the “Company” or “we”) will hold our 2021 Annual Meeting of Stockholders as
follows:

Friday, July 30, 2021
11:00 A.M. (Central Daylight Time)
Via live webcast available at www.virtualshareholdermeeting.com/CRUS2021

This year’s Annual Meeting will again be a virtual-only meeting, which we intend to hold in a manner
that affords you the same rights and opportunities to participate as you would have at an in-person
meeting. You will be able to attend, vote, and submit your questions during the meeting on a live
webcast via the internet at www.virtualshareholdermeeting.com/CRUS2021. To access this website
and enter the meeting, you must have your control number available. You will not be able to attend the
Annual Meeting in person.

While connected to the Annual Meeting via the internet, you may vote and submit questions. We will
answer any timely submitted and relevant questions on a matter to be voted on at the Annual Meeting
before voting is closed on the matter. Following adjournment of the formal business of the Annual
Meeting, we will address appropriate general questions from stockholders regarding the Company as
time allows. Questions relating to stockholder proposals or the Company may be submitted in the field
provided in the web portal at or before the time the questions are to be discussed. If we receive
substantially similar questions, we may group those questions together and provide a single response to
avoid repetition. Answers to any relevant questions not answered at the Annual Meeting will be posted
on the “Ask the CEO” section of our website at investor.cirrus.com following the Annual Meeting.

We are utilizing a leading virtual meeting solution from Broadridge Financial Solutions, Inc., or
Broadridge. Both we and Broadridge will test the platform technology before going “live” for the
Annual Meeting. If you have any questions about accessing the virtual meeting website for the Annual
Meeting, please contact Broadridge VSM support at 844-986-0822 / International: 303-562-9302. If
you encounter any technical difficulties with the virtual meeting during the log in or meeting time,
please call the technical support number that will be posted on the virtual meeting login page.

At the meeting, stockholders will vote on the following matters:

(i)

(ii)

(iii)

(iv)

the election of seven nominees named in this proxy statement to serve as Company directors for
one-year terms;

the ratification of the appointment of Ernst & Young LLP as our independent registered public
accounting firm for the fiscal year ending March 26, 2022;

an advisory (non-binding) vote to approve executive compensation; and

such other business as may properly come before the meeting.

You can vote four different ways. You can vote by participating in the virtual meeting online, or you
can vote in advance of the virtual meeting by internet, by telephone, or by mail. For specific voting
information, please see “Questions and Answers about the Proxy Materials, the Annual Meeting, and
Voting Procedures” on page 3.

Stockholders of record at the close of business on June 1, 2021, are entitled to notice of, and to vote at,
the Annual Meeting. On June 1, 2021, approximately 57,525,391 shares of the Company common
stock were outstanding. Each share entitles the holder to one vote. A complete list of the stockholders
entitled to vote at the meeting will be open to the examination of any stockholder for any purpose
germane to the meeting for at least 10 days prior to the meeting and during the meeting.

The Board of Directors of the Company asks you to vote in favor of the seven nominated directors and
for Proposal Nos. 2 and 3. The Company knows of no other matters that will be presented for
consideration at the Annual Meeting. If any other matters properly come before the Annual Meeting, it
is the intention of the persons named in the proxy to vote the shares they represent as the Board may
recommend. Discretionary authority with respect to such other matters is granted by the execution of
the proxy. This proxy statement provides you with detailed information about each proposal. We are
also using this proxy statement to discuss our corporate governance and compensation practices and
philosophies.

We encourage you to read this proxy statement carefully. In addition, you may obtain information
about the Company from the Annual Report to Stockholders and from other documents that we have
filed with the Securities and Exchange Commission.

PROXY STATEMENT

2021 ANNUAL MEETING OF STOCKHOLDERS
To Be Held Friday, July 30, 2021

Cirrus Logic, Inc.
800 W. 6th Street
Austin, Texas 78701
www.cirrus.com

These proxy materials are furnished to you in connection with the solicitation of proxies by the Board
of Directors (the “Board”) of Cirrus Logic, Inc. (the “Company” or “we”) for use at our 2021 Annual
Meeting of Stockholders and any adjournments or postponements of the meeting (the “Annual
Meeting”). The Annual Meeting will be held on July 30, 2021, at 11:00 a.m., Central Daylight Time,
and may be accessed on a live webcast via the internet at www.virtualshareholdermeeting.com/
CRUS2021.

Beginning on June 18, 2021, Cirrus Logic will make these proxy materials available to our
stockholders on the internet or through the mail in connection with the solicitation of proxies by the
Board for proposals to be voted on at the Annual Meeting.

QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS,
THE ANNUAL MEETING, AND VOTING PROCEDURES

Q: Why am I receiving these materials?
A: The Board, on behalf of the Company, is soliciting your proxy for the Annual Meeting of

Stockholders to take place on July 30, 2021. As a stockholder of record as of the close of business
on June 1, 2021 (the “Record Date”), you are invited to participate in the meeting and are entitled
to and requested to vote on the proposals described in this proxy statement.

Q: Who is entitled to notice of and to vote at the Annual Meeting?
A: Stockholders of record as of the Record Date are entitled to notice of and to vote at the Annual

Meeting.

Q: What information is contained in these materials?
A: The information included in this proxy statement relates to the proposals to be voted on at the
meeting, the voting process, the compensation of directors and our most highly paid executive
officers, and certain other required information. Our 2021 Annual Report to Stockholders on Form
10-K for the fiscal year ended March 27, 2021, is also being made electronically available or
mailed to each stockholder as of the Record Date.

If you requested and received a copy of these materials by mail or email, then the proxy materials
also include a proxy card or a voting instruction card for the Annual Meeting.

Q: Why did I receive a notice in the mail regarding the internet availability of the proxy materials

instead of a paper copy of the proxy materials?

A: We are complying with the U.S. Securities and Exchange Commission (the “SEC”) rule that allows
companies to furnish their proxy materials over the internet. As a result, we are mailing to our
stockholders a Notice of Internet Availability of the proxy materials instead of a paper copy of the
proxy materials. All stockholders receiving the Notice of Internet Availability will have the ability
to access the proxy materials over the internet, or alternatively, request to receive a copy of the
proxy materials by mail or email.

Q. How can I access the proxy materials over the internet?
A: Your Notice of Internet Availability of the proxy materials contains instructions regarding how to:

Š
Š
Š

view the proxy materials for the Annual Meeting on the internet;
request a paper copy of the proxy materials for the Annual Meeting; and
instruct us to send future proxy materials to you by email.

Q: How may I obtain a paper copy of the proxy materials?
A: Your Notice of Internet Availability of the proxy materials contains instructions regarding how to

obtain a paper copy of the proxy materials.

Q: What if I receive more than one Notice of Internet Availability of the proxy materials or more

than one paper copy of the proxy materials?

A: If you receive more than one Notice of Internet Availability or set of proxy materials, it means your
shares are registered differently or are in more than one account. To vote all your shares by proxy,
you must vote using all Notices of Internet Availability you receive, or all proxy cards and voting
instruction cards you received.

Q: What proposals will be voted on at the meeting?
A: There are three proposals scheduled to be voted on at the meeting:

(1)

(2)

the election of seven nominees named in this proxy statement to serve as Company directors
for one-year terms;
the ratification of the appointment of Ernst & Young LLP (“Ernst & Young”) as our
independent registered public accounting firm for the fiscal year ending March 26, 2022; and

(3) an advisory (non-binding) vote to approve executive compensation.

Q: Will I be able to attend the Annual Meeting?
A: We will host the Annual Meeting live via the internet. You will not be able to attend the meeting
in person. Any stockholder can listen to and participate in the Annual Meeting live via the internet
at www.virtualshareholdermeeting.com/CRUS2021. The webcast will begin at 11:00 a.m., Central
Daylight Time, on July 30, 2021. Stockholders as of the Record Date may vote and submit
questions while connected to the Annual Meeting via the internet. We will answer any timely
submitted and relevant questions on a matter to be voted on at the Annual Meeting before voting is
closed on the matter. Following adjournment of the formal business of the Annual Meeting, we will
address appropriate general questions from stockholders regarding the Company as time allows.
Questions relating to stockholder proposals or the Company may be submitted in the field provided
in the web portal at or before the time the questions are to be discussed. If we receive substantially
similar questions, we may group those questions together and provide a single response to avoid
repetition. Answers to any relevant questions not answered at the Annual Meeting will be posted
on the “Ask the CEO” section of our website at investor.cirrus.com following the Annual Meeting.

Q: What do I need to do to be able to participate in the Annual Meeting online?
A: The Annual Meeting will be held live via the internet. You will not be able to attend the meeting in
person. A summary of the information you need to attend the meeting online is provided below:
Š

Any stockholder can listen to the meeting and participate live via the internet at
www.virtualshareholdermeeting.com/CRUS2021.

Š Webcast begins at 11:00 a.m. Central Daylight Time on July 30, 2021.
Š

Stockholders as of the Record Date may vote and submit questions while connected to the
meeting via the internet.
Please have your control number to enter the meeting.
Instructions on how to connect and participate via the internet, including how to demonstrate
proof of stock ownership, are posted at www.virtualshareholdermeeting.com/CRUS2021.

Š
Š

Š A webcast replay of the meeting will be available after the meeting at

www.virtualshareholdermeeting.com/CRUS2021.

Q: What are the Board’s voting recommendations?
A: The Board recommends that you vote your shares as follows:

Š
Š

“FOR” each of the director nominees;
“FOR” the ratification of the appointment of Ernst & Young as our independent registered
public accounting firm for the fiscal year ending March 26, 2022; and
“FOR” the approval, on a non-binding, advisory basis, of executive compensation.

Q: What shares owned by me can be voted?
A: All shares owned by you as of the close of business on the Record Date may be voted by you.
These shares include (1) shares held directly in your name as the stockholder of record, and
(2) shares held for you as the beneficial owner through a stockbroker, bank, or other nominee;
however you will need to demonstrate proof of ownership pursuant to the instructions provided at
www.virtualshareholdermeeting.com/CRUS2021. Stockholders who hold their shares through a
stock brokerage account or by a bank or other nominee will need to obtain a legal proxy from their
nominee in advance of the meeting in order to vote during the meeting.

Q: What is the difference between holding shares as a stockholder of record and as a beneficial

owner?

A: Most stockholders of the Company hold their shares through a stockbroker, bank, or other nominee
rather than directly in their own name. As summarized below, there are some distinctions between
shares held of record and those owned beneficially.

Stockholder of Record
If your shares are registered directly in your name with the Company’s transfer agent,
Computershare Investor Services, you are considered, with respect to those shares, the stockholder
of record, and, if you held those shares as of the Record Date, you have the right to vote by proxy
by following the instructions in the Notice of Internet Availability of the proxy materials or to vote
online at the meeting.

Beneficial Owner
If your shares are held in a stock brokerage account or by a bank or other nominee, you are
considered the beneficial owner of shares held in street name, and your stockbroker, bank, or other
nominee is considered, with respect to those shares, the stockholder of record. As the beneficial
owner, you have the right to direct your stockbroker, bank, or other nominee how to vote, and you
are also invited to participate in the meeting.

Q: How can I vote my shares at the meeting?
A: Shares may be voted at the Annual Meeting via the internet on a live webcast at

www.virtualshareholdermeeting.com/CRUS2021. To access the meeting and vote your shares, you
must have your control number.

Even if you currently plan to participate in the Annual Meeting via the live webcast, we recommend
that you submit your proxy in advance of the meeting so that your vote will be counted if you later
decide not to attend the meeting.

Q: How can I vote my shares without participating in the meeting?
A: Whether you hold shares directly as the stockholder of record or beneficially in street name, you

may direct your vote without participating in the meeting. You may vote by granting a proxy or by
submitting voting instructions to your stockbroker, bank, or other nominee for shares held in street
name. In most instances, you will be able to do this over the internet, by telephone, or by mail, but
if you hold shares in street name, you should refer to the voting instructions provided to you by
your stockbroker, bank, or other nominee for voting instructions specific to your holdings. If you
are the stockholder of record, please refer to the summary instructions below and those included on
your Notice of Internet Availability of the proxy materials. Specifically, you may vote without
participating in the meeting:

BY INTERNET – If you have internet access, you may vote by going to www.proxyvote.com and
following the instructions included with the proxy materials. You will need to have the control
number on your Notice of Internet Availability on your proxy card in order to vote by internet.

BY TELEPHONE – If you have access to a touch-tone telephone, you may vote by calling
1-800-690-6903 and following the instructions within the proxy materials. You will need to have
the control number that appears on your Notice of Internet Availability of the proxy materials
available when voting by telephone.

BY MAIL – If you have requested and received a paper copy of a proxy card, you may submit a
proxy by signing your proxy card and returning it by mail using the enclosed, postage prepaid and
addressed envelope. If you sign but do not provide instructions, your shares will be voted as
described in the response to “What are the Board’s voting recommendations?” above.

Q: What if I hold shares in street name and do not transmit voting instructions before the

stockholder meeting to my stockbroker, bank, or other nominee?

A: If you do not transmit voting instructions, your stockbroker is permitted to vote on your behalf on

routine matters only. The ratification of the appointment of independent registered public
accounting firm (Proposal No. 2) is the only routine matter, and therefore, the only matter that
brokers may vote on without instruction from the beneficial owner. Your stockbroker is not
permitted to vote on your behalf on non-routine matters if you do not transmit your voting
instructions. The election of directors (Proposal No. 1) and the advisory vote to approve executive
compensation (Proposal No. 3) are considered non-routine matters. Therefore, if you do not
transmit your voting instructions to your stockbroker or other nominee, then they cannot vote on
these non-routine matters and your vote will be counted as “broker non-votes” as further described
in the response to “How are abstentions and broker non-votes counted?” below.

Q: Can I revoke my proxy?
A: You may revoke your proxy instructions at any time prior to the vote at the Annual Meeting. For

shares held directly in your name, you may revoke your proxy instructions by granting a new proxy
bearing a later date (that automatically revokes the earlier proxy) or by voting during the Annual
Meeting. For shares held beneficially by you, you may revoke your proxy by submitting new
instructions to your stockbroker, bank, or other nominee.

Q: What is the quorum requirement for the meeting?
A: The quorum requirement for holding the meeting and transacting business is the presence, either in
person or represented by proxy, of the holders of a majority of the outstanding shares entitled to be
voted at the Annual Meeting. For the Annual Meeting, both abstentions and broker non-votes are
counted as present for the purpose of determining the presence of a quorum.

Q: How are votes counted?
A: In the election of directors, you may vote “FOR” all of the nominees or you may “WITHHOLD”
your vote with respect to one or more of the nominees. For all other proposals you may vote
“FOR,” “AGAINST,” or “ABSTAIN,” and if you “ABSTAIN” on any of these matters, it has the
same effect as a vote “AGAINST,” as described in response to the question below.

If you sign your proxy card with no further instructions, your shares will be voted in accordance
with the recommendations of the Board.

Q: What is the voting requirement to approve each of the proposals?
A: Directors are elected by a plurality of votes cast, which means that, for this year, the seven persons

receiving the highest number of “FOR” votes will be elected. All other proposals require the
affirmative “FOR” vote of a majority of those shares present and entitled to vote. If you are a
beneficial owner and do not provide your stockbroker, bank, or other nominee with voting
instructions on a non-routine matter such as a director election, your shares may constitute broker
non-votes, as described in “How are abstentions and broker non-votes counted?” below.

Q: How are abstentions and broker non-votes counted?
A: Abstentions and broker non-votes are counted as present for purposes of determining the shares

present and entitled to vote for purposes of the quorum requirement. For Proposal Nos. 2 and 3, an
abstention is treated as a vote cast for purposes of counting votes, and therefore the effect of an
abstention will be the same as a vote against a proposal as described in “How are votes counted?”
above. Broker non-votes are not counted as votes cast, and therefore have no impact on non-routine
matters. Generally, broker non-votes occur when shares held by a stockbroker for a beneficial
owner are not voted with respect to a particular proposal because the proposal is a non-routine
matter, the stockbroker has not received voting instructions from the beneficial owner, and the
stockbroker lacks discretionary voting power to vote the shares.

Q: Where can I find the voting results of the meeting?
A: We will announce preliminary voting results at the meeting and will file with the SEC via EDGAR

a Current Report on Form 8-K within four business days of the meeting with the final voting
results. If final voting results are not available at the time of such filing, the Company intends to
disclose preliminary voting results at the time of the filing and file an amended Current Report on
Form 8-K within four business days after obtaining the final results.

Q: What happens if additional proposals are presented at the meeting?
A: Other than the proposals described in this proxy statement, we do not expect any matters to be
presented for a vote at the Annual Meeting. If you grant a proxy, the persons named as proxy
holders, Gregory Scott Thomas, our Corporate Secretary, and Thurman Case, our Chief Financial
Officer, will have the discretion to vote your shares on any additional matters properly presented
for a vote at the meeting. If for any unforeseen reason any of our nominees is not available as a
candidate for director, the persons named as proxy holders will vote your shares for such other
candidate or candidates as may be nominated by the Board or the Board may reduce the size of the
Board.

Q: What classes of shares are entitled to be voted?
A: Each share of common stock of the Company (“common stock”) outstanding as of the Record Date
is entitled to one vote on each item being voted upon at the Annual Meeting. On the Record Date,
we had approximately 57,525,391 shares of common stock outstanding.

Q: Is cumulative voting permitted for the election of directors?
A: No.

Q: Who will count the votes?
A: A representative of Broadridge Investor Communications Solutions will tabulate the votes. A

representative of the Company will act as the inspector of election.

Q: Is my vote confidential?
A: Proxy instructions, ballots, and voting tabulations that identify individual stockholders are handled
in a manner that protects your voting privacy. Your vote will not be disclosed either within the
Company or to third parties except (1) as necessary to meet applicable legal requirements, (2) to
allow for the tabulation of votes and certification of the vote, or (3) to facilitate a successful proxy
solicitation by the Board.

Q: Who will bear the cost of soliciting votes for the meeting?
A: The Company will pay the entire cost of soliciting proxies to be voted, along with the costs of
preparing, assembling, printing, mailing, and distributing the proxy materials. If you choose to
access the proxy materials and/or submit your proxy over the internet or by telephone, however,
you are responsible for internet access or telephone charges you may incur. In addition to the
mailing of the proxy materials, the solicitation of proxies or votes may be made by our directors,
officers, and employees, either in person, by telephone, or by electronic communication. Our
directors, officers, and employees will not receive any additional compensation for the solicitation
activities. We will also reimburse brokerage houses and other custodians, nominees, and fiduciaries
for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our
stockholders.

Q: May I propose actions for consideration at next year’s annual meeting of stockholders or

nominate individuals to serve as directors?

A: You may make nominations and submit proposals for consideration at future stockholder meetings.
Any proposal that a stockholder wishes to include in the Company’s proxy materials for the 2022
annual meeting of stockholders, in accordance with the regulations of the SEC, must be received by
no later than 120 calendar days prior to the anniversary date that the Company released this proxy
statement for the Annual Meeting (February 18, 2022). The written proposal will need to comply
with the regulations of the SEC under Rule 14a-8 regarding the inclusion of stockholder proposals
in company-sponsored proxy materials. Any proposal or nomination for election of directors that a
stockholder wishes to propose for consideration at the 2022 annual meeting of stockholders, other
than pursuant to Rule 14a-8, must be submitted in accordance with our Bylaws. To be considered
timely, our Bylaws provide that such notice must be received at our principal executive offices no
earlier than 120 calendar days (April 1, 2022) and no later than 90 calendar days (May 1, 2022)
prior to the first anniversary date of the previous year’s annual meeting of stockholders. Proposals
and nominations should be addressed to: Corporate Secretary, Cirrus Logic, Inc., 800 W. 6th Street,
Austin, Texas 78701.

Copy of Bylaw Provisions: You may contact the Corporate Secretary at our headquarters, 800 W.
6th Street, Austin, Texas 78701, for a copy of the relevant Bylaw provisions regarding the
requirements for making stockholder proposals and nominating director candidates.

CORPORATE GOVERNANCE

Board Meetings and Committees
During the fiscal year ended March 27, 2021, the Board held 12 meetings. Directors are expected to
attend each meeting of the Board and the committees of the Board (the “Committees”) on which they
serve. During the period of their service, no director attended less than 75% of the aggregate of (i) the
total number of Board meetings and (ii) the total number of their Committee meetings. Pursuant to our
Corporate Governance Guidelines, directors are also expected to attend the Company’s Annual

Meeting of Stockholders absent extraordinary circumstances. All directors attended the Company’s
2020 annual meeting of stockholders.

We have three Committees: Audit, Compensation and Human Resources, and Governance and
Nominating. Each member of the Audit, Compensation and Human Resources, and Governance and
Nominating Committees is independent in accordance with the applicable SEC rules and applicable
Nasdaq Stock Market, Inc. (the “Nasdaq”) listing standards, including, with respect to members of the
Audit and Compensation and Human Resources Committees, the heightened requirements applicable
to members of those committees. Each Committee has a written charter that has been approved by the
Board; the Committee charters are available under the Corporate Governance section of our
“Investors” page on our website at investor.cirrus.com.

During fiscal year 2021, effective January 1, 2021, Jason Rhode resigned from our Board, and John
Forsyth was appointed to the Board to fill Dr. Rhode’s vacancy. These changes corresponded with
transitioning the role of Chief Executive Officer from Dr. Rhode to Mr. Forsyth, effective January 1,
2021, which is discussed elsewhere in this proxy statement. Also effective January 1, 2021, director
David Tupman became Chair of the Board, succeeding Alan Schuele ahead of his retirement from the
Board at this year’s Annual Meeting.

The composition of the Board and each Committee is identified in the following table, and the function
of each Committee is described below. On occasion, the Board may appoint special committees or
designate directors to undertake special assignments on behalf of the Board.

Current Directors
John C. Carter
Alexander M. Davern
Timothy R. Dehne
John M. Forsyth
Deirdre R. Hanford
Catherine P. Lego
Alan R. Schuele
David J. Tupman, Chair
Former Directors (served
during fiscal year)
Jason P. Rhode
Number of Meetings Held in
Fiscal Year 2021

Independent
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes

Audit
X
Chair

Compensation
and Human
Resources
X

Chair

Governance and
Nominating

X
Chair

Audit Committee
The Audit Committee is currently composed of three independent directors. The responsibilities of the
Audit Committee include:
Š

selecting, retaining, compensating, overseeing, evaluating, and, where appropriate, terminating
the Company’s independent auditors;

resolving any disagreements between management and the independent auditors regarding
financial reporting;

adopting and implementing pre-approval policies and procedures for audit and non-audit
services to be rendered by the independent auditors;

reviewing with management and the independent auditors the financial information and the
Management’s Discussion and Analysis proposed to be included in each of the Company’s
Quarterly Reports on Form 10-Q prior to their filing;

reviewing before release the unaudited interim financial results in the Company’s quarterly
earnings release;

reviewing with management and the independent auditors, at the completion of the annual audit,
the audited financial statements and the Management’s Discussion and Analysis proposed to be
included in the Company’s Annual Report on Form 10-K prior to its filing and provide or review
judgments about the quality, not only the acceptability, of accounting principles, and such other
matters required to be discussed with the independent auditors under generally accepted auditing
standards;

reviewing with management and the independent auditors any required Environmental, Social,
and Governance (“ESG”) disclosures included within the Company’s SEC filings, including
human capital disclosures required by Item 101(c) of Regulation S-K, and the adequacy and
effectiveness of applicable internal controls related to such disclosures;

reviewing with the independent auditors critical audit matters (CAMs) and related CAM
disclosures;

reviewing and approving, if appropriate, material changes to the Company’s auditing and
accounting principles and practices as suggested by the independent auditors or management;

establishing procedures for (i) the receipt, retention, and treatment of complaints received by the
Company regarding accounting, internal accounting controls, or auditing matters, and (ii) the
confidential, anonymous submission by employees of the Company of concerns regarding
questionable accounting or auditing matters;

evaluating the professional competency of the financial staff and the internal auditors, as well as
the quality of their performance in discharging their respective responsibilities;

discussing policies with respect to risk assessment and risk management, including appropriate
guidelines and policies to govern the process; and

reviewing with management the Company’s major financial and regulatory risk exposures,
including cybersecurity-related risks, and the steps management has taken to monitor and
control such exposures.

The Board has determined that each of the members of the Audit Committee is able to read and
understand fundamental financial statements and is independent under applicable SEC rules and
applicable Nasdaq listing standards. The Board has also determined that each member is an “audit
committee financial expert” as defined under applicable SEC rules.

For additional information relating to the Audit Committee, see the section of this proxy statement
entitled, “Report of the Audit Committee of the Board” and the Audit Committee Charter, which is
available under the Corporate Governance section of our “Investors” page on our website at
investor.cirrus.com.

Compensation and Human Resources Committee
The Compensation and Human Resources Committee (“Compensation Committee”) is currently
composed of three independent directors. The Compensation Committee reviews and approves salaries
and other matters relating to executive compensation; reviews the Company’s leadership development
initiatives and succession planning process for our Chief Executive Officer and other executive

officers; and administers the Company’s stock incentive plans, including reviewing and granting stock
incentive awards to executive officers and other employees and reviewing and approving policies and
procedures for awarding grants under these plans. The Compensation Committee also reviews and
recommends to the Board for approval various other Company compensation plans, policies and
matters related to the Company’s non-employee directors. Additionally, the Compensation Committee
assists the Board in its ESG oversight by reviewing ESG matters relating to the Company’s workforce,
including human capital management, inclusion and diversity, and the workforce portion of the
Company’s ESG report. For additional information relating to the Compensation Committee, see the
Compensation and Human Resources Committee Charter, which is available under the Corporate
Governance section of our “Investors” page on our website at investor.cirrus.com.

Please see the “Compensation Discussion and Analysis” section of this proxy statement for additional
information regarding the Compensation Committee’s processes and procedures for the consideration
and determination of executive officer compensation, including the Compensation Committee’s
engagement of Compensia, Inc. (“Compensia”) as its external compensation consultant.

Governance and Nominating Committee
The Governance and Nominating Committee is currently composed of three independent directors. The
Governance and Nominating Committee provides counsel to the Board with respect to corporate
governance matters and Board organization, membership, and function, as well as committee structure
and membership. The Governance and Nominating Committee is responsible for defining the
qualifications for candidates for director positions, evaluating qualified candidates, recommending
candidates to the Board for election as directors, and proposing a slate of directors for election by
stockholders at each annual meeting. Additionally, this committee assists the Board in its ESG
oversight by reviewing ESG matters, including the Company’s ESG report, not assigned to other
committees. For more information relating to the Governance and Nominating Committee, see the
Governance and Nominating Committee Charter, which is available under the Corporate Governance
section of our “Investors” page on our website at investor.cirrus.com.

The Governance and Nominating Committee annually reviews the needs of the Board for various
skills, experience, expected contributions, and other characteristics in determining the director
candidates to be nominated at the Annual Meeting of Stockholders. The Governance and Nominating
Committee will evaluate candidates for directors proposed by directors, stockholders, or management
in light of the Governance and Nominating Committee’s views of the current needs of the Board for
certain skills; the candidate’s background, skills, experience, expected contributions, or other
characteristics; and the qualification standards established from time to time by the Governance and
Nominating Committee. If the Governance and Nominating Committee believes that the Board
requires additional candidates for nomination, the Governance and Nominating Committee may engage
a third-party search firm to assist in identifying qualified candidates. All directors and nominees will
submit a completed form of directors’ and officers’ questionnaire as part of the nominating process.
The process may also include interviews and additional background and reference checks for
non-incumbent nominees, at the discretion of the Governance and Nominating Committee. The
Governance and Nominating Committee believes it is important to consider diversity of gender, race,
ethnicity, age, education, cultural background, and professional experiences and has formalized its
existing practice to require inclusion of women and underrepresented minority candidates in the pool
from which nominees are identified. The Board’s objective is to nominate a diverse group of directors
who can best ensure the continuing success of our business and represent stockholder interests through
the exercise of sound judgment and constructive working relationships.

The Governance and Nominating Committee believes that members of the Board should possess
certain basic personal and professional qualities in order to properly discharge their fiduciary duties to

stockholders, provide effective oversight of the management of the Company, and monitor the
Company’s adherence to principles of sound corporate governance. Therefore, the Governance and
Nominating Committee has determined that nominees for election as director should have the
following qualifications: (i) possess the highest personal and professional ethics, integrity, and values;
(ii) be committed to representing the long-term interests of the Company’s stockholders; (iii) have an
inquisitive and objective perspective and mature judgment; (iv) possess strong business and financial
acumen and judgment acquired through education, training, or experience; (v) possess experience at
policy-making levels in business, government, education, or technology, and in areas that are relevant
to the Company’s global business activities; (vi) have experience in matters of corporate governance;
(vii) have experience in positions with a high degree of responsibility in the companies or institutions
with which they are affiliated; and (viii) be prepared to devote appropriate time and attention to the
Board and Committee duties required of a public company board member. Additionally, for
non-employee director candidates, the nominees should have personal and business circumstances that
permit them to serve on one or more of the various Committees.

These are not meant to be the exclusive criteria, however, and the Governance and Nominating
Committee will also consider the contributions that a candidate can be expected to make to the
collective functioning of the Board based upon the totality of the candidate’s credentials, experience,
and expertise; the composition of the Board at the time; and other relevant circumstances.

Stockholder Nominations
Stockholders are able to recommend individuals to the Governance and Nominating Committee for
consideration as potential director nominees by submitting their names, together with appropriate
biographical information and background materials, and a statement as to whether the stockholder or
group of stockholders making the recommendation has beneficially owned more than 5% of common
stock for at least one year as of the date such recommendation is made. An eligible stockholder
wishing to recommend a candidate must submit the following no later than 120 calendar days prior to
the anniversary date that the Company released this proxy statement for the Annual Meeting: (A) a
recommendation that identifies the candidate and provides contact information; (B) the written consent
of the candidate to serve as a director of the Company, if elected; and (C) documentation establishing
that the stockholder making the recommendation is an eligible stockholder.

Recommendations should be submitted to:

Governance and Nominating Committee
c/o Corporate Secretary
Cirrus Logic, Inc.
800 W. 6th Street
Austin, Texas 78701

The Governance and Nominating Committee will consider stockholder-recommended candidates
pursuant to the Director Nominations Process outlined in the Corporate Governance Guidelines, which
are available under the Corporate Governance section of our “Investors” page on our website at
investor.cirrus.com.

Stockholders also have the right under the Company’s Bylaws to nominate candidates for election as
directors by following the procedures, providing the information, and conforming to the submission
deadlines specified in the Company’s Bylaws. Please see the section of this proxy statement entitled,
“Questions and Answers about the Proxy Materials, the Annual Meeting and Voting Procedures: May
I propose actions for consideration at next year’s annual meeting of stockholders or nominate
individuals to serve as directors?” for further information.

Determination of Independence
The Board, which currently consists of eight directors, has determined that six of the seven nominated
directors are independent as defined by the applicable listing and regulatory standards. Specifically, the
Governance and Nominating Committee has reviewed the independence of each director and
determined that nominees Carter, Davern, Dehne, Hanford, Lego, and Tupman qualify as independent
directors under these standards. No director has a familial relationship with another director. Although
at the present Annual Meeting Mr. Schuele is not a director nominee, the Board also determined that
Mr. Schuele was independent.

In determining the independence of Mr. Davern—who serves as a member of National Instrument’s
Board of Directors—the Governance and Nominating Committee and the Board reviewed the
Company’s transactions with National Instruments and determined that the transactions do not interfere
with Mr. Davern’s exercise of independent judgment in carrying out the responsibilities of a director.
These transactions included the purchase of certain test equipment and software, along with associated
support and maintenance services, for equipment used in the development and testing of our products.
These transactions did not constitute material related party transactions requiring disclosure under SEC
regulations.

In determining the independence of Ms. Hanford—who is Chief Security Officer and Member of
Corporate Staff of Synopsys, Inc.—the Governance and Nominating Committee and the Board
reviewed the Company’s transactions with Synopsys and determined that the transactions do not
interfere with Ms. Hanford’s exercise of independent judgment in carrying out the responsibilities of a
director. These transactions included software tool licenses, software maintenance, training, and related
consulting. These transactions did not constitute material related party transactions requiring disclosure
under SEC regulations.

Corporate Governance Guidelines
On an annual basis, the Company reviews its corporate governance practices in light of any changes to
applicable law, the rules of the SEC, and the Nasdaq listing standards. Among other matters, the
Corporate Governance Guidelines include the following requirements:

Two-thirds of the members of the Board must be independent directors as defined in the
Corporate Governance Guidelines.

If the Chair of the Board is not an independent director, the Board will designate a “lead
independent director.”

Directors shall retire at the first stockholders’ meeting in which directors will be elected
following the director’s 75th birthday.

Stock Ownership Guidelines require our Chief Executive Officer, non-employee directors, and
officers of the Company to accumulate and maintain, after a phase-in period, an ownership
position in the Company’s stock to more closely link their interests with those of other Company
stockholders.

The Board will have an Audit Committee, Compensation Committee, and Governance and
Nominating Committee, each of which shall consist solely of independent directors.

The independent directors shall meet in executive session either before or after each regularly
scheduled Board meeting.

In considering stockholder proposals and candidates recommended by stockholders for the
Board, the Governance and Nominating Committee will follow the procedures outlined in the
Corporate Governance Guidelines.

For additional details, see the Corporate Governance Guidelines, which are available under the
Corporate Governance section of our “Investors” page on our website at investor.cirrus.com.

Board Leadership Structure
The Board is committed to maintaining an independent Board comprised primarily of independent
directors. To enhance the independence of the Board from management, we separate the roles of our
President and Chief Executive Officer (“CEO”), John Forsyth, and Chair of the Board, David J.
Tupman. We believe that this leadership structure demonstrates our commitment to good corporate
governance and benefits our stockholders by enhancing the oversight of management by the Board,
balancing power on the Board, and encouraging balanced decision making.

The Board’s Role in Risk Oversight
Although management is responsible for identifying, assessing, and managing the material risks facing
the Company, the Board plays an ongoing and active role in the oversight of the Company’s risk
management processes, along with the oversight of the most significant strategic and operational risks
faced by the Company and management’s efforts to mitigate those risks. The Board is involved in the
setting of the Company’s business strategy, which necessarily entails a determination of what
constitutes an appropriate level of risk for the Company.

Each of the Committees also considers risk within the Committee’s area of responsibility. Our Audit
Committee, comprised fully of independent members, discusses risk assessment and risk management
policies and regularly reviews with management the Company’s major financial and regulatory risk
exposures, including information security and cybersecurity-related risks, and the steps management
has taken to monitor and control such exposures. Also, in designing our compensation programs and
structuring awards, the Compensation Committee considers whether such compensation programs may
lead to undue risk taking. Finally, our Governance and Nominating Committee oversees risks relating
to corporate governance policies and related governance matters.

Environmental, Social, and Governance (ESG)
Our Company is committed to creating a responsible and sustainable business environment that drives
value for our key stakeholders including employees, investors, customers, suppliers, and our global
communities. Pursuant to their charters, each of the Committees assists the Board in its oversight of
ESG matters that are within the Committee’s area of responsibility, and the Governance and
Nominating Committee assists in such oversight by reviewing ESG matters, such as the Company’s
ESG report, that are not assigned to other Committees.

The Company is taking measures to ensure our products are produced in a sustainable and responsible
manner. As an Affiliate Member, we are committed to adopting the approach of the Responsible
Business Alliance (“RBA”), a non-profit organization that sets the standards for supply chain
compliance issues related to labor, health and safety, the environment, ethics, and management
systems. We have adopted a Supplier Code of Conduct (the “Supplier Code”) and aligned our
operations to comply with the Supplier Code. To support our efforts, we work closely with our third-
party suppliers to encourage their compliance with our Supplier Code.

As part of our ESG efforts, we work to attract and retain top talent in our diverse, global workforce
through programs based on competitive compensation, benefits, and a first-rate corporate culture based
on respect and fairness for all employees. We adhere to core principles of human rights by complying
with international standards and by establishing a safe, healthy working environment based on respect
and fairness for all employees, regardless of gender, nationality, or ethnicity. We are committed to
promoting equality in the workforce and developing the STEM pipeline of all students through
volunteer activities and financial resources.

For more information about our ESG efforts, including the Company’s ESG Report, please refer to the
Environment, Social, and Governance section of our website at https://www.cirrus.com/company/esg/.

Code of Conduct
The Company has adopted a Code of Conduct that applies to all of its directors, officers, and
employees (including its principal executive officer, principal financial officer, principal accounting
officer or controller, or persons performing similar functions). A copy of the Code of Conduct is
available under the Corporate Governance section of our “Investors” page on our website at
investor.cirrus.com. The Code of Conduct, as applied to the Company’s senior financial officers,
constitutes the Company’s “code of ethics” within the meaning of Section 406 of the Sarbanes-Oxley
Act of 2002 (the “Sarbanes-Oxley Act”) and constitutes the Company’s “code of conduct” under the
Nasdaq listing standards.

DIRECTOR COMPENSATION ARRANGEMENTS

Non-employee directors receive a combination of cash and equity-based compensation. Directors who
are employed by the Company do not receive any additional compensation for their Board service.
Non-employee directors may not receive consulting, advisory, or other compensatory fees from the
Company in addition to their Board compensation.

The following table sets forth the quarterly cash payments paid to non-employee directors for Board
service during the fiscal year ended March 27, 2021:

Director Compensation Retainers
Quarterly Director Retainer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Board Chair Quarterly Retainer
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Audit Chair Quarterly Retainer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Audit Committee Member Quarterly Retainer . . . . . . . . . . . . . . . . . . . . . .
Compensation Committee Chair Quarterly Retainer . . . . . . . . . . . . . . . . .
Compensation Committee Member Quarterly Retainer . . . . . . . . . . . . . . .
Governance and Nominating Committee Chair Quarterly Retainer . . . . . .
Governance and Nominating Committee Member Quarterly Retainer
. . .
Lead Independent Director Quarterly Retainer . . . . . . . . . . . . . . . . . . . . . .

$15,000
$18,750
$ 6,250
$ 2,500
$ 6,250
$ 1,875
$ 2,500
$ 1,250
$ 2,500

Directors receive cash payments for each retainer category applying to them. The Company also
reimburses non-employee directors for all reasonable out-of-pocket expenses incurred for attending
Board and Committee meetings.

In addition to the cash compensation described above, each non-employee director receives equity-
based compensation. Upon re-election to the Board, each non-employee director receives a full value
stock award that vests immediately. In fiscal year 2021, the total number of shares subject to this award
granted to each non-employee director had a fair market value up to $190,000 as estimated on the date
of grant. For any director who is re-elected after having been appointed to the Board since the previous
year’s annual meeting, their grant upon re-election is prorated to reflect the actual duration of service
as a director since their appointment.

For newly appointed or elected non-employee directors, the Company awards an option to purchase
shares of common stock of the Company at an exercise price equal to the fair market value of the stock
on the date of grant upon becoming a director, with 25% vesting after one year and the remainder
vesting ratably each month over the following 36 months. The total number of stock options granted to
newly appointed or elected non-employee directors has a fair market value of $225,000 as estimated on
the date of grant.

In a meeting on May 14, 2021, the Board approved modifications to director compensation
arrangements, which become effective at the Annual Meeting. Specifically, the Board increased the
quarterly retainer for the Governance and Nominating Committee Chair from $2,500 to $3,000.
Additionally, the Board modified certain aspects of non-employee director equity compensation,
resulting in the following equity-based compensation components:
Š

New non-employee directors shall receive, at the time of first joining the Board through
appointment or election, options having a fair market value of $225,000, as estimated at or
around the time of grant, with 25% vesting after one year and the remainder vesting ratably each
month over the following 36 months;

New non-employee directors who first join the Board by appointment prior to an annual meeting
shall receive, upon appointment, a full-value stock award having a fair market value up to
$190,000 prorated to reflect the period from the time of appointment up until the annual
meeting, such award vesting at the annual meeting; and

Each non-employee director, upon first election and each subsequent re-election at an annual
meeting, shall receive a full-value value stock award having a fair market value up to $190,000,
such award vesting at the earlier of the next annual meeting or one year from the date of grant.

Our 2018 Long Term Incentive Plan, adopted by the Board and approved by stockholders in August
2018, provides that, in a calendar year, the aggregate value of all compensation paid to or granted to
any non-employee member of the Board, including equity awards (valued on the grant date pursuant to
FASB ASC Topic 718) and cash compensation, shall not exceed $750,000.

The following table sets forth information regarding the cash and equity-based compensation paid to
our non-employee directors for services as members of the Board or any Committee during fiscal year
2021.

Note that throughout this proxy statement, amounts may not compute exactly across individual lines of
a table, and such differences are due to rounding to the nearest dollar.

DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR 2021

Name

(a)

John C. Carter(4)
Alexander M. Davern(5)
Timothy R. Dehne(6)
Deirdre R. Hanford(7)
Catherine P. Lego(8)
Alan R. Schuele(9)
David J. Tupman(10)

Fees
Earned or
Paid in
Cash(1)
($)
(b)
$ 77,500
$ 95,000
$102,500
$ 65,000
$ 59,451
$119,038
$100,220

Stock Awards(2)
($)
(c)
$189,965
$189,965
$189,965
$189,965
$ 51,672
$189,965
$189,965

Option Awards(3)
($)

Total

(d)

—
$
—
$
—
$
$
—
$224,984
—
$
—
$

($)
(h)
$267,465
$284,965
$292,465
$254,965
$336,107
$309,003
$290,185

(1) Represents fees earned or paid in cash for services as a director during the fiscal year ended

March 27, 2021, including quarterly retainer fees and Committee chair and membership retainer
fees.

(2) On July 31, 2020, upon their re-election as directors at the Company’s 2020 annual meeting of

stockholders, directors Carter, Davern, Dehne, Hanford, Schuele, and Tupman received a full value
stock award that vested immediately upon re-election to the Board having a fair market value of up
to $190,000 on the date of grant. Director Lego received a prorated stock award to reflect her
appointment as a director on April 23, 2020; this award vested immediately upon her election to the
Board at the 2020 annual meeting of stockholders. Amounts reported in this column represent the
aggregate grant date fair value of the stock awards granted in fiscal year 2021, computed in
accordance with FASB ASC Topic 718. See Note 10, Equity Compensation, in our Annual Report
on Form 10-K for the fiscal year ended March 27, 2021 for additional detail regarding the
assumptions underlying the value of these awards.

(3) On April 23, 2020, upon her appointment as a director, Ms. Lego received an option to purchase

shares of common stock with an exercise price equal to the closing price of common stock reported
on Nasdaq on the date of grant. The amount in this column represents the aggregate grant date fair
value of the options computed in accordance with FASB ASC Topic 718. See Note 10 Equity
Compensation, in our Annual Report on Form 10-K for the fiscal year ended March 27, 2021 for
additional detail regarding the assumptions underlying the value of these awards.

(4) At the end of fiscal year 2021, Mr. Carter had no options outstanding.

(5) At the end of fiscal year 2021, Mr. Davern had no options outstanding.
(6) At the end of fiscal year 2021, Mr. Dehne had no options outstanding.
(7) At the end of fiscal year 2021, Ms. Hanford had 15,515 options outstanding.
(8) At the end of fiscal year 2021, Ms. Lego had 7,657 options outstanding.
(9) At the end of fiscal year 2021, Mr. Schuele had 10,000 options outstanding.
(10) At the end of fiscal year 2021, Mr. Tupman had 15,346 options outstanding.

PROPOSALS TO BE VOTED ON

Proposal No. 1:

Election of Directors

The Board approved seven nominees for election to the Board this year.

During fiscal year 2021, effective January 1, 2021, Jason Rhode resigned from the Board, and John
Forsyth was appointed to fill such vacancy, concurrent with the role of CEO transitioning from
Dr. Rhode to Mr. Forsyth. Additionally, Alan Schuele is retiring from the Board at the Annual
Meeting.

Information regarding the business experience of each nominee and the particular experience,
qualifications, attributes, or skills that qualify that person to serve as a director of the Company is
provided below. All directors are elected annually to serve until the next annual meeting and until their
respective successors are elected, or until their earlier resignation or removal. There are no family
relationships among the Company’s executive officers and directors.

Background
Years on Board
Age
Gender identification

Carter Davern Dehne Forsyth Hanford Lego Tupman
12
66
Male Male Male Male

1
64
Female Male

3
58
Female

0.5
47

12
55

6
58

6
54

Vote Required
In the election of directors, the seven persons receiving the highest number of “FOR” votes will be
elected.

Director Resignation Policy
Any nominee for director who receives a greater number of “WITHHOLD” votes than “FOR” votes in
an uncontested election of directors shall tender to the Board their resignation as a director promptly
following the certification of the election results. For purposes of this policy, (i) an “uncontested”
election is one in which the Secretary determines that the number of nominees does not exceed the
number of directors to be elected as of the date seven days prior to the scheduled mailing date of the
proxy statement for such meeting, and (ii) abstentions and broker non-votes will not be considered as
either “WITHHOLD” votes or “FOR” votes. The Governance and Nominating Committee will
consider any resignation tendered under this policy and recommend to the Board whether to accept or
reject it and the Board will act on such resignation, taking into account the Governance and
Nominating Committee’s recommendation, within 90 days following the certification of the election
results. The Governance and Nominating Committee in making its recommendation, and the Board in
making its decision, may consider any information it deems appropriate including without limitation
any reasons given by stockholders for their “WITHHOLD” votes, the qualifications of the Director,
and the Director’s contributions to the Board and the Company. The Board will promptly disclose
publicly its decision to accept or reject such resignation and, if rejected, the reasons for doing so.

Information about Nominees

JOHN C. CARTER
Director since 2009
Mr. Carter, age 66, is currently a Principal at TCGen, which is a management consulting and advisory
services firm that Mr. Carter founded in 2002 and is located in Menlo Park, California. Between
November 2007 and January 2008, Mr. Carter was an Executive in Residence at Vantage Point
Venture Partners, a venture capital firm in San Bruno, California, where he assisted in the management
of several portfolio companies. Mr. Carter also served as Chief Technical Officer at Klipsch Group, a
manufacturer of audio devices in Indianapolis, Indiana, between February 2005 and October 2007.
Mr. Carter began his career as an engineer at Bose Corporation in 1978, later becoming its Chief
Engineer. Mr. Carter holds a B.S. in Engineering from Harvey Mudd College in Claremont, California,
and a Master’s in Electrical Engineering from Massachusetts Institute of Technology.

The Governance and Nominating Committee believes that Mr. Carter’s extensive management
experience with companies in the consumer audio market and his knowledge of that market, in addition
to his background in venture and private equity investment transactions, make him well qualified to be
on the Board. Mr. Carter also has relevant prior engineering and technical experiences in the markets
we serve.

ALEXANDER M. DAVERN
Director since 2015
Mr. Davern, age 54, is currently a member of the Board of Directors of National Instruments
Corporation (“NI”). NI is an Austin-based public company that supplies measurement and automation
products used by engineers and scientists in a wide range of industries. Mr. Davern worked at NI
between February 1994 and May 2020, and during his career at NI he served in numerous leadership
positions, including as Chief Financial Officer, Chief Operating Officer, and Chief Executive Officer.
Prior to joining NI, Mr. Davern worked both in Europe and in the United States for the international
accounting firm of Price Waterhouse, LLP. Since 2020, he also has a teaching position at the
University of Texas McCombs School of Business. Mr. Davern received his bachelor’s degree in
Commerce and a diploma in professional accounting from University College in Dublin, Ireland.

The Governance and Nominating Committee believes that Mr. Davern is well qualified to be on the
Board based on his extensive leadership experience in all aspects of managing a high technology
company in Austin, Texas. In addition, Mr. Davern has extensive international finance experience
within the technology industry. The Governance and Nominating Committee further believes that his
experiences, along with his financial expertise, his familiarity with acquisitions and integrations, and
his international tax experience make him well qualified to provide valuable insights to the Board and
to serve a role in the oversight of our financial reporting and accounting practices as Chair of the Audit
Committee.

TIMOTHY R. DEHNE
Director since 2009
Mr. Dehne, age 55, is currently a consultant for technology-based companies. Most recently, he was
the Chief Operating Officer of Xplore Technologies, a public company that was acquired by Zebra
Technologies in August of 2018. Prior to that role, he served as Vice President of Engineering for
Briggo, Inc., a privately held corporation in Austin, Texas from November 2013 until January 2018.
Prior to this position, he served as the Vice President, Global Marketing, at Luminex Corporation
between May 2012 and August 2013, an Austin-based company that develops, manufactures, and
markets innovative biological testing technologies with applications throughout the life science and
diagnostic industries. Prior to his appointment to Vice President, Global Marketing, Mr. Dehne held
the position of Vice President of Systems Research and Development, a position he held between July
2009 and May 2012. He previously worked at National Instruments Corporation, an Austin-based
supplier of measurement and automation products used by engineers and scientists in a wide range of
industries. Mr. Dehne spent over 21 years at National Instruments Corporation where he held many
leadership positions while helping to significantly grow the Company to more than 4,000 employees
and over $800 million in annual revenue. At National Instruments Corporation, he held the position of
Senior Vice President, Research & Development. Prior to his role as Senior Vice President,
Research & Development at National Instruments Corporation, Mr. Dehne served in various executive
positions in marketing and engineering. Mr. Dehne holds a B.S. in Electrical Engineering from Rice
University and serves on the Board of Directors for Asset Intertech, a privately held company, where
he also is Chair of its Compensation Committee.

The Governance and Nominating Committee believes that Mr. Dehne is well qualified to be on the
Board based on his extensive leadership experience in all aspects of managing high technology
companies in Austin, Texas, and his unique insight into significantly growing revenues at high
technology companies while maintaining an innovative corporate culture and a great work
environment. His leadership skills, experience in creating and capturing business opportunities, and
experience in scaling up a business to enable growth are valuable to the Company and the Board.

JOHN M. FORSYTH
Director since 2021
Mr. Forsyth, age 47, was appointed President of the Company in January 2020 and assumed the
additional role of Chief Executive Officer in January 2021. Previously, from June 2018, he was the
Company’s Chief Strategy Officer. Prior to that position, from August 2014, he served as Vice
President of Product Marketing. Mr. Forsyth joined the Company in 2014 through the acquisition of
Wolfson Microelectronics, where he served as Vice President of Audio Products.

The Governance and Nominating Committee believes that Mr. Forsyth’s current role as President and
CEO of the Company makes him well qualified to be on the Board based on his detailed and unique
knowledge of the Company’s operations, opportunities, and challenges. In addition, the Governance
and Nominating Committee believes that having Mr. Forsyth serve on the Board helps to bridge the
gap between the Board and management, to facilitate the regular flow of information between
management and the Board, and to ensure that the Board and management act with a common purpose
to execute our strategic initiatives and business plans.

DEIRDRE R. HANFORD
Director since 2018
Ms. Hanford, age 58, is currently Chief Security Officer and Member of Corporate Staff of Synopsys,
Inc., a leading company in the fields of electronic design automation, semiconductor intellectual
property, and software security. In this role, Ms. Hanford leads information security efforts to enable
secure hardware, software, and semiconductor design. Previously, from December 2016 through May
2019, Ms. Hanford held the title of Co-General Manager, Design Group for Synopsys where she co-led
the development and deployment of Synopsys’s analog/mixed-signal product lines, digital
implementation product lines and professional design services organization. Previously, from 2003-
2016, Ms. Hanford was the Executive Vice President of Customer Engagement for Synopsys where
she led global technical services. Ms. Hanford earned a B.S. in Engineering with a concentration in
Electrical Engineering from Brown University and an M.S. in Electrical Engineering from the
University of California, Berkeley. Ms. Hanford currently chairs Brown University’s Engineering
Advisory Committee and serves on the Engineering Advisory Board for University of California
Berkeley’s College of Engineering. In December 2017 she was named to VLSI Research’s 2017 All
Stars of the Semiconductor Industry.

The Governance and Nominating Committee believes that Ms. Hanford is well qualified to be on the
Board based on her extensive leadership skills and engineering and technology experience in the
semiconductor, semiconductor tools, and software fields, including her business and technical
experience with analog and mixed-signal products. The Governance and Nominating Committee also
believes that Ms. Hanford’s substantial information security experience and expertise make her well
qualified to be on the Board and to serve a role in the oversight of cybersecurity as a member of the
Audit Committee.

CATHERINE P. LEGO
Director since April, 2020
Ms. Lego, age 64, is the founder of Lego Ventures LLC, a consulting services firm and source of
start-up capital for early-stage technology companies, which she operated from 1992 until December
2018. She currently serves as a member of the Board of Directors of Guidewire Software, Inc., an
industry platform provider for property and casualty insurers, since September 2019 and serves as its
Audit Committee chair and is a member of the Nominating and Governance Committee and Lam
Research Corporation, a wafer fabrication equipment company, since 2006, where she was Chair of its
Compensation Committee from 2015 to 2021 and where she has been a member of the Nominating and
Governance Committee since 2014, and in 2021 rejoined the Audit Committee which she had chaired
from 2009 to 2014. Ms. Lego also served as a member of the Board of Directors of IPG Photonics
Corporation, a high-power fiber laser and amplifier company for diverse applications, since July 2016
until her retirement from this board in May 2021, where she was a member of the Audit Committee
and Chair of its Compensation Committee.

In the past five years, Ms. Lego has served on the boards of Cypress Semiconductor Corp., a developer of
advanced embedded system solutions, between September 2017 and April 2020, where she served as
Chair of its Audit Committee and a member of the Nominating and Corporate Governance Committee;
Fairchild Semiconductor, a fabricator of power management devices, between August 2013 and
September 2016, where she was a member of the Compensation Committee and Nominating and
Governance Committee; and SanDisk Corporation, from 1989 to 2016 (except for 2002-2004), where she
was Chair of its Audit Committee. Prior to 2015, she served on several other public company boards,
along with other privately-held technology companies. Ms. Lego previously was a partner at two venture
capital funds and practiced as a certified public accountant with Coopers & Lybrand (now
PricewaterhouseCoopers). Ms. Lego received a B.A. degree in economics and biology from Williams
College and a M.S. degree in accounting from the New York University Stern School of Business.

The Governance and Nominating Committee believes that Ms. Lego is well qualified to serve as a
director of the Company based on her extensive board-level experience; her substantial risk
management, accounting, and finance expertise; her knowledge of the electronics and semiconductor
industries; her experience with mergers, acquisitions, and corporate financing; and her Board
governance experience and knowledge, including her service as a chair of an audit committee and
member of audit, compensation, and nominating and governance committees.

DAVID J. TUPMAN
Director since 2015
Dr. Tupman, age 58, is currently the owner of Details Lab Inc., an advisory firm focusing on scaling
organizations for high-growth, technology development and new product introduction. From 2001 to
2011, Dr. Tupman rose from manager to Vice President of hardware engineering at Apple Inc., where
he led the hardware engineering and technology teams for multiple mobile devices. Prior to Apple,
Dr. Tupman worked at Psion Computers in London, England, from 1995 to 2001 as a hardware-
engineering manager, developing a number of personal digital assistant products. From 1988 to 1995,
Dr. Tupman was a Principal Design Engineer at Schlumberger in Farnborough, England, where he
developed low power, high precision sensors for the gas, fuel and aerospace industries. Dr. Tupman
holds a Bachelor’s degree in Electronics Engineering and an honorary doctorate (D.Sc.) from the
University of Salford, England. Dr. Tupman is named as an inventor on more than 30 U.S. patents.
Dr. Tupman has also served as a director of Pixelworks, Inc., a company that develops video display
processing technology, since April 2014.

The Governance and Nominating Committee believes that Dr. Tupman is well qualified to be on the
Board based on his extensive engineering and technology experience in the consumer electronics and
industrial markets.

The Board recommends a vote “FOR” the election to the Board of each of the foregoing
nominees.

Proposal No. 2:

Ratification of Appointment of Independent Registered Public
Accounting Firm

The Audit Committee has appointed Ernst & Young LLP (“Ernst & Young”) as the Company’s
independent registered public accounting firm to audit the Company’s consolidated financial
statements for the fiscal year ending March 26, 2022. During the fiscal year that ended March 27,
2021, Ernst & Young served as the Company’s independent registered public accounting firm and also
provided certain tax services.

The Audit Committee pre-approves and reviews all audit and non-audit services provided by Ernst &
Young. In considering the services to be provided by Ernst & Young, the Audit Committee considers
whether the provision of non-audit services is compatible with maintaining the independence of
Ernst & Young.

For additional information relating to the Audit Committee, see the section of this proxy statement
entitled, “Report of the Audit Committee of the Board,” as well as the Audit Committee Charter, which
is available under the Corporate Governance section of our “Investors” page on our website at
investor.cirrus.com.

A representative of Ernst & Young is expected to attend the Annual Meeting and be available to
respond to questions and, if they desire, to make a statement.

The Board recommends a vote “FOR” Proposal No. 2.

If the appointment is not ratified, the Audit Committee retains the discretion to select other auditors for
the following fiscal year or to determine that Ernst & Young will continue to serve as the independent
auditor. Ratification of the appointment of Ernst & Young as the Company’s independent registered
public accounting firm for the fiscal year ending March 26, 2022, requires the affirmative vote of a
majority of the shares of common stock present or represented by proxy and entitled to vote at the
meeting.

Proposal No. 3:

Advisory Vote to Approve Executive Compensation

Section 14A of the Securities Exchange Act of 1934 and related rules of the SEC enable our
stockholders to vote to approve, on an advisory, non-binding basis, the compensation of our CEO, our
Chief Financial Officer (“CFO”), and our three other most highly compensated executive officers
(collectively, our “Named Executive Officers”) as disclosed in this proxy statement. This vote is
advisory and, therefore, not binding on the Company, the Compensation Committee, or the Board.
However, the Board and the Compensation Committee value the opinions of our stockholders and to
the extent there is a significant vote against the compensation of the Named Executive Officers, we
will consider our stockholders’ concerns, and the Compensation Committee will evaluate whether any
actions are necessary to address those concerns.

As described in detail in the section of this proxy statement entitled, “Compensation Discussion and
Analysis,” our executive compensation program is designed to attract, motivate, and retain executive
officers, while aligning their interests with those of our stockholders. Under this program, our
executive officers are rewarded for the achievement of strategic and operational objectives and the
realization of increased stockholder value. Please read the Compensation Discussion and Analysis and
the accompanying compensation tables of this proxy statement for additional information about our
executive compensation program, including information about the compensation of the Named
Executive Officers for fiscal year 2021.

By way of this proposal, commonly known as a “Say-on-Pay” proposal, we are asking our
stockholders to indicate their support for the compensation of the Named Executive Officers as
described in this proxy statement. Please note that this vote is not intended to address any specific item
of compensation, but rather the overall compensation of the Named Executive Officers and the
philosophy, policies, and practices described in this proxy statement.

The stockholders are being asked to approve the following resolution at the Annual Meeting:

“RESOLVED, that the compensation paid to the company’s Named Executive Officers, as
disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and
Analysis, compensation tables and narrative discussion, is hereby APPROVED.”

The Board recommends a vote “FOR” Proposal No. 3.

OTHER MATTERS

The Company knows of no other matters that will be presented for consideration at the Annual
Meeting. If any other matters properly come before the Annual Meeting, it is the intention of the
persons named in the proxy to vote the shares they represent as the Board may recommend.
Discretionary authority with respect to such other matters is granted by the execution of the proxy.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT

The following table contains information regarding the beneficial ownership of common stock as of
May 11, 2021, by:

Š The stockholders we know to beneficially own more than 5% of outstanding common stock;
Š Each director and nominee named in this proxy statement;
Š Each executive officer named in the Summary Compensation Table included in this proxy

statement; and

Š All of our directors and executive officers as a group.

Common stock is the only class of voting securities issued by the Company. Unless otherwise
indicated in the footnotes, the beneficial owner has sole voting and investment power with respect to
the securities beneficially owned, subject only to community property laws, if applicable. In addition,
unless otherwise indicated in the footnotes, the beneficial owner’s address is 800 W. 6th Street, Austin,
Texas 78701.

Beneficial Owner

5% or Greater Stockholders:
FMR LLC(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Blackrock, Inc.(3)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Vanguard Group(4)
Directors and Named Executive Officers:
Jason P. Rhode, Former Chief Executive Officer(5)
Jeffrey W. Baumgartner, Vice President, Research and Development(6)
Gregory S. Thomas, Senior Vice President, General Counsel and Corporate

. . . . . . . . . . . . . . . . . . . . .
. . . . .

Secretary(7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . .

Jo-Dee M. Benson, Vice President, Chief Culture Officer(8)
Thurman K. Case, Vice President, Chief Financial Officer and Principal

Accounting Officer(9) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Alan R. Schuele, Director(10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
David J. Tupman, Director(11)
. . . .
John M. Forsyth, President and Chief Executive Officer and Director(12)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Alexander M. Davern, Director(13)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Timothy R. Dehne, Director(14)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deirdre R. Hanford, Director(15)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
John C. Carter, Director(16)
Catherine P. Lego, Director(17) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
All current directors and executive officers as a group (17 persons)(18) . . . . .

* Less than 1% of the outstanding common stock

Shares
Beneficially Owned
Number

Percent(1)

8,694,735
6,368,902
5,820,380

15.1146%
11.0715%
10.1179%

603,787
80,706

73,889
67,253

62,761
32,965
32,308
22,333
19,075
16,014
14,663
14,406
5,987
1,188,093

1.0424%

*
*

*
*
*
*
*
*
*
*
*

2.0380%

(1) Percentage ownership is based on 57,525,391 shares of common stock issued and outstanding on

May 11, 2021. Shares of common stock issuable under stock options that are currently exercisable
or will become exercisable within 60 days after May 11, 2021, and shares of common stock
subject to restricted stock units (“RSUs”) and performance-based RSUs (“PBRSUs”) that will
vest and be issued within 60 days after May 11, 2021, are deemed to be outstanding and
beneficially owned by the person holding such options or RSUs or PBRSUs for the purpose of
computing the number of shares beneficially owned and the percentage ownership of such person,
but are not deemed outstanding for the purpose of computing the percentage of any other person.
This table does not include options, PBRSUs, or RSUs that vest more than 60 days after May 11,
2021.

(2) Based on a Schedule 13G filed with the SEC on February 8, 2021, FMR LLC, 245 Summer

Street, Boston, Massachusetts 02210, is the beneficial owner of 8,694,735 shares, with sole voting
power as to 2,227,196 shares, and sole dispositive power as to 8,694,735 shares.

(3) Based on a Schedule 13G filed with the SEC on January 27, 2021, Blackrock, Inc., 55 East 52nd
Street, New York, NY 10055, is the beneficial owner of 6,368,902 shares, with sole voting power
as to 5,858,587 shares, and sole dispositive power as to 6,368,902 shares.

(4) Based on a Schedule 13G filed with the SEC on February 10, 2021, The Vanguard Group, 100

Vanguard Blvd., Malvern, PA 19355, is the beneficial owner of 5,820,380 shares, with sole voting
power as to 0 shares, sole dispositive power as to 5,735,031 shares, shared dispositive power as to
85,349 shares, and shared voting power as to 38,137 shares.
Includes 397,646 shares issuable upon exercise of options held by Dr. Rhode and 206,141 shares
held directly.
Includes 52,916 shares issuable upon exercise of options held by Mr. Baumgartner and 27,790
shares held directly.
Includes 60,603 shares issuable upon exercise of options held by Mr. Thomas and 13,286 shares
held directly.
Includes 55,957 shares issuable upon exercise of options held by Ms. Benson and 11,296 shares
held directly.
Includes 54,240 shares issuable upon exercise of options held by Mr. Case and 8,521 shares held
directly.

(5)

(6)

(7)

(8)

(9)

(10) Includes 10,000 shares issuable upon exercise of options held by Mr. Schuele and 22,965 shares

held directly.

(11) Includes 15,346 shares issuable upon exercise of options held by Mr. Tupman and 16,962 shares

held directly.

(12) Includes 20,281 shares issuable upon exercise of options held by Mr. Forsyth and 2,052 shares

held directly.

(13) Includes 0 shares issuable upon exercise of options held by Mr. Davern and 19,075 shares held

directly.

(14) Includes 0 shares issuable upon exercise of options held by Mr. Dehne and 16,014 shares held

directly.

(15) Includes 9,696 shares issuable upon exercise of options held by Ms. Hanford and 4,967 shares

held directly.

(16) Includes 0 shares issuable upon exercise of options held by Mr. Carter and 14,406 shares held

directly.

(17) Includes 2,233 shares issuable upon exercise of options held by Ms. Lego and 3,754 shares held

directly.

(18) Includes options held by all executive officers and directors to purchase an aggregate of 782,270

shares of common stock that are exercisable within 60 days of May 11, 2021.

EXECUTIVE OFFICERS

Carl J. Alberty – Vice President, Mixed-Signal Products
Mr. Alberty, age 44, was appointed Vice President of Mixed-Signal Products in March 2019. Prior to
this position, since March 2015, he was Vice President of Product Marketing. Mr. Alberty joined the
Company in 1999 in an engineering role supporting audio products and has worked in various audio
product marketing leadership roles, leading up to his most recent positions.

Scott A. Anderson – Senior Vice President, Supply Chain and Engineering Operations
Mr. Anderson, age 67, was appointed Senior Vice President, Supply Chain and Engineering Operations
in March 2019. Previously, since October 2007, he was Senior Vice President and General Manager,
Mixed-Signal Audio Division. Prior to joining the Company, Mr. Anderson served as the President and
Chief Operating Officer of Freescale Semiconductor between March 2004 and February 2005, and as
President and Chief Executive Officer of Motorola Semiconductor Products Sector between February
2003 and December 2003.

Jeffrey W. Baumgartner – Vice President, Research and Development
Mr. Baumgartner, age 47, was appointed Vice President of Research and Development in October
2018. Previously, since April 2018, he was Vice President of Silicon Development. Prior to that
position, since March 2015, he was Vice President of Engineering. Mr. Baumgartner joined the
Company in 1998 as a design engineer, and in 2006, he began his career in engineering management.

Jo-Dee M. Benson – Vice President, Chief Culture Officer
Ms. Benson, age 61, was appointed Vice President, Chief Culture Officer, as of July 2011. She joined
the Company in July 1995 and served in various marketing communications management roles. Prior
to being appointed to her current position, Ms. Benson served as Vice President, Corporate
Communications and Human Resources between July 2005 and July 2011, and as Vice President,
Corporate Marketing Communications between January 2001 and July 2005.

Andrew Brannan – Vice President Worldwide Sales
Mr. Brannan, age 54, joined Cirrus Logic as part of the Wolfson Microelectronics plc (“Wolfson”)
acquisition in August 2014. Mr. Brannan had worked at Wolfson since 2009, where he was Chief
Commercial Officer. Immediately before joining Wolfson, Mr. Brannan served as a board member and
Executive Vice President of Sales and Customer Operations at Symbian Software Limited.

Thurman K. Case – Vice President, Chief Financial Officer and Principal Accounting Officer
Mr. Case, age 64, was appointed CFO in February 2007. He joined the Company in October 2000 and
was appointed Vice President, Treasurer, Financial Planning & Analysis, in September 2004. Prior to
being appointed to his current position, Mr. Case served as Vice President, Finance between June 2002
and September 2004, and as Director of Finance between October 2000 and June 2002. Mr. Case
currently serves as a Director, Audit Committee Chair, and Corporate Governance Committee member
of Helen of Troy (Nasdaq: HELE), a consumer products company based in El Paso, Texas.

John M. Forsyth – President and Chief Executive Officer, and Director Nominee
Mr. Forsyth, age 47, was appointed President of the Company in January 2020 and assumed the
additional role of Chief Executive Officer on January 1, 2021. Previously, from June 2018 to January
2020, he was the Company’s Chief Strategy Officer. Prior to that position, from August 2014, he
served as Vice President of Product Marketing. Mr. Forsyth joined the Company in 2014 through the
acquisition of Wolfson Microelectronics, where he served as Vice President of Audio Products.

Allan W. Hughes – Vice President Cirrus Logic International and Information Technology
Mr. Hughes, age 60, joined Cirrus Logic as part of the Wolfson acquisition in August 2014.
Mr. Hughes joined Wolfson in March 2009 as Vice President Marketing and Applications. In 2013, he
assumed the role of Chief Operating Officer.

Gregory Scott Thomas – Senior Vice President, General Counsel and Corporate Secretary
Mr. Thomas, age 55, was appointed Vice President, General Counsel and Corporate Secretary in
December 2003. He joined the Company in December 2000 as Vice President and Associate General
Counsel, Intellectual Property.

COMPENSATION DISCUSSION AND ANALYSIS

Table of Contents

Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Advisory Vote on Executive Compensation and Last Year’s Result . . . . . . . . . . . . . . . . . . . . . . . . . 32
Our General Philosophy and Overall Compensation Framework . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
How We Set Target Total Direct Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Our Use of a Compensation Consultant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
The Information We Use for Comparisons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
The Role of Our Executive Officers in Establishing Compensation . . . . . . . . . . . . . . . . . . . 35
The Elements Making Up Compensation and Our Target Compensation Levels . . . . . . . . . 35
Executive Compensation Review for Fiscal Year 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Base Salaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Cash Bonuses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Incentive Plan Pay-Out Percentage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Semiannual Target Bonus Percentages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Target Total Cash Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Actual Cash Bonuses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Equity Grants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Stock Options and RSUs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Performance-Based Restricted Stock Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Equity Awards and Comparisons to Compensation Market Data . . . . . . . . . . . . . . . 45
Administrative and Timing Aspects of Our Equity Awards . . . . . . . . . . . . . . . . . . . . 48
Stock Ownership Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Perquisites and Other Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Employment Arrangements and Post-Employment Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . 49
Clawback Policy and Prohibition Against Short Selling, Hedging, and Pledging . . . . . . . . . . . . . . . 49
Tax Considerations Related to Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Compensation Committee Interlocks and Insider Participation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50

Purpose

The purpose of this Compensation Discussion and Analysis is to explain the Compensation
Committee’s philosophy for determining the compensation program for our Chief Executive Officer
(“CEO”), our Chief Financial Officer (“CFO”), and the three other most highly compensated executive
officers (collectively, the “Named Executive Officers”) for fiscal year 2021 and to discuss why and
how the fiscal year 2021 compensation decisions for these executives were reached. As used in this
Compensation Discussion and Analysis, all references to the 2021 fiscal year are applicable to the time
period that began on March 29, 2020, and ended on March 27, 2021. Following this discussion are
tables that include compensation information for the Named Executive Officers. This Compensation

Discussion and Analysis contains descriptions of various employee compensation and benefit plans.
These descriptions are qualified in their entirety by reference to the full text or detailed descriptions of
the plans that are filed as exhibits to the Company’s Annual Report on Form 10-K for fiscal year 2021.

The Named Executive Officers for fiscal year 2021 were as follows:

John M. Forsyth, President and Chief Executive Officer;

Jason P. Rhode, Former Chief Executive Officer;

Thurman K. Case, Vice President, Chief Financial Officer and Principal Accounting Officer;

Jeffrey W. Baumgartner, Vice President, Research and Development;

Gregory S. Thomas, Senior Vice President, General Counsel and Corporate Secretary; and

Jo-Dee M. Benson, Vice President and Chief Culture Officer.

The Compensation Committee reviews and approves base salaries and other matters relating to
executive compensation and administers the Company’s stock incentive plans, including reviewing and
granting stock incentive awards to our executive officers and other employees and reviewing and
approving policies and procedures for granting awards under these plans.

II. Executive Summary

Listed below are select business highlights for fiscal year 2021 and significant actions taken by our
Compensation Committee in fiscal year 2021. Additional details are described in the discussion and
analysis that follows.

CEO Change During Fiscal Year 2021

On November 2, 2020, we announced that Mr. Forsyth, who was serving as our President, was
appointed as our CEO, effective January 1, 2021, and that he would continue to serve as our President.
We also announced that Dr. Rhode, who was serving as our CEO, would remain as our CEO until
January 1, 2021, and then transition into an Executive Fellow role, whereby he would provide certain
transition and advisory services to the Company through January 1, 2022. Effective January 1, 2021,
Dr. Rhode also resigned from the Company’s Board, and Mr. Forsyth was appointed to the Board to
fill such vacancy. Effective as of January 1, 2021, Dr. Rhode was no longer deemed to be an executive
officer of the Company and is therefore no longer listed as a current officer in the section above titled
“Executive Officers.”

Business Highlights

Revenue. We reported revenue of $1.37 billion, which was up 7% from the prior year. The
growth in revenue was primarily driven by content gains in smartphones, tablets, and
wearables and higher unit volumes in smartphones and tablets.

Š Cash Generation. Cash from operations was $348.9 million for the full fiscal year, and our
cash and cash equivalents as of the end of the fiscal year was $810.6 million. We used
$110 million to repurchase approximately 1.5 million shares at an average price of $75.72.
Š Company Strategy. In the past fiscal year, we expanded our position in audio in Android

smartphones, gained traction in applications beyond smartphones and further diversified our
product portfolio with the introduction of our first camera controller. Going forward, we
remain focused on three growth vectors that are expected to fuel opportunities in the coming
years. First, we anticipate strengthening our position as the leading audio supplier in

smartphones. Second, we are focused on increasing sales of audio components in applications
beyond smartphones. Third, we are drawing on our extensive mixed-signal engineering
expertise to develop solutions in new, adjacent product areas that we believe will drive
diversification beyond the audio domain.

Beyond Audio. In the past fiscal year, we successfully introduced our first camera controller
targeting a new technology area beyond our traditional audio domain. This high-precision,
low-latency component enables faster processing to focus and stabilize image capture,
significantly improving results. Interest in our haptic and sensing solutions continues to be
strong across smartphones, laptops, wearables, and AR/VR controllers, driven by a desire to
maximize display size, deliver high-definition tactile feedback, and differentiate with
advanced haptics to enable immersive and unique gaming experiences. Additionally, we have
continued to make progress on our power conversion and control integrated circuit and are on
track to begin ramping this product in the second half of the calendar year.

Compensation Highlights

Promotion of Mr. Forsyth. Based on a CEO-compensation analysis performed in October
2020, the Compensation Committee adjusted Mr. Forsyth’s base salary and semiannual target
bonus percentage in connection with his appointment as our CEO, effective January 1, 2021.
The Compensation Committee took into account, among other factors, that Mr. Forsyth was
internally promoted to CEO as part of the Company’s transition plan announced in November
2020.

CEO Transition. Pursuant to a Transition Agreement dated October 30, 2020, the
compensation of Dr. Rhode was adjusted in connection with the transition from his service as
CEO on January 1, 2021 into an Executive Fellow role through January 1, 2022.

Š Annual Compensation Review Timing. In fiscal year 2021, the Compensation Committee

shifted its annual review of executive officer compensation to take place during the fourth
quarter instead of the second quarter. Consequently, this year’s annual executive review and
associated equity grants took place 16-months after the prior annual review and grants,
representing a four-month deferral when compared to previous cycles. Where applicable, the
Compensation Committee took into account this longer cycle when making its compensation
decisions.

Base Salaries. Based on a compensation analysis performed in the fourth quarter of fiscal year
2021, the Compensation Committee raised base salaries of our Named Executive Officers,
other than Dr. Rhode and Mr. Forsyth, by 6%–10% depending on factors discussed herein,
such as market comparisons and individual performance.

Equity Grants. Based on the fourth-quarter compensation analysis, the Compensation
Committee approved restricted stock units (“RSUs”), Performance-Based Restricted Stock
Units (“PBRSUs”), and stock option grants to our Named Executive Officers other than
Dr. Rhode. The approved grants maintained general alignment with the 50th percentile of
applicable market data for target total direct compensation, took into account internal pay
equity, and with respect to our CEO, reflected his recent promotion into the CEO role.

PBRSU Performance. In view of the Company’s three-year stock price performance, the
PBRSUs granted within fiscal year 2018 had a payout percentage of zero, and therefore no
corresponding performance-based shares vested within fiscal year 2021.

Š Cash Bonuses. In the first semiannual performance period, the Company’s Operating Profit
Margin (a non-GAAP operating-income measure that excludes bonus payments and other

items as defined in the section of this proxy statement entitled, “Incentive Plan Pay-Out
Percentage”) was slightly below target, yielding cash bonuses below target levels, while in the
second semiannual performance period a stronger Operating Profit Margin and revenue
growth drove cash bonuses significantly higher than target levels.

We are committed to paying our executive officers based on Company and individual performance. A
significant portion of each executive officer’s compensation is based on the achievement of short- and
long-term corporate goals and objectives.

The Compensation Committee believes that the compensation paid to our executive officers as
reflected in this proxy statement reflects, and is fully supported by, the Company’s performance over
the relevant time periods. While our one-year revenue growth fell near the bottom of our Proxy Group
(as defined below in the section of the Compensation Discussion and Analysis entitled, “The
Information We Use for Comparisons”), our revenue growth, operating income and net income for the
four quarters preceding our compensation data-gathering efforts placed us above the 50th percentile of
this Proxy Group.

III. Advisory Vote on Executive Compensation and Last Year’s Result

We conducted our annual stockholder advisory vote on named executive officer compensation at our
2020 annual meeting of stockholders. While this vote was not binding on the Company, it gives our
stockholders an opportunity to vote on the compensation of our Named Executive Officers on an
annual basis as a means to express their views regarding our executive compensation philosophy, our
compensation policies and practices, and our decisions regarding executive compensation, all as
disclosed in our proxy statement. The Board and the Compensation Committee value the opinions of
our stockholders and, to the extent that there is any significant vote against the compensation of our
Named Executive Officers as disclosed in this proxy statement, we will consider our stockholders’
concerns, and the Compensation Committee will evaluate whether any actions are necessary to address
those concerns.

At our 2020 annual meeting of stockholders, 95% of the votes cast on our executive compensation
proposal were voted in favor of our Named Executive Officers’ compensation as disclosed in the proxy
statement, and as a result, our Named Executive Officers’ compensation was approved. The
Compensation Committee reviewed the final vote results and determined that, given the significant
level of support, no specific changes to our executive compensation philosophy or general policies and
practices were necessary to address any stockholder concerns.

We provide our stockholders with the opportunity to cast an advisory vote on named executive officer
compensation each year. For more information, see “Proposal No. 3 – Advisory Vote to Approve
Executive Compensation” within this proxy statement.

IV. Our General Philosophy and Overall Compensation Framework

We provide our executive officers with compensation opportunities that are based on their personal
performance, the financial performance of the Company, their contribution to that performance, and
the Company’s total shareholder return relative to certain other semiconductor companies through a
mix of base salary, annual cash incentive awards, and equity compensation including RSUs, PBRSUs,
and stock options. These opportunities are designed to attract and retain highly skilled individuals and
to align their incentives with the long-term interests of our stockholders.

We believe that the amounts payable under the compensation program for our executive officers
should reflect the Company’s performance and the value created for our stockholders. In addition, the

compensation program should balance the short- and long-term strategic goals and objectives of the
Company and reward individual contribution to the Company’s success. We are engaged in a very
competitive industry, and the Company’s success depends on our ability to attract and retain qualified
executives through the competitive compensation packages we offer.

A. How We Set Target Total Direct Compensation

The Compensation Committee annually reviews and establishes each executive officer’s target total
direct compensation package. The Compensation Committee considers a broad range of facts and
circumstances in setting executive compensation, including Company performance, individual
performance, relative stockholder return, external pay practices of peer companies, the strategic
importance of the executive officer’s position, and the history of pay adjustments, as well as internal
pay equity and the executive officer’s time in the position. The weight given to each of these factors by
the Compensation Committee is not preestablished and may differ from year to year, and among the
individual executive officers.

The Company’s executive compensation program is heavily weighted toward performance-based
compensation that rewards achievement of short- and long-term corporate goals and objectives. In
setting target total direct compensation for our executive officers, the Compensation Committee seeks
to strike a balance between providing compensation that is competitive with the compensation paid to
executives of peer companies, while ensuring that a significant percentage of compensation is
dependent on the Company’s performance, individual performance, and stock price appreciation.
Please see the section of this proxy statement entitled, “The Elements Making Up Compensation and
Our Target Compensation Levels” for additional information regarding the target total direct
compensation for our Named Executive Officers.

B. Our Use of a Compensation Consultant

To support the Compensation Committee in fulfilling its duties, the Compensation Committee directly
retained an external compensation consultant to assist with its design and evaluation of compensation
for our CEO, executive officers, and directors for fiscal year 2021. Pursuant to its charter, the
Compensation Committee is authorized to retain and terminate any consultant, as well as approve the
consultant’s fees and other terms of retention. During fiscal year 2021, the Compensation Committee
retained Compensia, Inc. (“Compensia”) to provide executive and director compensation consulting
services. Compensia has served as the Compensation Committee’s independent compensation
consultant since fiscal year 2013.

At the direction of the Compensation Committee, in fiscal year 2021 Compensia performed two
comprehensive compensation reviews: first, as a special assignment in October 2020, it reviewed CEO
compensation as the CEO position was transitioned from Dr. Rhode to Mr. Forsyth, and, second, in
January 2021, it provided its annual review of our CEO’s and other executive officers’ compensation.
Dr. Rhode’s compensation was not assessed during this annual review because, effective January 1,
2021, his compensation as Executive Fellow was set pursuant to the Transition Agreement noted
previously and approved by the Board.

Additionally, in December 2020, Compensia reviewed and recommended changes to our previous
compensation peer group to use for purposes of analyzing the competitive market for executive and
director compensation. The Compensation Committee considered the information provided by
Compensia in setting executive compensation.

As required by the Nasdaq listing standards, the Compensation Committee performed an independence
assessment of Compensia for fiscal year 2021. The Compensation Committee determined that
Compensia should be considered independent based on the following factors:

Compensia provided no services to the Company other than its work for the Compensation
Committee;

The fees paid to Compensia by the Company for fiscal year 2021 were less than 1% of
Compensia’s revenues for that year;

Compensia has developed and provided to the Company a Conflict of Interest Policy;

The advisers from Compensia have no business or personal relationship with any members of
the Company’s Compensation Committee or the Company’s executive officers; and

Compensia has confirmed that none of the advisers from Compensia own any shares of our
common stock.

Accordingly, the Compensation Committee determined that the services provided by Compensia to the
Compensation Committee for fiscal year 2021 did not give rise to any conflicts of interest.

C. The Information We Use for Comparisons

In October 2020, as part of its special assignment to aid the Compensation Committee’s compensation
review concerning the transition of the CEO position from Dr. Rhode to Mr. Forsyth, Compensia
prepared an assessment of CEO compensation based on (a) publicly available data gathered from the
Company’s then-current proxy group (such group being approved in March 2019 and reported in last
year’s proxy statement) and (b) additional publicly available data from similarly sized technology
companies having an internally promoted CEO.

In December 2020, based on the criteria described below, and with the direction of the Compensation
Committee on companies to consider for inclusion in the “Proxy Group” (as defined below),
Compensia reviewed the then-existing proxy group and made recommendations regarding potential
additions and removals.

The Proxy Group generally consists of public companies listed on U.S. stock exchanges in the
semiconductor industry that are comparable in size (approximately $400 million – $3.7 billion in
revenue and approximately $800 million – $16.3 billion in market capitalization) and share common
characteristics with the Company, including location and similarity of business model and product
lines. In determining the number of companies to include within the Proxy Group, the Compensation
Committee considered the ability to achieve year-over-year consistency and position-specific
executive-compensation comparisons. The Compensation Committee also considered whether a
proposed peer was historically in the Company’s proxy group to maintain additional consistency.
Another factor considered by the Compensation Committee was the likelihood that the Company might
compete for executive talent with companies selected for the Proxy Group. For example, due in part to
the specialized field within which the Company operates, the targeted talent pool from which to attract
skilled leadership is narrow, and as such, the Compensation Committee will continue to revisit and
revise its proxy group in future years to ensure the Company remains competitive in its continuing
recruitment and retention efforts.

Specifically, Compensia recommended that the following two companies be added to the Proxy Group:
Lattice Semiconductor Corporation and MaxLinear, Inc. Compensia recommended that the following
two companies be removed from the Proxy Group: Cypress Semiconductor Corporation (due to
acquisition) and SMART Global Holdings, Inc. (due to falling below the market capitalization range).

After review, the Compensation Committee approved such recommendations, and the following group
of 20 companies was approved as the “Proxy Group”: (1) CMC Materials, Inc. (formerly named Cabot
Microelectronics Corporation); (2) Cree, Inc.; (3) Diodes Incorporated; (4) Entegris, Inc.; (5) First
Solar, Inc.; (6) FormFactor, Inc.; (7) Knowles Corporation; (8) Lattice Semiconductor Corporation;
(9) MACOM Technology Solutions Holdings, Inc.; (10) Marvell Technology Group Ltd.; (11) Maxim
Integrated Products, Inc.; (12) MaxLinear, Inc.; (13) Monolithic Power Systems, Inc.; (14) Power
Integrations, Inc.; (15) Qorvo, Inc.; (16) Semtech Corp.; (17) Silicon Laboratories, Inc.; (18) SunPower
Corporation; (19) Synaptics Incorporated; and (20) Xilinx, Inc.

In January 2021, to aid the Compensation Committee’s annual executive compensation review,
Compensia prepared and presented a compensation assessment of the Company’s executive
compensation program. Compensia’s assessment was based on (a) publicly available data gathered
from the Proxy Group, enumerated above and (b) market data obtained from the Radford Global
Technology Survey specific to 18 of the 20 companies in such Proxy Group (the “Survey Data”) who
participated in such survey.

In conjunction with this January 2021 assessment, Compensia developed comparison compensation
data for each Cirrus Logic executive officer (“Compensation Market Data”). For Mr. Forsyth and
Mr. Case, the Compensation Market Data consisted solely of data derived from the Proxy Group
because data associated with the CEO and CFO positions is publicly available from each Proxy Group
company. For Mr. Baumgartner and Ms. Benson, the Compensation Market Data consisted solely of
Survey Data because data matching their position was not available from the Proxy Group. For
Mr. Thomas, a blend of Survey Data and Proxy Group data was used, reflecting that while some
matching data was available from the Proxy Group, the consideration of additional data from the
Survey Data provided a more reliable dataset.

Compensation Market Data was not obtained for Dr. Rhode in connection with his position as
Executive Fellow and, accordingly, market comparisons for Dr. Rhode are not presented in subsequent
sections of this proxy statement. The compensation associated with Dr. Rhode’s Executive Fellow
position was set according to the Transition Agreement approved by the Board and was based on pay
comparisons for similar positions at the Company.

D. The Role of Our Executive Officers in Establishing Compensation

Our Human Resources and Legal departments support the Compensation Committee’s work related to
our compensation programs. This support consists of assistance with providing Survey Data, proposals
of potential ranges of various components of compensation for our executive officers, and information
regarding the Company’s 2018 Long Term Incentive Plan. Regular meetings of the Compensation
Committee are generally attended by our CEO, CFO, Chief Culture Officer, and our General Counsel.
Because the Company’s executive officers report up to the CEO, the Compensation Committee
requests input and recommendations from him regarding executive compensation (other than his own).
The Compensation Committee considers and sets the compensation of our CEO when no members of
management are present. In addition, members of management are not present while their specific
compensation is being discussed and determined.

E. The Elements Making Up Compensation and Our Target Compensation Levels

Each executive officer’s compensation package comprises the following elements: (i) base salary that
reflects individual performance and relevant market data, (ii) annual cash incentive awards tied to the
Company’s achievement of specific performance objectives, (iii) long-term incentives in the form of
equity awards (RSUs and options) designed to strengthen the mutuality of interests between the
executive officers and the Company’s stockholders, (iv) additional long-term equity incentives

explicitly tied to certain Company performance-based criteria (PBRSUs), (v) other benefits that are
generally available to the Company’s employees, including a 401(k) (or other retirement plan) and
medical, vision, and dental plans, and (vi) post-employment compensation (see sections of this proxy
statement entitled, “Employment Arrangements and Post-Employment Compensation” and “Potential
Payments upon Termination or Change of Control”).

In general, the Compensation Committee has attempted to establish a strong relationship between total
cash compensation, the Company’s performance, and individual executive performance by typically
setting base salaries with reference to the 50th percentile range of the Compensation Market Data and
by providing additional incentive opportunities that typically place the target total cash compensation
opportunity (base salary plus target annual cash incentive compensation) also within the 50th
percentile range, with the potential to earn above the 50th percentile level for higher levels of
performance. We also aim to maintain internal pay equity and set the semiannual target bonus
percentage (discussed in more detail below) for each executive officer other than our CEO at the same
level.

The Compensation Committee also provides equity awards so that an executive officer’s target total
direct compensation opportunity is set with reference to the 50th percentile level of the applicable
Compensation Market Data.

Market-related percentiles are intended only as guidelines for evaluating and establishing each
executive officer’s compensation and are not applied on a rigid or formulaic basis. Sometimes,
depending on the totality of the circumstances for particular executive officers, and as determined by
the Compensation Committee, compensation levels may fall above or below the referenced percentile
ranges. Other factors such as an executive officer’s additional responsibilities, prior work experience,
and the number of years of experience with the Company may lead to certain executive officers having
target total direct compensation above the 50th percentile of the applicable Market Compensation
Data.

V. Executive Compensation Review for Fiscal Year 2021

In October 2020, the Compensation Committee reviewed the base salary and cash bonus compensation
of Mr. Forsyth in connection with his promotion to the position of CEO, effective January 1, 2021. The
Compensation Committee deferred its assessment of any equity-based compensation for the CEO until
its annual compensation review in January 2021.

In January 2021, the Compensation Committee performed its annual review of executive officers’
compensation at a regularly scheduled Compensation Committee meeting. At that time, with respect to
the CEO, the Compensation Committee considered only equity-based compensation because it had
recently adjusted Mr. Forsyth’s base salary and cash bonus compensation in connection with his
promotion to the CEO position. As part of its annual review, the Compensation Committee reviewed
the Company’s performance as compared to the Proxy Group and, other than for Mr. Forsyth,
considered any changes to an executive officer’s base salary or target amounts for their annual cash
incentive awards. The Compensation Committee further considered any annual equity awards for our
executive officers, and at a regularly scheduled meeting on February 26, 2021, the Compensation
Committee approved executive equity awards, which were granted in March 2021.

Ultimately, any decision to adjust compensation was made in the discretion of the Compensation
Committee in view of the numerous factors and circumstances discussed in this proxy statement.

As noted in last year’s proxy statement, for fiscal year 2021, the timing of the annual executive
compensation review and associated equity grants was shifted to the fourth quarter to better align with
our fiscal-year calendar. See the section of this proxy statement entitled, “Administrative and Timing

Aspects of Our Equity Awards.” However, as noted in the Executive Summary of this section, this shift
in timing resulted in a 4-month longer period between the annual executive review and associated
equity grants from fiscal year 2020 to fiscal year 2021. Where applicable, the Compensation
Committee took into account this longer cycle when making its compensation decisions.

A. Base Salaries

The base salary for each executive officer is designed to be commensurate with the salary levels for
comparable positions within the Compensation Market Data, to reflect each individual’s personal
performance during the year, to take into consideration the individual’s responsibilities within the
Company, and to be consistent with our internal salary alignment. The relative weight given to each
factor is not preestablished and may vary as determined by the Compensation Committee. In setting
base salaries, the Compensation Committee reviews the Compensation Market Data, the
recommendations of our CEO for base salaries other than his own, and each executive officer’s
individual performance for the year, as well as the factors discussed above in the section entitled,
“How We Set Target Total Direct Compensation.” The Company’s profitability and operational
performance and the history of past salary adjustments may also be factors in determining the base
salaries of our executive officers. The Compensation Committee considers all of these factors when
making its decisions.

In October 2020, in connection with Mr. Forsyth’s promotion to the position of CEO, effective
January 1, 2021, the Compensation Committee set Mr. Forsyth’s annual base salary as CEO at
$600,000. His previous annual base salary, as President, was $400,000.

Also in October 2020, in connection with Dr. Rhode’s transition from CEO to Executive Fellow,
effective January 1, 2021, the Board approved a corresponding Transition Agreement that set
Dr. Rhode’s annual base salary as Executive Fellow at $300,000. His previous annual base salary, as
CEO, was $800,000.

In January 2021, the Compensation Committee took the following actions with respect to the base
salaries of the Company’s other Named Executive Officers, which became effective in the second-half
of fiscal year 2021, on February 1, 2021:

Adjusted our CFO’s annual base salary 7% from $410,865 to $440,000;

Adjusted Mr. Baumgartner’s annual base salary 10% from $341,250 to $375,000;

Adjusted Mr. Thomas’s annual base salary 7% from $382,200 to $410,000; and

Adjusted Ms. Benson’s annual base salary 6% from $371,280 to $395,000.

The Compensation Committee took these actions in view of the factors noted above in the section
entitled “How We Set Target Total Direct Compensation,” including the Company’s performance over
the prior 12 months, each individual executive’s performance, past salary adjustments, typical annual
market adjustments, and the objective of setting target total cash compensation (including base salary
and target incentive plan payments discussed below) with reference to the 50th percentile of applicable
Compensation Market Data. Additionally, with respect to setting Mr. Forsyth’s initial base salary as
CEO, the Compensation Committee considered publicly available market data from similarly sized
technology companies having internally promoted CEOs.

With respect to the applicable Compensation Market Data, the base salary of:

Š Mr. Forsyth falls below the 25th percentile; and
Š Mr. Case, Mr. Baumgartner, Mr. Thomas, and Ms. Benson fall between the 50th and 75th

percentile.

In view of the Company’s 12-month performance prior to the compensation analysis, as well as
individual performance considerations and typical annual market adjustments, the Compensation
Committee brought base salaries of the Named Executive Officers to fall between the 50th and 75th
percentile level, except for Dr. Rhode (for whom Compensation Market Data was not obtained) and
Mr. Forsyth. The base salary determination for Mr. Forsyth was influenced not only by the factors and
considerations noted above, but also by his new appointment to the position of CEO as part of the
Company’s CEO transition plan announced in November 2020.

Since the Company’s annual base-salary determinations were made during the fourth quarter of the
fiscal year, the salary column of the Summary Compensation Table, which totals base salary for the
entire fiscal year, will reflect a blend of salary amounts before and after the yearly adjustments.

B. Cash Bonuses

In fiscal year 2021, our Named Executive Officers participated in our 2007 Management and Key
Individual Contributor Incentive Plan (“Incentive Plan”), which bases payments on our fiscal year
financial performance and provides for semiannual cash bonuses.

The Incentive Plan is designed to provide employees who are in management or leadership positions in
the Company, or who are key individual contributors whose efforts potentially have a material impact
on the Company’s performance, with incentives to enhance the Company’s performance through the
achievement of pre-established financial goals.

Each semiannual cash bonus is calculated as the product of three components: (1) an individual’s
annual base salary (as measured at the end of the given semiannual performance period), (2) an
individual’s semiannual target bonus percentage, and (3) an “Incentive Plan Pay-Out Percentage,”
which is a multiplier reflecting whether, and the extent to which, the Company has met or exceeded
performance measures concerning Operating Profit Margin and revenue growth for the given
semiannual performance period:

Semiannual Cash Bonus = Annual Base Salary × Semiannual Target Bonus Percentage × Incentive
Plan Pay-Out Percentage

Prior to the commencement of each semiannual performance period of fiscal year 2021, the
Compensation Committee set the formula and performance measures under which the Incentive Plan
Pay-Out Percentage was determined.

Incentive Plan Pay-Out Percentage

The Operating Profit Margin used in the Incentive Plan Pay-Out Percentage is defined in the Incentive
Plan as the Company’s consolidated GAAP operating income excluding (a) Incentive Plan and other
bonus accruals and (b) any non-recurring items such as gains on sales of assets not otherwise included
in revenue, losses on sales of assets, restructuring charges, merger-related costs including amortization
or impairments of acquisition-related intangible assets, stock compensation expense, asset write-offs,
write-downs, and impairment charges, and such other items as the Compensation Committee may
determine in its sole discretion (part (b) collectively termed as “Excluded Items”).

For a given semiannual performance period, the Incentive Plan Pay-Out Percentage may range
anywhere between 0–250% depending on the Company’s specific Operating Profit Margin and
revenue growth.

The Incentive Plan Pay-Out Percentage for each semiannual performance period is calculated as the
product of an operating profit payout and a revenue growth multiplier.

Incentive Plan Pay-Out Percentage = Operating Profit Payout × Revenue Growth Multiplier

For both semiannual periods of fiscal year 2021, the Compensation Committee determined that the
operating profit payout would be determined according to the following graph, which remained
unchanged relative to the prior fiscal year:

Operating Profit Payout

t
u
o
y
a
P
t
i
f
o
r
P
g
n

i
t
a
r
e
p
O

300%

250%

200%

150%

100%

50%

10%

15%

20%

25%

30%

35%

40%

Company Operating Profit Margin

As shown, the operating profit payout is 0% for Operating Profit Margins less than 10%. The operating
profit payout is 25% when the Operating Profit Margin is 10%. The operating profit payout increases
linearly from 25–100% as the Operating Profit Margin increases from 10–23%. Finally, the operating
profit payout increases linearly from 100–200% as the Operating Profit Margin increases from 23–32%
and follows this same slope for Operating Profit Margin values greater than 32%.

For both semiannual periods of fiscal year 2021, the Compensation Committee determined that the
revenue growth multiplier would be determined according to the same methodology as the prior fiscal
year:

Revenue Growth Multiplier

r
e
i
l

p
i
t
l

u
M
h
t
w
o
r
G
e
u
n
e
v
e
R

275%

250%

225%

200%

175%

150%

125%

100%

75%

50%

25%

10%

15%

20%

25%

30%

Revenue Growth

As shown, the revenue growth multiplier is 100% for revenue growth of 10% or lower. The revenue
growth multiplier then increases linearly from 100–200% as revenue growth increases from 10–20%
and follows this same slope for revenue growth values greater than 20%.

With reference to the two graphs above, the Compensation Committee set a threshold level
corresponding to an Operating Profit Margin of 10%. If that performance level is not met the operating
profit payout would be 0% and hence, regardless of the revenue growth multiplier, the corresponding
Incentive Plan Pay-Out Percentage would also be 0%, meaning no semiannual cash bonuses would be
paid. The Compensation Committee set a target level corresponding to an Operating Profit Margin of
23%. At that level, if revenue growth was 10% or less, the operating profit payout and revenue growth
multipliers would both be 100%, and the corresponding Incentive Plan Pay-Out Percentage would also
be 100%.

Some combinations of Operating Profit Margin and revenue growth would result in Incentive Plan
Pay-Out Percentages higher than 100%, which would yield cash bonus payments above target levels.
The Incentive Plan, however, provides that its semiannual cash bonuses may not exceed 250% of a
participant’s target bonus for any applicable semiannual performance period (i.e., the Incentive Plan
Pay-Out Percentage cannot exceed 250%). Further, the semiannual cash bonuses are also again subject
to a cap of 12% of the Company’s non-GAAP operating profit on total payments under the Company’s
variable compensation plans. The Compensation Committee instituted a payment cap because it
determined that the proposed targets and thresholds under the Incentive Plan created a risk that a large
percentage of the Company’s operating profit for a period could be paid out as bonuses. The
Compensation Committee set the cap at 12% based on its desire to provide a reasonable payout for

achieving the Company’s performance target levels while maintaining a reasonable cap on payments
under all of the Company’s variable compensation plans.

The performance measures reflected in the Incentive Plan are designed to balance short- and long-term
financial and strategic objectives for building stockholder value and are further based on a review of
the operating results of peer companies and competitors, including the performance of the Proxy
Group. As designed, the Operating Profit Margin and revenue growth goals are intended by the
Compensation Committee to be based on the Company’s long-term strategic plan, not the Company’s
annual operating plan, and to further reflect the Compensation Committee’s belief that the achievement
of both of these levels of performance would reflect a level of performance that would be required to
outperform the majority of those peer companies and competitors. The Compensation Committee sets
the target levels for these performance measures so that participants will earn their target bonuses if the
Company’s Operating Profit Margin and revenue growth goals are achieved during the measurement
period. In contrast to how it has set the target levels for the Incentive Plan, the Compensation
Committee typically has set the threshold levels for payments based in part on a review of the
Company’s annual operating plan along with current economic and market conditions.

Semiannual Target Bonus Percentages

For fiscal year 2021, effective January 1, 2021, and coinciding with the appointment of Mr. Forsyth as
CEO, the Compensation Committee adjusted the semiannual target bonus percentage for the CEO to
50% (previously, when Dr. Rhode held the position, the CEO’s semiannual target bonus percentage
was 75%). Also effective January 1, 2021, to coincide with his transition to Executive Fellow,
Dr. Rhode’s semiannual target bonus percentage was reduced to 37.5% pursuant to the Transition
Agreement. Throughout fiscal year 2021, the semiannual target bonus percentage for our other Named
Executive Officers’ remained unchanged from last year at 37.5%.

Target Total Cash Compensation

Target cash bonuses for each semiannual performance period are calculated using the formula
discussed above and by assuming an Incentive Plan Pay-Out Percentage of 100%:

Target Semiannual Cash Bonus = Annual Base Salary (as of the end of the semiannual period) ×
Semiannual Target Bonus Percentage × 100%

Target total cash compensation is annual base salary plus both target semiannual cash bonuses:

Target Total Cash Compensation = Annual Base Salary (as of the end of the fiscal year) + Target
First Half Cash Bonus + Target Second Half Cash Bonus

For fiscal year 2021, the target total cash compensation for our Named Executive Officers was:

Named Executive Officer

John M. Forsyth, President and Chief

Base Salary

Target First Half
FY21 Cash Bonus

Target Second Half
FY21 Cash Bonus

FY21 Target Total
Cash Compensation

Executive Officer . . . . . . . . . . . . . . . . . . .

$600,000

$150,000

$300,000

$1,050,000

Jason P. Rhode, Former Chief Executive

Officer . . . . . . . . . . . . . . . . . . . . . . . . . . .

$300,000

$600,000

$369,643

$1,269,643

Thurman K. Case, Vice President, Chief

Financial Officer and Principal
Accounting Officer . . . . . . . . . . . . . . . . .

Jeffrey W. Baumgartner, Vice President,

Research and Development . . . . . . . . . . .
Gregory S. Thomas, Senior Vice President,

General Counsel and Corporate
Secretary . . . . . . . . . . . . . . . . . . . . . . . . .

Jo-Dee M. Benson, Vice President, Chief

$440,000

$154,074

$165,000

$ 759,074

$375,000

$127,969

$140,625

$ 643,594

$410,000

$143,325

$153,750

$ 707,075

Culture Officer . . . . . . . . . . . . . . . . . . . . .

$395,000

$139,230

$148,125

$ 682,355

Dr. Rhode’s target second half cash bonus reflects prorating pursuant to the Transition Agreement.
Specifically, Dr. Rhode’s second half cash bonus reflects (1) his base salary and semiannual target
bonus percentage for the portion of the second semiannual period during which he served as the
Company’s CEO, and (2) his base salary and semiannual target bonus percentage for the portion of the
second semiannual period during which he served as an Executive Fellow.

With respect to the applicable Compensation Market Data, the target total cash compensation of:

Š Mr. Forsyth falls below the 25th percentile;
Š Mr. Baumgartner falls at approximately the 50th percentile; and
Š Mr. Thomas, Mr. Case, and Ms. Benson fall between the 50th and 75th percentile.

4. Actual Cash Bonuses

The actual cash bonuses paid for each semiannual performance period for fiscal year 2021 were based
on the Incentive Plan Pay-Out Percentages for each semiannual performance period:

Actual Semiannual Cash Bonus = Annual Base Salary (as of the end of the semiannual period) ×
Semiannual Target Bonus Percentage × Incentive Plan Pay-Out Percentage

As a result of the Company’s performance in the first half of fiscal year 2021, the Incentive Plan
Pay-Out Percentage was 93%. For that semiannual performance period, our Operating Profit Margin
was 22% (which corresponded to a GAAP operating profit margin of 14%), and revenue growth was
-6%.

As a result of the Company’s performance in the second half of fiscal year 2021, the Incentive Plan
Pay-Out Percentage was 243%. For that semiannual performance period, our Operating Profit Margin
was 27% (which corresponded to a GAAP operating profit margin of 20%), and revenue growth was
19%.

For more details concerning each of these semiannual performance periods, see the section of this
proxy statement entitled, “Annex,” which includes a reconciliation of the Company’s GAAP operating
profit margin to the Operating Profit Margin used in the Incentive Plan calculations.

For fiscal year 2021, the actual cash bonuses and actual total cash compensation for our Named
Executive Officers were therefore:

Named Executive Officer

John M. Forsyth, President and Chief

Actual FY21
Salary

Actual First Half
FY21 Cash Bonus

Actual Second Half
FY21 Cash Bonus

FY21 Actual Total
Cash Compensation

Executive Officer

. . . . . . . . . . . . . . . . . .

$443,077

$139,957

$728,175

$1,311,209

Jason P. Rhode, Former Chief Executive

Officer . . . . . . . . . . . . . . . . . . . . . . . . . . .

$692,308

$559,827

$897,216

$2,149,351

Thurman K. Case, Vice President, Chief

Financial Officer and Principal
Accounting Officer . . . . . . . . . . . . . . . . .

Jeffrey W. Baumgartner, Vice President,

Research and Development . . . . . . . . . . .
Gregory S. Thomas, Senior Vice President,

General Counsel and Corporate
Secretary . . . . . . . . . . . . . . . . . . . . . . . . .

Jo-Dee M. Benson, Vice President, Chief

$414,787

$143,758

$400,496

$ 959,041

$345,794

$119,401

$341,332

$ 806,527

$385,943

$133,729

$373,190

$ 892,862

Culture Officer

. . . . . . . . . . . . . . . . . . . .

$374,473

$129,908

$359,536

$ 863,917

Our above-target Operating Profit Margin and revenue growth in the second semiannual performance
period drove that period’s above-target cash bonuses.

C. Equity Grants

We provide long-term incentive opportunities in the form of equity awards to motivate and reward our
executive officers for their contributions to achieving our business objectives by tying incentives to the
performance of our common stock over the long term. Our equity awards include RSUs, PBRSUs, and
stock options, and the Compensation Committee reviews and determines possible relative value
weights that can be assigned to each component to achieve a suitable, overall compensation package
for our Named Executive Officers.

The use of equity further reinforces the link between the interests of our executive officers and our
stockholders. Generally, equity awards are made annually by the Compensation Committee to each of
our executive officers under our 2018 Long Term Incentive Plan.

Stock Options and RSUs

Options are designed to align the interests of our executive officers and employees with those of our
stockholders and provide each individual with a significant incentive to manage the Company from the
perspective of an owner with an equity stake in the business. Each option award enables the recipient
to purchase a specified number of shares of our common stock at a specified price per share (the
market price of our common stock on the grant date) over a specified period of time (up to 10 years).
Each option typically becomes exercisable in a series of installments over a specified period – over
four years, with one-year cliff vesting for 25% of the options on the first anniversary of the grant date
and 1/36 of the remaining options vesting on a monthly basis over the following three years –
contingent upon the recipient’s continued employment with the Company. Accordingly, the options
provide a potential return only if the executive officer remains employed by the Company during the
vesting period, and then only if the market price of common stock appreciates over the option term.

The use of time-vested RSUs balances the benefits of stock options with the executive retention and
stockholder dilution benefits that RSUs provide. In particular, the Compensation Committee believes
that the use of time-vested RSUs with a three-year “cliff” vesting requirement helps further our
retention objectives by encouraging our executive officers to remain with the Company and fully

execute our long-term strategies, which generally take a number of years to be fully implemented and
reflected in our financial performance. Because RSUs are typically granted at a lower number of shares
than an equivalent option grant, the dilutive impact of our long-term incentive awards as a whole is
reduced by using RSUs.

Performance-Based Restricted Stock Units

The Compensation Committee believes that the use of PBRSUs further promotes the achievement of
our long-term strategic and operational objectives by strengthening the link of our Named Executive
Officers’ compensation to stockholder value creation.

PBRSU awards for fiscal year 2021 consisted of RSUs subject to a three-year performance period. The
number of shares earned, relative to a target number of shares, will be based on the Company’s total
shareholder return (“TSR”) measured relative to the TSR of the component companies of the
Philadelphia Semiconductor Index (“Index”). Thus, the measurement entails determining our ranking
among the companies that make up the components of the Index. The TSR determines a payout
percentage ranging between 0–200%, which is then multiplied by the target number of PBRSUs.

To determine the payout percentage, the Company’s TSR for the performance period is compared
against that of the companies in the Index to yield a Percentile Measurement (for example, if our
Company would rank in the 75th percentile of the performance of companies in the Index during the
performance period, our Percentile Measurement would be 75%). The payout percentage is a function
of the Percentile Measurement as follows:

If our Percentile Measurement is less than 25%, the payout percentage is zero;

Threshold performance: if our Percentile Measurement is 25%, the payout percentage is 25%;

Target performance: if our Percentile Measurement is 50%, the payout percentage is 100%;

Š Maximum performance: if our Percentile Measurement is 75% or higher, the payout

percentage is 200%;

A straight line connects the threshold, target, and maximum performance points; and

If the Company’s TSR is negative during the performance period, the maximum payout
percentage is 100%.

The PBRSU payout percentage is therefore determined according to the following graph, which
remains unchanged relative to the prior fiscal year:

PBRSU Payout Percentage

250%

200%

150%

100%

50%

e
g
a
t
n
e
c
r
e
P
t
u
o
y
a
P
U
S
R
B
P

0.0%

25.0%

50.0%

75.0%

100.0%

TSR Percentile Measurement

Within fiscal year 2018 (on November 1, 2017), PBRSUs were granted to Dr. Rhode, Mr. Case,
Ms. Benson, and Mr. Thomas (at that time, Mr. Forsyth and Mr. Baumgartner were not executive
officers). Over the following three-year performance period, our Percentile Measurement was 0%,
leading to a payout percentage of 0%. Therefore, no corresponding shares vested during fiscal year
2021. This result comported with the Compensation Committee’s intention of linking PBRSU payout
with a relative level of achievement, based on shareholder return. Vesting amounts for PBRSUs
granted in conjunction with annual executive equity grants in fiscal years 2019, 2020, and 2021 have
yet to be determined.

For information concerning the number of shares underlying the PBRSUs granted for fiscal year 2021,
see the “Fiscal Year 2021 Grants of Plan-Based Awards Table” below. For information concerning the
value realized during fiscal year 2021 as a result of exercised options and vested stock awards, see the
“Fiscal Year 2021 Options Exercised and Stock Vested Table” below.

3. Equity Awards and Comparisons to Compensation Market Data

As discussed above, the Compensation Committee’s long-term incentive compensation philosophy is
typically to grant awards to our executive officers that position their target total direct compensation
approximately at the 50th percentile of the applicable Compensation Market Data, subject to other
factors considered by the Compensation Committee. For example, the Compensation Committee also
takes into account past increases or decreases in overall compensation and the number, and current
unrealized value, of outstanding options and unvested RSUs and PBRSUs held by each executive
officer to maintain an appropriate level of equity-based incentive for that individual. The
Compensation Committee further considers the Company’s overall performance, current equity burn

rate, and dilution in setting the amount of equity available for grant to our executive officers. The size
of the equity award to each executive officer is set by the Compensation Committee at a level that is
intended to create a meaningful opportunity for stock price appreciation based upon the individual’s
position with the Company, current performance, anticipated future contribution based on that
performance, and ability to affect corporate and/or business unit results. The Compensation Committee
looks collectively at all of these factors when making its decisions.

For fiscal year 2021, based on Compensia’s analysis of competitive market practices and the other
relevant factors summarized above, the Compensation Committee approved the grant of a mix of
approximately one-third stock options, one-third RSUs, and one-third PBRSUs (all relative to an
estimated accounting valuation when the awards were approved) to our Named Executive Officers.
Although the Compensation Committee intended to grant a one-third mix of the various equity awards
to the Named Executive Officers (based on the Company’s estimated grant date fair value for those
awards at the time of approval), the actual mix of awards deviated from the Compensation
Committee’s intention (as indicated in the chart below and in other compensation tables in this proxy
statement) due to subsequent changes in the model inputs and assumptions used by the Company to
compute the actual grant date fair value under FASB ASC Topic 718.

These equity awards were approved by the Compensation Committee on February 26, 2021, and
granted in March 2021 on the Company’s Monthly Grant Date (see the section of this proxy statement
immediately below entitled, “Administrative and Timing Aspects of Our Equity Awards”). The
Company previously granted its annual equity awards to executives in November 2019, representing a
16-month cycle.

In fiscal year 2021, no special equity award grants were made to executives.

For fiscal year 2021, the target total direct compensation (the base salary plus target annual cash bonus
plus the grant date fair value of equity awards) for our Named Executive Officers was:

Named Executive Officer

John M. Forsyth, President and Chief

Base
Salary

Target
Annual FY21
Cash Bonus FY21 RSUs

FY21
PBRSUs

FY21
Options

FY21 Target
Total Direct
Compensation

Executive Officer . . . . . . . . . . . . . . . . . . . $600,000 $450,000

$949,728 $681,503 $878,258 $3,559,489

Jason P. Rhode, Former Chief Executive

Officer

. . . . . . . . . . . . . . . . . . . . . . . . . . . $300,000 $969,643

— $

— $1,269,643

Thurman K. Case, Vice President, Chief

Financial Officer and Principal
Accounting Officer . . . . . . . . . . . . . . . . . . $440,000 $319,074

Jeffrey W. Baumgartner, Vice President,

$273,858 $196,466 $253,220 $1,482,618

Research and Development

. . . . . . . . . . . $375,000 $268,594

$353,262 $253,475 $326,728 $1,577,059

Gregory S. Thomas, Senior Vice President,

General Counsel and Corporate
Secretary . . . . . . . . . . . . . . . . . . . . . . . . . . $410,000 $297,075

Jo-Dee M. Benson, Vice President, Chief

$284,934 $204,443 $263,477 $1,459,929

Culture Officer . . . . . . . . . . . . . . . . . . . . . $395,000 $287,355

$273,858 $196,466 $253,220 $1,405,899

With respect to the applicable Compensation Market Data, the target total direct compensation of:

Š Mr. Forsyth and Mr. Case fall below the 25th percentile;
Š Mr. Baumgartner falls at approximately the 50th percentile;
Š Mr. Thomas falls slightly below the 50th percentile; and
Š Ms. Benson falls between the 50th and 75th percentiles.

The Compensation Committee determined that the size of its equity awards for fiscal year 2021 was
warranted and appropriate in view of the totality of circumstances, including the Company’s
performance over the 12 months prior to its compensation analysis and the numerous other factors
noted in this proxy statement as being considered by the Compensation Committee. For example, the
Compensation Committee approved grants for fiscal year 2021 that resulted in general alignment with
the 50th percentile of the applicable Compensation Market Data for the majority of the Named
Executive Officers, maintained internal pay equity, and with respect to the CEO also reflected his
recent internal promotion as part of the Company’s CEO transition plan announced in November 2020.

The following charts are based on figures presented in the Fiscal Year 2021 Summary Compensation
Table below and show the primary components of our Named Executive Officers’ fiscal year 2021
compensation (excluding values listed in the “All Other Compensation” column), along with the
performance-based percentage of that compensation.

CEO Compensation, FY2021

CEO Percentage of Performance-Based
Compensation, FY2021

RSUs
25%

Cash Incentive
23%

Base Salary
11%

PBRSUs
18%

Options
23%

Non Performance
Based
36%

Performance Based
64%

Named Executive Officer (other
than CEO and former CEO)
Compensation, FY2021

Named Executive Officer (other
than CEO and former CEO)
Percentage of Performance-Based
Compensation, FY2021

RSUs
18%

Base Salary
23%

Cash Incentive
30%

PBRSUs
13%

Options
16%

Non Performance
Based
41%

Performance Based
59%

In the charts immediately above, the following were considered performance-based compensation:
cash incentive awards, stock option awards (which provide a potential return only if the market price of
our common stock appreciates over the option term), and PBRSUs.

4. Administrative and Timing Aspects of Our Equity Awards

New-employee equity awards and special stock awards are granted and priced on the first Wednesday
of each calendar month (the “Monthly Grant Date”). The purpose of this process is to minimize the
administrative burdens that would be created with multiple monthly grant dates and to ensure that all
required approvals are obtained on or before the Monthly Grant Date. If the Monthly Grant Date
occurs on a Company holiday, or on other days that the Company or Nasdaq is closed for business, the
Monthly Grant Date will be the next regularly scheduled business day. The Compensation Committee
does not have any program, plan, or practice to time option grants or other stock awards to our
executive officers in coordination with the release of material non-public information.

Annual equity awards to executive officers were granted in March 2021 – just prior to the end of our
fiscal year. The previous annual grants to executive officers were in November 2019. The
Compensation Committee decided to defer executive officer grants until March 2021 to better align
with our fiscal-year calendar. The Compensation Committee’s decision allows us to benchmark our
compensation decisions based on our full fiscal year performance and better aligns with the market
conditions underlying our peers’ disclosures.

Stock Ownership Guidelines

Stock ownership guidelines apply to our CEO, non-employee directors, and executive officers to more
closely link their interests with those of our other stockholders. Within the later of five years from the
2016 Annual Meeting or five years from their appointment as an executive officer or initial election to
the Board, each individual subject to the guidelines is expected to accumulate and maintain an
ownership position in Company shares that is the lesser of the following:

CEO:
Other Executive Officers:
Non-employee Directors:

Either three times annual salary or 60,000 shares
Either one time annual salary or 10,000 shares
Either three times annual cash retainer or 4,500 shares

Additional details concerning our stock ownership guidelines are provided in our Corporate
Governance Guidelines, which are available under the Corporate Governance section of our
“Investors” page on our website at investor.cirrus.com.

D. Perquisites and Other Benefits

Our CEO and other executive officers are eligible to participate in our retirement, welfare, and health
benefit programs to the same extent as all other salaried employees based in the United States or
United Kingdom, as applicable. For example, as applicable to the United States or United Kingdom,
we provide medical, dental and vision insurance, a retirement/401(k) plan, life and disability insurance,
flexible spending accounts, health savings account contributions, and other plans and programs.
Although perquisites are not a material part of our compensation programs for executive officers and
are generally not provided, we do reimburse up to $500 for an annual physical examination for each of
our executive officers to the extent the physical examination is not covered under our standard health
care plans.

From time to time, employees may request chartered aircraft services to facilitate travel that is directly
and integrally related to the performance of their job duties and where the use of a chartered plane will

increase efficiency. Occasionally, a spouse or immediate family members may accompany the
employee on these flights. When this occurs, we require the employee to pay the greater of the
incremental cost, if any, to accommodate such guests on the flight, or the imputed income amount
determined using the IRS Standard Industry Fare Level (SIFL) rate. Accordingly, there is no aggregate
incremental cost to the Company for accompaniment on chartered business flights, and no amounts for
such guests’ travel are included in our Summary Compensation Table for any Named Executive
Officer.

VI. Employment Arrangements and Post-Employment Compensation

With the exception of the Transition Agreement described below, we do not maintain separate
individual severance or change of control agreements with our Named Executive Officers; however, on
July 26, 2007, after a review of other companies’ practices with respect to management severance
plans, the Compensation Committee approved and adopted an Executive Severance and Change of
Control Plan, which was amended and restated as of April 1, 2018 (the “2007 Severance Plan”). The
2007 Severance Plan provides certain payments and other benefits to eligible executive officers
(“Eligible Executives”), including each of our Named Executive Officers, whose employment is
involuntarily terminated by the Company (other than for cause) or whose employment terminates
following a change of control of the Company. The 2007 Severance Plan originally became effective
on October 1, 2007. Details and specific terms of the Severance Plan are set forth in the section of this
proxy statement entitled, “Potential Payments upon Termination or Change of Control.”

We maintain the 2007 Severance Plan because we believe it is consistent with the practices of peer
companies and helps ensure that we are able to attract and retain top talent. Further, we believe that our
plan provides a level of stability to Eligible Executives during volatile business conditions that have
historically existed in our industry so that they remain focused on their responsibilities and the long-
term interests of the Company during such times.

The 2007 Severance Plan provides for “double-trigger” rather than “single-trigger” payment and
benefits in the event of a change of control of the Company. In other words, payments to Eligible
Executives are contingent upon an involuntarily termination of employment following a change of
control. This plan design is intended to provide a level of security to Eligible Executives negotiating a
transaction to avoid any misalignment with the interests of our stockholders without resulting in a
windfall to Eligible Executives who remain employed following such a transaction.

On October 30, 2020, the Company entered into a Transition Agreement with Jason P. Rhode, the
current CEO, pursuant to which Dr. Rhode transitioned from his service as CEO on January 1, 2021
(the “Transition Commencement Date”) into an Executive Fellow role, whereby he would provide
certain transition and advisory services to the Company through January 1, 2022 (the “Transition
Completion Date”). Dr. Rhode also resigned from the Company’s Board effective on the Transition
Commencement Date. During the period between the Transition Commencement Date and the
Transition Completion Date (the “Transition Period”), Dr. Rhode will work with Mr. Forsyth following
the transition of the CEO responsibilities, as well as continuing to be directly involved in customer
relationships and talent development within the Company. In exchange for his services, Dr. Rhode will
be entitled to receive an annual base salary of $300,000 per year and continue to receive his current
benefits. He will also be eligible to participate in the Company’s Incentive Plan at a semiannual target
bonus of 37.5% of his base annual salary, prorated as described herein.

VII. Clawback Policy and Prohibition Against Short Selling, Hedging, and Pledging

Effective May 25, 2018, our executive officers became subject to a clawback policy entitled, “Policy
Regarding Recoupment of Certain Incentive Compensation” that provides for forfeiture of excess

incentive compensation in the event of misconduct resulting in a restatement of our financial
statements. The clawback policy governs all incentive compensation (cash or equity-based
compensation) that is granted, earned, or vested based upon the achievement of financial or stock
performance metrics, and which was granted following the adoption of the clawback policy and paid in
the preceding three-year period from the time the Company determines that it must restate its financial
statements.

The Company prohibits directors, officers, and employees (or their designees) from investing in
derivative securities based on or related to the Company’s common stock, engaging in any short sale or
hedging transactions involving the Company’s common stock, and pledging any shares of the
Company’s common stock as collateral for any margin account or any other similar account or debt
instrument where a sale of the Company’s stock could occur. Prohibited hedging transactions generally
involve the purchase of any financial instrument that will hedge or offset, or is designed to hedge or
offset, any decrease in the market value of the Company’s common stock. Our policy does not restrict
the ownership of Company-granted equity awards, such as stock options, restricted stock, RSUs,
PBRSUs, or other equity awards issued by the Company.

VIII. Tax Considerations Related to Compensation

Section 162(m) of the Internal Revenue Code was amended by the Tax Cuts and Jobs Act of 2017 (the
“Tax Act”) effective for taxable years beginning after December 31, 2017. Section 162(m) generally
disallows a publicly-held corporation a deduction for federal income tax purposes of remuneration in
excess of $1 million paid in any taxable year to its covered employees. Although the exception for
“performance-based compensation” was repealed by the Tax Act, remuneration paid pursuant to a
written binding contract in effect on November 2, 2017, and not materially modified after that date,
will not be subject to the deduction limitation if specified requirements are met. For all other
compensation, amounts in excess of $1 million paid to any covered employee generally will not be
deductible.

The Compensation Committee considers deductibility, so long as it is reasonable and consistent with
the Company’s overall compensation and retention objectives, when designing our executive
compensation program. However, the Compensation Committee may award compensation that is not
deductible if it determines that doing so is appropriate and in the best interests of the Company and its
stockholders. Additionally, the Compensation Committee cannot guarantee that past compensation, or
compensation granted in the future, generally designed to be deductible will in fact be deductible.

Section 280G of the IRC disallows the deduction of any “excess parachute payment” paid in
connection with certain events. A portion of amounts payable under the 2007 Severance Plan may
constitute “excess parachute payments” to our executive officers. Accordingly, the 2007 Severance
Plan provides for a modified Section 280G “cut back” pursuant to which payments and benefits under
the 2007 Severance Plan will be reduced in the event such reduction produces a greater after-tax
benefit to an executive officer. See the section of this proxy statement entitled, “Potential Payments
Upon Termination or Change of Control.”

IX. Compensation Committee Interlocks and Insider Participation

The Compensation Committee currently consists of Timothy R. Dehne (Chair), John C. Carter, and
David J. Tupman. During fiscal year 2021, none of our executive officers served on the board of
directors or compensation committee of another company whose executive officer served on our Board
or Compensation Committee. The members of the Compensation Committee are considered
independent under the Board and the Compensation Committee independence standards as set forth in
the Corporate Governance Guidelines, which are available under the Corporate Governance section of
our “Investors” page on our website at investor.cirrus.com.

COMPENSATION COMMITTEE REPORT

We, the Compensation Committee of the Board of Directors, have reviewed and discussed the
Compensation Discussion and Analysis (“CD&A”) required by Item 402(b) of Regulation S-K with
management of the Company. Based on such review and discussion, we have recommended to the
Board of Directors that the CD&A be included as part of this proxy statement.

Submitted by the Compensation Committee of the Board of Directors:
Timothy R. Dehne, Chair
John C. Carter
David J. Tupman

CONSIDERATION OF RISK RELATED TO COMPENSATION PROGRAMS

The Compensation Committee structures our executive compensation program to provide incentives to
appropriately reward our executive officers without undue risk taking. Our approach is similar for the
compensation practices and polices applicable to all employees throughout the Company. Overall, we
believe that our compensation programs do not create risks that are reasonably likely to have a material
adverse effect on the Company. In general, we attempt to align our compensation programs with the
long-term interests of the Company and its stockholders and mitigate the likelihood of inducing
excessive risk-taking behavior. More specifically, we believe the following program features and
policies help to mitigate the likelihood of inducing excessive risk-taking behavior:

Š The Company pays a mix of fixed and variable compensation, with variable compensation

tied both to short-term objectives and the long-term value of our stock price.

Š Our annual cash incentive program is based on a mix of bottom-line objectives (e.g.,

operating profit goals) and top-line objectives (e.g., revenue growth) in order to avoid the
risk of excessive focus on one goal or performance measure.

Š We review the short-term performance incentive targets used in our incentive program every

six months to ensure alignment with our business plans.

Š To prevent the risk that our annual cash incentive program pays bonuses despite weak short-

term performance, no payout may occur without a threshold level of operating profit
performance being met.

Š The aggregate payout under our annual cash incentive program for our executive and

leadership team is capped at a percentage of overall operating profit to prevent the risk of
excessive payout of the Company’s operating profit.

Š The individual payout under our annual cash incentive program for our executive and

leadership team is further capped so that no participants may receive a payout of greater than
250% of their target payout.

Š Long-term incentives are awarded to our executive officers in the form of equity awards that
vest or are earned over a significant period of time, typically three or four years. The vesting
or performance period, as the case may be, is intended to align the interests of our executive
officers with the long-term interests of stockholders and to provide an incentive for our
executive officers to remain with the Company.

Š Long-term incentives are typically granted annually so our executive officers will have

unvested awards that may decrease in value if our business is not managed with long-term
goals in mind.

Š We use a mix of stock options, RSUs, and PBRSUs to create an overall long-term incentive
package that aligns with stockholder interests, appropriately balances risk and performance,
and provides competitive incentives for the purpose of executive retention.

Š We use performance-based equity based on the Company’s TSR as a means to align a

portion of an executive officer’s compensation with the interests of our stockholders. In
addition, we cap the payout of these awards at a 100% payout if the Company’s TSR is
negative over the performance period (typically, three years).

Š Our annual equity awards to executive officers are granted near the end of our fiscal year,
which allows us to benchmark our compensation decisions based on our full fiscal year
performance and to better align with the market conditions underlying our peers’ disclosures.
This alignment in timing reduces risks associated with compensation being analyzed in
timeframes significantly different than those used in such disclosures.

Š Our CEO, non-employee directors, and executive officers of the Company are obligated to
meet certain stock ownership guidelines that require accumulation and maintenance of a
prescribed value or number of shares.

Š The Compensation Committee retains an independent compensation consultant and uses

market data, when available, to inform our focus on pay for performance.

Š Our executive officers are subject to a clawback policy (“Policy Regarding Recoupment of

Certain Incentive Compensation”) that provides for forfeiture of excess incentive
compensation that was awarded on or after May 25, 2018, in the event of misconduct
resulting in a restatement of financial statements.

EXECUTIVE COMPENSATION TABLES

Fiscal Year 2021 Summary Compensation Table
The following table provides certain summary information concerning the compensation awarded to,
earned by, or paid to our Named Executive Officers. The table sets forth compensation for services
rendered by our Named Executive Officers for the fiscal years ended March 27, 2021; March 28, 2020;
and March 30, 2019; as applicable.

Name and Principal
Position

Year

Salary

Stock
Awards(1)

Option
Awards(1)

($)
(e)

($)
(f)

Non-Equity
Incentive Plan
Compensation(2)
($)
(g)

All Other
Compensation

($)
(i)

Total

($)
(j)

(b)

2021
2020

2021
2020
2019

($)
(c)

$443,077
325,077

$692,308
800,000
800,000

$414,787
400,631
391,300

$1,631,231
2,091,292

$ 878,258
360,976

$ 868,132
380,581

$14,382 (3)

62,785

$3,835,080
3,220,711

—
2,550,240
2,163,850

$ 470,324
561,792
358,663

—
1,504,072
1,276,439

$ 253,221
342,930
221,251

$1,457,042
1,666,954
660,245

$ 544,255
420,984
161,471

$ 9,560 (4)
11,058
10,787

$13,742 (5)
14,483
14,154

$2,158,910
6,532,324
4,911,321

$1,696,329
1,740,820
1,146,839

2021

$345,794

$ 606,737

$ 326,728

$ 460,733

$ 8,808 (6)

$1,748,800

2021
2020
2019

$385,943
374,511
367,500

$374,473
363,811
357,000

$ 489,377
561,792
378,227

$ 470,324
517,440
358,663

$ 263,478
342,930
229,760

$ 253,221
315,857
221,251

$ 506,918
392,878
151,650

$ 489,444
381,653
147,317

$14,684 (7)
11,904
11,315

$14,109 (8)
14,434
12,986

$1,660,400
1,684,015
1,138,452

$1,601,571
1,593,195
1,097,217

(a)

John M. Forsyth,
President and Chief
Executive Officer

Jason P. Rhode,
Former Chief
Executive Officer

Thurman K. Case,
Vice President, Chief
Financial Officer and
Principal Accounting Officer

Jeffrey W. Baumgartner,
Vice President, Research
and Development

Gregory S. Thomas,
Senior Vice President,
General Counsel and
Corporate Secretary

Jo-Dee M. Benson,
Vice President,
Chief Culture Officer

(1) The amounts reported in the column entitled “Stock Awards” represent the RSUs and PBRSUs
granted to our Named Executive Officers. The amounts reported in the column entitled “Option
Awards” represent the stock options granted to our Named Executive Officers. In each case, the
value reported is the aggregate grant date fair value calculated pursuant to FASB ASC Topic 718,
excluding any assumptions regarding potential forfeitures, and with respect to PBRSUs this
valuation entails a Monte Carlo calculation. With respect to the row corresponding to fiscal year
2020, the amounts reflect an update to correct the grant date accounting values. The assumptions
underlying calculations under FASB ASC Topic 718 are discussed under Note 10, Equity
Compensation, in our Annual Report on Form 10-K for the fiscal year ended March 27, 2021.
(2) This column, entitled “Non-Equity Incentive Plan Compensation,” represents the amounts earned

for each fiscal year under the Incentive Plan, which is described in further detail in the
“Compensation Discussion and Analysis” section of this proxy statement. Payments earned in the
second semiannual period of a fiscal year are included in this table for that fiscal year even though
they were paid in the following fiscal year.

(3) This amount includes $11,446 in matched contributions under our 401(k) plan, $1,500 in

employee contributions to a health savings account under our health benefits program, $990
associated with the value of insurance premiums paid with respect to life insurance for the benefit
of Mr. Forsyth, and $446 in tax gross-ups paid to all employees of the Company with respect to
the Company’s long-term disability plan.

(4) This amount includes $7,596 in matched contributions under our 401(k) plan, $1,518 associated
with the value of insurance premiums paid with respect to life insurance for the benefit of
Dr. Rhode, and $446 in tax gross-ups paid to all employees of the Company with respect to the
Company’s long-term disability plan.

(5) This amount includes $8,010 in matched contributions under our 401(k) plan, $5,286 associated
with the value of insurance premiums paid with respect to life insurance for the benefit of
Mr. Case, and $446 in tax gross-ups paid to all employees of the Company with respect to the
Company’s long-term disability plan.

(6) This amount includes $7,372 in matched contributions under our 401(k) plan, $990 associated
with the value of insurance premiums paid with respect to life insurance for the benefit of
Mr. Baumgartner, and $446 in tax gross-ups paid to all employees of the Company with respect to
the Company’s long-term disability plan.

(7) This amount includes $9,900 in matched contributions under our 401(k) plan, $1,500 in employee
contributions to a health savings account under our health benefits program, $2,838 associated
with the value of insurance premiums paid with respect to life insurance for the benefit of
Mr. Thomas, and $446 in tax gross-ups paid to all employees of the Company with respect to the
Company’s long-term disability plan.

(8) This amount includes $9,306 in matched contributions under our 401(k) plan, $4,357 associated
with the value of insurance premiums paid with respect to life insurance for the benefit of
Ms. Benson, and $446 in tax gross-ups paid to all employees of the Company with respect to the
Company’s long-term disability plan.

Fiscal Year 2021 Grants of Plan-Based Awards Table

The following table sets forth certain information with respect to grants of plan-based awards for the
fiscal year ended March 27, 2021, to our Named Executive Officers. All of the stock options, RSUs,
and PBRSUs that are reflected in the table were granted under our 2018 Long Term Incentive Plan.

The amounts reported in the “Estimated Future Payouts Under Non-Equity Incentive Plan Awards”
column below set forth potential payouts under the Company’s Incentive Plan, which is described
further in the “Compensation Discussion and Analysis” section of this proxy statement.

The amounts reported in the “Estimated Future Payouts Under Equity Incentive Plan Awards” column
below set forth potential payouts that are associated with PBRSUs. The PBRSUs will vest as to the
number of shares earned on the third anniversary of the grant date. The number of PBRSUs that vest, if
any, is based on Company performance during this three-year period and is determined relative to the
target number of shares as described further in the “Compensation Discussion and Analysis” section of
this proxy statement. Holders of PBRSUs are not eligible to receive any dividends or dividend
equivalents with respect to outstanding PBRSUs.

Each stock option has a maximum term of 10 years, subject to earlier termination if the optionee’s
services are terminated. Unless noted, the exercisability of options vests with respect to 25% of the
shares underlying the option one year after the date of grant and with respect to the remaining shares
underlying the option thereafter in 36 equal monthly installments. The exercise price of each stock
option is equal to the closing market price of our common stock as reported on Nasdaq on the date of
grant.

The RSUs will vest with respect to 100% of the shares underlying the award on the third anniversary of
the grant date. Holders of RSUs are not eligible to receive any dividends or dividend equivalents with
respect to outstanding RSUs.

Special accelerated vesting provisions applicable to the equity awards upon a Named Executive Officer’s termination
of employment or upon a change of control of the Company are described in the section of this proxy statement
entitled, “Potential Payments Upon Termination or Change of Control.”

Name

Grant
Date(1)

Approval
Date(1)

Estimated Future
Payouts Under
Non-Equity
Incentive Plan Awards(2)

Estimated Future
Payouts Under
Equity
Incentive Plan Awards(3)

(a)
John M. Forsyth,
President and Chief
Executive Officer

Jason P. Rhode,
Former Chief
Executive Officer

Thurman K. Case,
Vice President, Chief
Financial Officer and
Principal Accounting
Officer

(b)

3/3/2021 2/26/2021
3/3/2021 2/26/2021
3/3/2021 2/26/2021

Jeffrey W. Baumgartner,
Vice President, Research
and Development

3/3/2021 2/26/2021
3/3/2021 2/26/2021
3/3/2021 2/26/2021

Gregory S. Thomas,
Senior Vice President,
General Counsel and
Corporate Secretary

Jo-Dee M. Benson,
Vice President,
Chief Culture Officer

3/3/2021 2/26/2021
3/3/2021 2/26/2021
3/3/2021 2/26/2021

Threshold
($)
(c)

Target
($)
(d)

Maximum
($)
(e)

Threshold
(#)
(f)

Target
(#)
(g)

Maximum
(#)
(h)

$150,000

$600,000

$1,500,000

$ 56,250

$225,000

$ 562,500

$ 82,500

$330,000

$ 825,000

$ 70,313

$281,250

$ 703,125

$ 76,875

$307,500

$ 768,750

$ 74,063

$296,250

$ 740,625

2,029

8,117

16,234

—

585

2,340

4,680

755

3,019

6,038

609

2,435

4,870

585

2,340

4,680

All Other
Stock
Awards:
Number of
Shares of
Stock or
Units

(#)
(i)
12,176

All Other
Option
Awards:
Number of
Securities
Underlying
Options

Exercise
or Base
Price of
Option
Awards
($/Sh)

(#)
(j)

(k)

25,687

$78.00

Grant Date
Fair Value
of Stock
and Option
Awards(4)

(l)
$949,728
$681,503
$878,258

—

3,511

4,529

3,653

3,511

$
$
$ — $

—
—
—

—

7,406

$78.00

9,556

$78.00

7,706

$78.00

7,406

$78.00

$273,858
$196,466
$253,220

$353,262
$253,475
$326,728

$284,934
$204,443
$263,477

$273,858
$196,466
$253,220

(1) The Company’s policy is to grant equity awards on the first Wednesday of the month (the “Monthly Grant

Date”) after the Compensation Committee approves the award. If the Monthly Grant Date occurs on a Company
holiday, or on other days that the Company or Nasdaq is closed for business, the Monthly Grant Date is the next
regularly scheduled business day when the Company and Nasdaq are open for business.

(2) The amounts reported in this column reflect potential payment amounts under the Incentive Plan. Actual amounts
earned under this plan are reported in the “Non-Equity Incentive Plan Compensation” column of the Summary
Compensation Table above. Semiannual payments may be made under the Incentive Plan only if certain financial
prerequisites, such as operating profit margin thresholds, are achieved, as described further in the “Compensation
Discussion and Analysis” section of this proxy statement. The threshold amounts reported in this column reflect
the minimum amount payable assuming achievement of the applicable financial-result thresholds (25% of the
target amount). The target amounts reported above reflect the target amount awarded to each Named Executive
Officer. The maximum amounts represent 250% of the target amount.

(3) The amounts reported in this column reflect the number of shares underlying potential payment amounts for

PBRSUs under the Company’s Performance-Based Restricted Stock Unit program. The number of PBRSUs that
will actually be earned and vest, if any, is based on Company performance during a three-year performance
period and is determined as further described in the “Compensation Discussion and Analysis” section of this
proxy statement.

(4) Amounts in this column represent the aggregate grant date fair value of the equity awards computed in

accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures, and with respect to
PBRSUs this valuation entails a Monte Carlo calculation. The assumptions underlying calculations under FASB
ASC Topic 718 are discussed under Note 10, Equity Compensation, in the Company’s Annual Report on
Form 10-K for the fiscal year ended March 27, 2021.

Fiscal Year 2021 Outstanding Equity Awards at Fiscal Year-End Table

The following table provides information concerning the outstanding equity award holdings of our Named
Executive Officers as of March 27, 2021.

Option Awards

Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)

Number of
Securities
Underlying
Unexercised
Options
Unexercisable(1)
(#)

Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)

Option
Exercise
Price
($)

Option
Expiration
Date(2)

Stock
Award
Grant
Date

Number of
Shares or
Units of
Stock That
Have Not
Vested(3)
(#)

Stock Awards
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested(4)
($)

Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested(5)

Name

(a)

John M. Forsyth,
President and Chief
Executive Officer

(b)

2,604
1,302
4,000
—

(c)

7,813
5,209
8,000
25,687

(d)

(e)

(f)

(g)

(h)

6/6/2028
$38.15
$41.49 11/7/2028
$68.56 11/6/2029
3/3/2031
$78.00

(#)

(i)

Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested(6)

($)

(j)

Jason P. Rhode,
Former Chief
Executive Officer

Thurman K. Case,
Vice President, Chief
Financial Officer and
Principal Accounting
Officer

110,000
73,063
75,000
62,500
43,750
16,666

5,000
2,666
6,957
7,046
8,239
10,833
6,583
3,800
—

—
—
—
12,500
31,250
21,875

—
—
—
—
—
2,167
5,417
7,600
7,406

6/6/2018
6/6/2018
11/7/2018
11/7/2018
11/6/2019
11/6/2019
2/5/2020
3/3/2021
3/3/2021

8,250

$ 684,833

4,125

$ 342,416

4,000

$ 332,040

18,815
12,176

$1,561,833
$1,010,730

13,000

$1,079,130

3,100

$ 257,331

800

66,408

2,029

$ 168,427

11/7/2018
11/7/2018
11/6/2019
11/6/2019

25,000

$2,075,250

17,250

$1,431,923

20,000

$1,660,200

3,450

$ 286,385

11/7/2018
11/7/2018
11/6/2019
11/6/2019
3/3/2021
3/3/2021

4,300

$ 356,943

3,800

$ 315,438

3,511

$ 291,448

3,200

$ 265,632

760

585

63,088

48,561

$38.99 10/3/2022
$31.25 11/4/2025
$54.65 11/2/2026
$55.72 11/1/2027
$41.49 11/7/2028
$68.56 11/6/2029

$38.99 10/3/2022
$23.34 10/2/2023
$20.37 10/1/2024
$31.25 11/4/2025
$54.65 11/2/2026
$55.72 11/1/2027
$41.49 11/7/2028
$68.56 11/6/2029
3/3/2031
$78.00

Option Awards

Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)

Number of
Securities
Underlying
Unexercised
Options
Unexercisable(1)
(#)

Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)

Option
Exercise
Price
($)

Option
Expiration
Date(2)

Stock
Award
Grant
Date

Number of
Shares or
Units of
Stock That
Have Not
Vested(3)
(#)

Stock Awards
Market
Value of
Shares or
Units of
Stock That
Have Not
Vested(4)
($)

Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested(5)

(#)

Name

(d)

(e)

(f)

(g)

(h)

(i)

Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights That
Have Not
Vested(6)

($)

(j)

(a)

Jeffrey W. Baumgartner,
Vice President, Research
and Development

(b)

35,416
7,291
4,000
—

(c)

14,584
5,209
8,000
9,556

Gregory S. Thomas,
Senior Vice President,
General Counsel and
Corporate Secretary

Jo-Dee M. Benson,
Vice President,
Chief Culture Officer

12,735
5,043
3,200
13,500
11,250
7,875
3,800
—

18,000
13,000
10,833
7,583
3,500
—

—
—
—
—
2,250
5,625
7,600
7,706

—
—
2,167
5,417
7,000
7,406

5/2/2028
$38.34
$41.49 11/7/2028
$68.56 11/6/2029
3/3/2031
$78.00

$23.34 10/2/2023
$20.37 10/1/2024
$31.25 11/4/2025
$54.65 11/2/2026
$55.72 11/1/2027
$41.49 11/7/2028
$68.56 11/6/2029
3/3/2031
$78.00

$38.99 10/3/2022
$54.65 11/2/2026
$55.72 11/1/2027
$41.49 11/7/2028
$68.56 11/6/2029
3/3/2031
$78.00

5/2/2018
5/2/2018
11/7/2018
11/7/2018
11/6/2019
11/6/2019
3/3/2021
3/3/2021

16,500

$1,369,665

4,125

$ 342,416

4,000

$ 332,040

4,529

$ 375,952

13,000

$1,079,130

3,100

$ 257,331

800

754

66,408

62,590

11/7/2018
11/7/2018
11/6/2019
11/6/2019
3/3/2021
3/3/2021

4,500

$ 373,545

3,800

$ 315,438

3,653

$ 303,236

3,400

$ 282,234

760

608

63,088

50,470

11/7/2018
11/7/2018
11/6/2019
11/6/2019
3/3/2021
3/3/2021

4,300

$ 356,943

3,500

$ 290,535

3,511

$ 291,448

3,200

$ 265,632

700

585

58,107

48,561

(1) All outstanding stock options vest over four years, with one-year cliff vesting for 25% of the options on the
first anniversary of the grant date, and 1/36 of the remaining options vesting on a monthly basis over the
following three years.

(2) Options have a maximum 10-year term. Therefore, the grant date is 10 years prior to the Option

Expiration Date listed in this column.

(3) This column corresponds to RSUs. Outstanding RSUs will vest with respect to 100% of the shares

underlying the award on the third anniversary of the grant date.

(4) The market value of unvested RSUs reported in column (h) is calculated by multiplying the

number of shares of common stock subject to each award reported in column (g) by the closing
market price of our common stock on March 26, 2021, (the last trading day of fiscal year 2021),
which was $83.01 per share.

(5) This column corresponds to PBRSUs. The disclosed number of PBRSUs is based on the next
higher performance level (threshold, target, or maximum) above the Company’s performance
through the most recently completed fiscal year. Accordingly, PBRSUs granted on November 6,
2019, and March 3, 2021, are listed at their threshold level because the Company’s relative TSR
performance for those awards through the most recently completed fiscal year would result in a
payout of 0%. PBRSUs granted on May 2, 2018, and November 7, 2018, are listed at their target
level because the Company’s relative TSR performance for those awards through the most
recently completed fiscal year would result in a payout of approximately 94%. PBRSUs granted
on June 6, 2018, are listed at the maximum level because the Company’s relative TSR
performance for those awards through the most recently completed fiscal year would result in a
payout of approximately 115%. The number of shares that ultimately vest, if any, will be based on
Company performance and will be relative to the target number of shares as further described in
the “Compensation Discussion and Analysis” section of this proxy statement. Such vesting will
occur on the third anniversary of the grant date. The PBRSUs granted on May 2, 2018 (listed at
their target level in this table) vested on May 2, 2021 with an actual payout percentage of 82%.
(6) The market value of unvested PBRSUs reported in column (j) is calculated by multiplying the
threshold number of shares subject to each award reported in column (i) by the closing market
price of our common stock on March 26, 2021, (the last trading day of fiscal year 2021), which
was $83.01 per share.

Fiscal Year 2021 Options Exercised and Stock Vested Table

The following table provides information on the value realized by each Named Executive Officer as a
result of options that were exercised and stock awards that vested during fiscal year 2021.

Name

(a)
John M. Forsyth, President and
Chief Executive Officer
Jason P. Rhode, Former Chief
Executive Officer
Thurman K. Case, Vice
President, Chief Financial
Officer and Principal
Accounting Officer
Jeffrey W. Baumgartner, Vice
President, Research and
Development
Gregory S. Thomas, Senior
Vice President, General
Counsel and Corporate
Secretary
Jo-Dee M. Benson, Vice
President, Chief Culture Officer

Option Awards

Stock Awards

Number of Shares
Acquired on
Exercise
(#)
(b)

Value Realized on
Exercise(1)
($)
(c)

Number of Shares
Acquired on Vesting
(#)
(d)

Value Realized
on Vesting(2)
($)
(e)

9,718

$ 421,921

8,000

$ 550,960

147,148

$6,722,993

25,000

$1,721,750

20,495

$ 869,891

4,300

$ 296,141

—

9,000

$ 619,830

4,500

$ 309,915

4,300

$ 296,141

(1) The value realized on the exercise of stock options was computed by determining the difference

between the market price of our common stock underlying each option on the date of exercise and
the exercise price of the options for each share exercised multiplied by the number of options
exercised (column b).

(2) The value realized on the vesting of stock awards was computed by multiplying the number of
shares acquired on vesting (column d) by the market price of our common stock on the date of
vesting.

Pension Benefits and Nonqualified Deferred Compensation
We do not sponsor or maintain either a defined benefit pension plan or a nonqualified deferred
compensation plan for the benefit of our executive officers.

Potential Payments upon Termination or Change of Control
Under the Transition Agreement noted herein (see the section of this proxy statement entitled,
“Employment Arrangements and Post-Employment Compensation”), if Dr. Rhode provides continual
services throughout the Transition Period and signs a release of all claims against the Company, then
any portion of Dr. Rhode’s unvested equity awards pursuant to the Company’s 2018 Long Term
Incentive Plan (the “LTI Plan”) that were scheduled or would become eligible to vest up to the
12-month period immediately following the Transition Completion Date shall fully vest automatically.
With respect to any Awards (as defined in the LTI Plan) that are subject to performance-based vesting
conditions, performance will be calculated based upon the actual performance of such Award as of the

Transition Completion Date as calculated in accordance with the terms and conditions of the LTI Plan
and any individual Award agreements governing such Award. The Board believes that the total
compensation, including the acceleration of vesting of Awards if Dr. Rhode provides continual
services through the Transition Period, properly balances the Board’s desire to induce Dr. Rhode to
remain engaged with the leadership of the Company as part of a planned executive succession strategy
while also supporting the timely transition of his management roles and responsibilities to Mr. Forsyth.

During the Transition Period, Dr. Rhode will continue to be eligible to receive the benefits, if any,
provided for non-CEO executives under the 2007 Severance Plan. In addition to the benefits provided
under the 2007 Severance Plan, in connection with any determination by the Company to terminate
Dr. Rhode without Cause or Dr. Rhode’s resignation following a Change of Control (capitalized terms
defined as in the 2007 Severance Plan), any portion of Dr. Rhode’s Awards (as defined in the LTI
Plan) that were scheduled or would become eligible to vest had Dr. Rhode remained employed with the
Company until the Transition Completion Date shall fully vest automatically. With respect to any
Awards referenced in the previous sentence that are subject to performance-based vesting conditions,
performance will be calculated based upon the actual performance of such Award as of the date of the
applicable termination, calculated in accordance with the terms and conditions of the LTI Plan and any
individual Award agreements governing such Award.

With the exception of the Transition Agreement, we do not maintain individual employment,
severance, or change of control agreements with our Named Executive Officers; however, we do
maintain the 2007 Severance Plan, which provides for certain payments and benefits to individuals
employed by the Company and its subsidiaries at the level of Chief Executive Officer and Vice
President or above and reporting directly to the Chief Executive Officer (“Eligible Executives”) in the
event that the employment of such an executive officer is involuntarily terminated other than for cause
or in certain circumstances following a change of control of the Company. The Named Executive
Officers may also receive certain benefits under the Incentive Plan in the event of certain terminations
of employment or change of control transactions that occur prior to the payment of the award for the
applicable fiscal year.

2007 Severance Plan

Each of our Named Executive Officers is considered an Eligible Executive under the 2007 Severance
Plan, including Dr. Rhode pursuant to the terms of his Transition Agreement. We maintain the 2007
Severance Plan because we believe it helps to ensure that we are able to attract and retain top talent.
Further, we believe that the 2007 Severance Plan provides a level of stability for our executive officers
during volatile business conditions that have historically existed so that they remain focused on their
responsibilities and the long-term interests of the Company during such times.

The 2007 Severance Plan provides that, in the event of an Eligible Executive’s involuntary termination
of employment by the Company other than for “cause” (as such term is defined below for purposes of
the 2007 Severance Plan) they will be eligible to receive: (i) a continuation of base salary for a period
of up to six months (up to 12 months in the case of our CEO) following termination of employment,
and (ii) payment in full of a reasonable estimate of COBRA premiums for three months (collectively,
the “Termination Payment”).

The 2007 Severance Plan further provides that, if an Eligible Executive’s employment is terminated
either by the Company without “cause” or by the Eligible Executive for “good reason” within 12
months following a “change of control” (each term as defined below for purposes of the 2007
Severance Plan) of the Company, they will be eligible to receive a “Change of Control Termination
Payment,” which is comprised of: (i) a lump sum payment equal to 12 months’ base salary (24 months
in the case of our CEO), (ii) acceleration in full of any unvested stock options or any other securities or

similar incentive awards that have been granted or issued to them as of the employment termination
date, and (iii) payment in full of a reasonable estimate of COBRA premiums for 12 months. In
addition, the Eligible Executive will have until six months from the employment termination date to
exercise any vested options, except that no option will be exercisable after the option’s original
expiration date. Dr. Rhode’s Transition Agreement modifies the payments and benefits that he could
receive pursuant to the 2007 Severance Plan by limiting the acceleration of equity awards to those that
were scheduled or would become eligible to vest up to the 12-month period immediately following the
Transition Completion Date, and modifying the qualifying termination scenarios to a termination
without cause or a resignation by Dr. Rhode following a change in control.

In the event of an Eligible Executive’s death or termination of employment due to “disability” (as such
term is defined below for purposes of the 2007 Severance Plan), the Eligible Executive or their estate,
as applicable, will receive the Termination Payment described above. If the death or termination due to
disability has occurred within 12 months following a change of control of the Company, they or their
estate, as applicable, will receive the Change of Control Termination Payment described above.

With respect to Dr. Rhode, his Transition Agreement provides for potential payments and benefits as
described in the section immediately above entitled, “Potential Payments upon Termination or Change
of Control.”

For purposes of the 2007 Severance Plan:

“cause” means (i) gross negligence or willful misconduct in the performance of an executive
officer’s duties; (ii) a material and willful violation of any federal or state law that if made
public would injure the business or reputation of the Company; (iii) a refusal or willful
failure to comply with any specific lawful direction or order of the Company or the material
policies and procedures of the Company including but not limited to the Company’s Code of
Conduct and the Company’s Insider Trading Policy as well as any obligations concerning
proprietary rights and confidential information of the Company; (iv) a conviction (including
a plea of nolo contendere ) of a felony, or of a misdemeanor that would have a material
adverse effect on the Company’s goodwill if the executive officer were to continue to be
retained as an employee of the Company; or (v) a substantial and continuing willful refusal
to perform duties ordinarily performed by an employee in the same position and having
similar duties as the executive officer.

“good reason” means: (i) without the executive officer’s express written consent, a material
reduction of the executive officer’s duties, authority, or responsibilities relative to the
executive’s duties, authority, or responsibilities as in effect immediately prior to such
reduction; (ii) a material reduction by the Company in the base salary of an executive officer
as in effect immediately prior to such reduction; or (iii) the relocation of an executive
officer’s principal work location to a facility or a location more than 50 miles from executive
officer’s then present principal work location. “Good reason” shall not exist unless the
executive officer provides written notice of the circumstances alleged to give rise to good
reason within 30 days of their occurrence and the Company (or our successor) fails to cure
such circumstances within 30 days.

“disability” means a mental or physical disability, illness or injury, evidenced by medical
reports from a duly qualified medical practitioner, which renders an Eligible Executive
unable to perform any one or more of the essential duties of their position after the provision
of reasonable accommodation, if applicable, for a period of greater than 90 days within a one
year period.

“change of control” means the occurrence of one or more of the following with respect to the
Company: (i) the acquisition by any person (or related group of persons), whether by tender
or exchange offer made directly to the Company’s stockholders, open market purchases or
any other transaction or series of transactions, of stock of the Company that, together with
stock of the Company held by such person or group, constitutes more than 50% of the total
fair market value or total voting power of the then outstanding stock of the Company entitled
to vote generally in the election of the members of the Company’s Board of Directors; (ii) a
merger or consolidation in which the Company is not the surviving entity, except for a
transaction in which both (A) securities representing more than 50% of the total combined
voting power of the surviving entity are beneficially owned (within the meaning of Rule
13d-3 promulgated under the Securities Exchange Act of 1934), directly or indirectly,
immediately after such merger or consolidation by persons who beneficially owned common
stock of the Company immediately prior to such merger or consolidation, and (B) the
members of the Board of Directors immediately prior to the transaction (the “Existing
Board”) constitute a majority of the Board of Directors immediately after such merger or
consolidation; (iii) any reverse merger in which the Company is the surviving entity but in
which either (A) persons who beneficially owned, directly or indirectly, common stock of the
Company immediately prior to such reverse merger do not retain immediately after such
reverse merger direct or indirect beneficial ownership of securities representing more than
50% of the total combined voting power of the Company’s outstanding securities or (B) the
members of the existing Board do not constitute a majority of the Board of Directors
immediately after such reverse merger; or (iv) the sale, transfer or other disposition of all or
substantially all of the assets of the Company (other than a sale, transfer or other disposition
to one or more subsidiaries of the Company).

The 2007 Severance Plan may not be amended or terminated without the consent of any Eligible
Executive during the one year prior to or following the occurrence of a change of control, if such
amendment would be adverse to the interest of such Eligible Executive. If any payment or benefit
under the 2007 Severance Plan would be a “parachute payment” (within the meaning of Section 280G
of the IRC) and would therefore result in the imposition of an excise tax, an Eligible Executive’s
payments and benefits will not exceed the amount that produces the greatest after-tax benefit to the
Eligible Executive.

To receive payments and benefits under the 2007 Severance Plan, an Eligible Executive must execute a
release of all claims against the Company. If the Eligible Executive is considered a “specified
employee” under Section 409A of the IRC at the time of their termination of employment, any
amounts payable under the 2007 Severance Plan will be delayed for a period of six months if it is
determined that such a delay is necessary in order to prevent the payment from imposing excise taxes
on the executive officer.

Incentive Plan

In addition, a participant in the Incentive Plan, as described further in the “Compensation Discussion
and Analysis” section of this proxy statement, may also receive payments upon termination of
employment or a change of control of the Company. Pursuant to the Incentive Plan, a participant,
including each of our Named Executive Officers, must be continuously employed through the last day
of the applicable semiannual performance period and through the date that cash bonuses under the
Incentive Plan for such semiannual performance period are actually paid. However, participants whose
employment terminates due to death or “disability” during a semiannual performance period will be
eligible to receive a pro rata cash bonus payment based on the number of days the participant was
employed during that semiannual performance period and the Company’s actual performance during

the semiannual performance period. The pro rata bonus amount will be paid to the terminated
participant on or before the 15th day of the third month after the later of (i) the last day of the calendar
year in which such participant died or incurred a “disability” or (ii) the last day of the Company’s
taxable year in which such participant died or incurred a “disability.” Payment under the Incentive Plan
would no longer be received if a participant’s employment was terminated for some other reason
during a semiannual performance period.

In addition, if a change of control of the Company occurs and our successor does not assume or
comparably replace the Incentive Plan, participants will receive a pro rata cash payment of their target
bonus, based on the number of calendar days completed in the current semiannual performance period
prior to the occurrence of the change of control.

For purposes of the Incentive Plan:

“disability” means total and permanent disability as defined in accordance with the
Company’s Long-Term Disability Plan.

“change of control” means (i) the sale, lease, conveyance or other disposition of all or
substantially all of the Company’s assets as an entirety or substantially as an entirety to any
person, entity or group of persons acting in concert, (ii) any “person” (as such term is used in
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becoming the
“beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of
securities of the Company representing 50% or more of the total voting power represented by
the Company’s then outstanding voting securities, or (iii) consummation of a merger or
consolidation of the Company with any other corporation, other than a merger or
consolidation that would result in the voting securities of the Company outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity or its parent) at least 50% of the
voting power represented by the voting securities of the Company or such surviving entity
(or parent) outstanding immediately after such merger or consolidation.

The discussion and tables below present an estimate of the amount of compensation and/or other
benefits payable to our Named Executive Officers in the event of their termination of employment and/
or in the event of a change of control of the Company. The amounts disclosed assume that such
termination and/or the occurrence of such change of control was effective as of March 27, 2021, the
last day of fiscal year 2021. We also assume that each Named Executive Officer was continuously
employed by the Company and under the 2007 Severance Plan and the Incentive Plan throughout at
least the second half of fiscal year 2021. The amounts below have been calculated using assumptions,
such as these, that we believe to be reasonable, along with further assumptions that are described in
more detail below. The actual amounts that would be paid under each scenario depend on various
factors, which may or may not exist at the time a Named Executive Officer’s employment is actually
terminated and/or a change of control actually occurs. Therefore, such amounts and disclosures should
be considered “forward-looking statements.”

Conditions Involving Involuntary Termination of Employment or Death/Disability

The estimated amount payable to each of our Named Executive Officers pursuant to the 2007
Severance Plan and the Incentive Plan in the event of an involuntary termination of employment by the
Company other than for cause, or due to the Named Executive Officer’s death or disability, in each
case, assuming such termination occurred on March 27, 2021 (and was not following a change in
control), and in view of the other assumptions above, is set forth in the table below. A termination of

employment will not result in the acceleration of vesting of outstanding equity awards, therefore there
is no value associated with stock options, RSUs, or PBRSUs in the table below. For purposes of our
calculations, we have assumed that all material compensation elements and expenses have been paid
current, and there would be no need to include additional values for items such as accrued vacation or
paid time off.

Name

Salary
Continuation(1)

Health Benefits
(up to 3 months)(2)

Cash Bonus
Under
Incentive Plan(3)

Total

John M. Forsyth, President and Chief Executive
Officer

Jason P. Rhode, Former Chief Executive Officer

Thurman K. Case, Vice President, Chief Financial
Officer and Principal Accounting Officer

Jeffrey W. Baumgartner, Vice President, Research and
Development

Gregory S. Thomas, Senior Vice President, General
Counsel and Corporate Secretary

Jo-Dee M. Benson, Vice President, Chief Culture
Officer

$600,000

$150,000

$5,919

$1,973

$300,000

$905,919

$112,500

$264,473

$220,000

$4,349

$165,000

$389,349

$187,500

$6,341

$140,625

$334,466

$205,000

$5,919

$153,750

$364,669

$197,500

$4,349

$148,125

$349,974

(1) The salary continuation payment for our CEO represents the value of 12 months of his base

salary, based on his base salary level in effect on March 27, 2021. For each of the other Named
Executive Officers, the amount is based on six months of base salary, at the base salary level in
effect on March 27, 2021.

(2) The valuation of the healthcare benefits has been computed based on an estimate of the COBRA
payments required for the three-month period payable by the Company at the rates in effect as of
March 27, 2021.

(3) The Named Executive Officers would only receive the payments enumerated in this column in the
event of a termination of employment due to death or disability. In the event employment is
terminated for any other reason, the noted Named Executive Officer would forfeit these amounts
because they would not be employed with the Company on the date of payment. On a termination
due to death or disability, the Named Executive Officer would be entitled to a pro rata payment of
their bonus under the Incentive Plan. Because March 27, 2021, is the last day of the semiannual
performance period, the Named Executive Officer would be entitled to a full payment of the
semiannual bonus. As such, we have calculated the cash bonus under the Incentive Plan as the
target Incentive Plan Payout Percentage (100%) applied to each individual’s current target bonus
under the Incentive Plan for the semiannual performance period ending on March 27, 2021.

Conditions Additionally Involving a Change of Control

The estimated amount payable to each of our Named Executive Officers pursuant to (i) the Incentive
Plan in the event of a change of control in which the Incentive Plan is not assumed or comparably
replaced, and (ii) the 2007 Severance Plan in the event of termination of employment following a
change of control of the Company either other than for cause by the Company, by the executive officer
for good reason (for all Named Executive Officers other than Dr. Rhode, as noted above), or due to the
executive officer’s death or disability, is set forth in the table below. In the event of termination of
employment following a change of control as described above in (ii), the 2007 Severance Plan provides
that outstanding equity awards will be accelerated (i.e., such awards are double trigger), although
acceleration for Dr. Rhode will be limited to awards that were scheduled or would become eligible to

vest up to the 12-month period immediately following the Transition Completion Date. The possible
application of any cutback required under the 2007 Severance Plan due to the operation of Sections
280G and 4999 of the IRC has not been included in these calculations:

Name

Lump
Sum Salary
Payment(1)

Accelerated
Vesting of
Unvested Equity(2)

Health Benefits
(up to 12 months)(3)

Total

Cash
Bonus
Under
Incentive
Plan(4)

John M. Forsyth, President and Chief
Executive Officer

Jason P. Rhode, Former Chief
Executive Officer

Thurman K. Case, Vice President,
Chief Financial Officer and Principal
Accounting Officer

Jeffrey W. Baumgartner, Vice
President, Research and Development

Gregory S. Thomas, Senior Vice
President, General Counsel and
Corporate Secretary

Jo-Dee M. Benson, Vice President,
Chief Culture Officer

$1,200,000

$6,479,233

$23,676

$300,000 $8,002,909

$ 300,000

$8,267,629

$ 7,891

$112,500 $8,688,020

$ 440,000

$2,107,030

$17,395

$165,000 $2,729,425

$ 375,000

$5,303,994

$25,364

$140,625 $5,844,983

$ 410,000

$2,172,312

$23,676

$153,750 $2,759,738

$ 395,000

$2,053,535

$17,395

$148,125 $2,614,055

(1) The lump sum salary payment for our CEO represents the value of 24 months of his base salary,

based on his base salary level in effect on March 27, 2021. For each of the other Named
Executive Officers, the amount is based on 12 months of base salary, at the level in effect on
March 27, 2021.

(2) The valuation of accelerated vesting of unvested equity awards has been computed based on:
(1) the estimated value that would have been realized based on the difference between the
exercise price of the options that were subject to accelerated vesting and the closing market price
of our common stock on March 26, 2021 (the last trading day prior to March 27, 2021), which
was $83.01 per share, and (2) the value of the RSUs and target-level PBRSUs subject to
accelerated vesting based on that same closing market price. With respect to Dr. Rhode, his equity
award acceleration is limited to the outstanding awards that were scheduled or would become
eligible to vest up to the 12-month period immediately following the Transition Completion Date.

(3) The valuation of healthcare benefits has been computed based on an estimate of the COBRA

payments required for the 12-month period payable by the Company at the rates in effect as of
March 27, 2021.

(4) The amounts in this column represent a pro rata cash payment of target bonuses under the

Incentive Plan, based on the number of calendar days completed in the semiannual performance
period prior to the occurrence of the change of control. Because the change of control is deemed
to occur on the last day of the fiscal year, the amounts above represent the target Incentive Plan
Payout Percentage (100%) applied to each individual’s current target bonus under the Incentive
Plan for the semiannual performance period ending on March 27, 2021.

EQUITY COMPENSATION PLAN INFORMATION

The following table provides information as of March 27, 2021 about shares of our common stock that
may be issued upon the exercise of options, warrants, and rights under the Company’s 2006 Stock
Incentive Plan and the 2018 Long Term Incentive Plan, which was first approved by stockholders on
August 3, 2018:

(A)
Number of
Securities to be
issued upon exercise
of outstanding
options

(B)
Weighted-average
exercise price of
outstanding
options

Equity Compensation Plans Approved

by Security Holders(1)

. . . . . . . . . . . .

3,805,410(2)

$49.87(3)

Equity Compensation Plans Not

Approved by Security Holders . . . . .
TOTAL . . . . . . . . . . . . . . . . . . . . . . .

0
3,805,410

0
$ 49.87

(C)
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (A))

4,025,179

0
4,025,179

(1) As of March 27, 2021, we were granting equity awards only under the 2018 Long Term

(2)

Incentive Plan. Under the 2018 Long Term Incentive Plan, a 1.5 full value award multiplier
is applied to all RSUs and PBRSUs granted.
Includes 2,745,558 shares granted under the 2006 Stock Incentive Plan and the 2018 Long
Term Incentive Plan that are issuable upon the vesting of the outstanding RSUs and
PBRSUs.

(3) The weighted average exercise price does not take into account the shares issuable upon the

vesting of the outstanding RSUs and PBRSUs.

PAY RATIO DISCLOSURE

In accordance with Item 402(u) of Regulation S-K, we are providing the following information about
the relationship of the annual total compensation of our employees and the annual total compensation
of our CEO.

In fiscal year 2021, the Company had two non-concurrent CEOs, Dr. Rhode and Mr. Forsyth.
Dr. Rhode served as CEO until January 1, 2021, and, as effective on that date, Mr. Forsyth has then
served as our CEO. For purposes of the CEO pay ratio, we calculated the compensation paid to
Dr. Rhode and Mr. Forsyth corresponding to the time each individual served as CEO and combined
those amounts. Specifically, base salaries were added according to dates of service as CEO, cash bonus
amounts were prorated according to the time served as CEO, and equity compensation was represented
by Mr. Forsyth’s equity grants since executive equity grants were made during the fourth quarter, at a
time when Mr. Forsyth was CEO. Dr. Rhode did not receive equity grants during fiscal year 2021.

For fiscal year 2021:

the median of the annual total compensation of all employees of our Company (excluding
Dr. Rhode and Mr. Forsyth) was $160,946; and

the annual total CEO compensation was $4,966,496. This figure represents $1,950,964 in
compensation associated with Dr. Rhode up until January 1, 2021, and $3,015,532 in
compensation associated with Mr. Forsyth from January 1, 2021 until the end of the fiscal
year.

Š Based on this information, the CEO annual total compensation was estimated to be 30.9 times
that of the median of the annual total compensation of all employees (excluding Dr. Rhode
and Mr. Forsyth).

We believe this ratio is a reasonable estimate calculated in a manner consistent with SEC rules.
Different companies may use different methodologies in arriving at a pay ratio, and as a result, these
ratios are not necessarily designed to facilitate comparisons among different companies. Rather, they
allow stockholders to better understand and assess each particular company’s internal compensation
practices.

Identifying the Median Employee

We identified our median employee by considering an employee population as of the last day of our
fiscal year, March 27, 2021. We considered all employees at our consolidated subsidiaries and all
worldwide employees (other than Dr. Rhode and Mr. Forsyth who had each served as CEO during the
fiscal year), whether employed on a full-time, part-time, temporary, or seasonal basis. For purposes of
selecting our median employee, we used a consistently applied compensation measure that included
(1) base pay during fiscal year 2021 using salary or base pay rate as of March 27, 2021, (2) all cash
bonuses earned during fiscal year 2021, and (3) the aggregate full grant date fair value of equity awards
granted during fiscal year 2021, calculated in accordance with FASB ASC Topic 718. Compensation
paid in foreign currencies was converted to U.S. dollars based on the average monthly exchange rate
for March, 2021. For employees who were employed for less than the full fiscal year, we annualized
their base pay. The value of the Company’s 401(k) plan and medical benefits provided was excluded,
as all employees in a given jurisdiction are offered the same benefits, and we did not make any
cost-of-living adjustments.

Using this methodology, we determined that the median employee was a full-time software developer
in Austin, Texas.

Calculating the Ratio

After identifying the median employee, we calculated the elements of such employee’s annual total
compensation for fiscal year 2021 pursuant to Item 402(c)(2)(x) of Regulation S-K: $160,946. For the
CEO annual total compensation, we calculated the compensation of Dr. Rhode and Mr. Forsyth
corresponding to their respective times as CEO as noted above: $4,966,496.

REPORT OF THE AUDIT COMMITTEE
OF THE BOARD

The Audit Committee is comprised solely of independent directors, as defined by the applicable
Nasdaq listing standards and rules of the SEC, and it operates under a written charter adopted by the
Board, which is available under the Corporate Governance section of our “Investors” page on our
website at investor.cirrus.com. The composition of the Audit Committee, the attributes of its members,
and the responsibilities of the Audit Committee, as reflected in its charter, are intended to comply with
applicable requirements for corporate audit committees. The Audit Committee continues to review and
assess the adequacy of its charter on an annual basis, and will revise it to comply with new rules and
regulations as they are adopted.

As described more fully in its charter, the primary focus of the Audit Committee is to assist the Board
in its general oversight of the Company’s financial reporting, internal control, and audit functions.
Management is responsible for the preparation, presentation, and integrity of the Company’s financial
statements; accounting and financial reporting principles; internal controls; and procedures designed to
assure compliance with accounting standards, applicable laws, and regulations. The Company’s
independent registered public accounting firm, Ernst & Young, is responsible for performing an
independent audit of the consolidated financial statements in accordance with the standards of the
Public Company Accounting Oversight Board (“PCAOB”).

In accordance with the Sarbanes-Oxley Act and the Nasdaq listing standards, the Audit Committee has
ultimate authority and responsibility to select, compensate, evaluate and, when appropriate, replace the
Company’s independent registered public accounting firm.

The Audit Committee serves an oversight role for the Board in which it provides advice, counsel, and
direction to management and the auditors on the basis of the information it receives, discussions with
management and the auditors, and the experience of the Audit Committee’s members in business,
financial, and accounting matters. The Audit Committee members are not professional auditors, and
their functions are not intended to duplicate or to certify the activities of management and the
independent auditors, nor can the Audit Committee certify that the independent auditors are
“independent” under applicable rules.

In this context, the Audit Committee has met and held discussions with management and Ernst &
Young. Management represented to the Audit Committee that the audited financial statements of the
Company contained in the Company’s Annual Report to Stockholders for the fiscal year ended
March 27, 2021, were prepared in accordance with U.S. generally accepted accounting principles, and
the Audit Committee has reviewed and discussed the consolidated financial statements with
management and the independent auditors. The Audit Committee discussed with Ernst & Young
matters required to be discussed by the applicable requirements of the PCAOB and the SEC.

The Audit Committee has received and reviewed the written disclosures and the letter from Ernst &
Young required by applicable PCAOB rules regarding the independent accountant’s communications
with the Audit Committee concerning independence, and the Audit Committee discussed with Ernst &
Young the firm’s independence. In addition, the Audit Committee has considered whether the
provision of non-audit services is compatible with maintaining Ernst & Young’s independence.

Based upon the Audit Committee’s discussions with management and the independent auditors, the
Audit Committee’s review of the representations of management, and the report of the independent
auditors to the Audit Committee, the Audit Committee recommended that the Board include the
audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal
year ended March 27, 2021, as filed with the SEC.

Submitted by the Audit Committee of the Board:

Alexander M. Davern, Chair
John C. Carter
Deirdre R. Hanford

AUDIT AND NON-AUDIT FEES AND SERVICES

Audit and Related Fees
The following table shows the fees accrued by the Company for the audit and other services provided
by Ernst & Young for fiscal years 2021 and 2020. All fees were pre-approved by the Audit Committee.

Audit Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Audit-Related Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tax Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
All Other Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total

2021
$1,395,000
4,500
$
$ 255,806
$
2,852
$1,658,158

2020
$1,377,000
32,078
$
$ 220,000
$
2,268
$1,631,346

Audit Fees. Audit services consisted of the audit of the Company’s consolidated financial statements
and of management’s assessment of the operating effectiveness of internal control over financial
reporting included in the Company’s Annual Report on Form 10-K, the review of the Company’s
financial statements included in its quarterly reports on Form 10-Q, and statutory audits required
internationally.

Audit-Related Fees. Audit-related services generally include fees for accounting consultations and
registration statements filed with the SEC.

Tax Fees. The fiscal year 2021 tax fees include $141,100 in tax compliance and tax return
preparation services. The remainder of the fiscal year 2021 tax fees relate to technical tax advice and
tax planning. The fiscal year 2020 tax fees include $120,000 in tax compliance and tax return
preparation services. The remainder of the fiscal year 2020 tax fees relate to technical fees including
technical tax advice and tax planning.

All Other Fees. The other fees correspond to an Ernst & Young research tool.

Pre-Approval Policies and Procedures
The Audit Committee has adopted a written policy for the pre-approval of audit, audit-related, and
non-audit services provided by the Company’s independent registered public accounting firm.

For audit and audit-related services, the independent auditor will provide the Audit Committee with an
engagement letter and estimated budget for formal acceptance and approval. A list of non-audit
services and estimated budget for such services for the upcoming fiscal year are submitted to the Audit
Committee by Company management for pre-approval. To ensure prompt handling of unexpected
non-budgeted non-audit related services, the Audit Committee has delegated to its Chair the authority
to amend or modify the list of approved permissible non-audit services and fees if the cost of the
service is less than $100,000. Any such unexpected services for which the cost is more than $100,000
are approved by the Audit Committee. If the Chair takes any action, the Chair will report such action to
the Audit Committee at the next Audit Committee meeting.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Indemnification and Insurance. Our Bylaws require us to indemnify our directors and executive
officers to the fullest extent permitted by Delaware law. We have entered into indemnification
agreements with all of our directors and executive officers and have purchased directors’ and officers’
liability insurance.

Procedures for Review, Approval, and Ratification of Related Party Transactions. The Board
recognizes that Related Party Transactions (as defined below) can present conflicts of interest and
questions as to whether transactions are in the best interests of the Company. Accordingly, the Board
has documented and implemented certain procedures for the review, approval, or ratification of
Related Party Transactions greater than $50,000. Related Party Transactions less than $50,000 are
reported to the Audit Committee at least annually.

Pursuant to these procedures, the Audit Committee must review, approve, or ratify any such
transactions with Related Persons (as defined below). When it is impractical to wait for a scheduled
Audit Committee meeting, a proposed Related Party Transaction may be submitted to the Audit
Committee Chair for approval and then subsequently reported to the Audit Committee at the next
Audit Committee meeting.

This procedure seeks to promote Company decisions that are based on the merits of the transaction and
the interests of the Company and its stockholders. While it is the Company’s preference to avoid
Related Party Transactions, this procedure sets forth a methodology for considering a proposed Related
Party Transaction in which the standard to be applied is whether such transaction is on terms no less
favorable than terms generally available to an unaffiliated third-party under the same or similar
circumstances and the extent of the Related Person’s interest in the transaction.

For these purposes, a “Related Person” is any person who: (1) is, or at any time since the beginning of
the Company’s last fiscal year was, a director or executive officer of the Company; (2) is known to be
the beneficial owner of more than 5% of any class of the Company’s voting securities; (3) is an
immediate family member of any of the foregoing persons; or (4) any firm, corporation, or other entity
in which any of the foregoing persons is employed or is a director, general partner or principal or in a
similar position, or in which such person has a 5% or greater beneficial ownership interest.

For these purposes, a “Related Party Transaction” is a transaction, arrangement or relationship (or any
series of similar transactions, arrangements or relationships) in which the Company was, is or will be a
participant and in which a Related Person had, has, or will have a direct or indirect interest.

Transactions with Related Persons. For fiscal year 2021, we had no material related party
transactions that were required to be disclosed in accordance with SEC regulations.

HOUSEHOLDING

The SEC has adopted rules that permit companies and intermediaries (such as stockbrokers) to
implement a delivery procedure called “householding.” Under this procedure, multiple stockholders
who reside at the same address may receive a single copy of our annual report and proxy materials,
including the Notice of Internet Availability of proxy materials, unless the affected stockholder has
provided contrary instructions. This procedure reduces printing costs and postage fees.

This year, we expect that a number of stockbrokers with account holders who beneficially own
common stock will be “householding” our annual report and proxy materials, including the Notice of
Internet Availability of the proxy materials. A single Notice of Internet Availability of the proxy
materials and, if applicable, a single set of annual report and other proxy materials will be delivered to

multiple stockholders sharing an address unless contrary instructions have been received from the
affected stockholders. Once you have received notice from your stockbroker that it will be
“householding” communications to your address, “householding” will continue until you are notified
otherwise or until you revoke your consent. Conversely, if multiple stockholders who reside at the
same address receive multiple copies of our annual report and proxy materials, they may provide
instructions if they prefer to receive only one copy of such materials. Stockholders may provide
instructions or change their instructions at any time by contacting Broadridge ICS, either by calling
toll-free (866)-540-7095, or by writing to Broadridge ICS, Householding Department, 51 Mercedes
Way, Edgewood, New York 11717.

If you contact Broadridge ICS using the contact information above, we will promptly deliver to you a
separate copy of our Annual Report, Notice of Internet Availability of the proxy materials, and the
proxy materials for the 2021 Annual Meeting, and for future meetings, if you so request. Please also
contact Broadridge ICS if you wish to request delivery of a single copy of those materials if you
currently receive multiple copies.

COMMUNICATING WITH US

Communicating with the Board
If you would like to contact the Board, including a Committee, you may write to the following address:

Board of Directors
c/o Corporate Secretary
Cirrus Logic, Inc.
800 W. 6th Street
Austin, Texas 78701

The Corporate Secretary or Chair of the Governance and Nominating Committee, as appropriate,
reviews all correspondence addressed to the Board and regularly forwards to the Board all such
correspondence that, in the opinion of the Corporate Secretary or Chair of the Governance and
Nominating Committee, deals with the functions of the Board or the Committees. Directors may at any
time review a log of all correspondence received by the Company that is addressed to the Board or
individual Board members. Concerns relating to accounting, internal controls, or auditing issues will be
immediately brought to the attention of the Chair of the Audit Committee.

Other Communications
If you would like to receive information about the Company, you may use one of these convenient
methods:

To have information such as our latest Annual Report on Form 10-K or Quarterly Report on
Form 10-Q mailed to you, please call our Investor Relations Department at (512) 851-4125.

To view our home page on the internet, use our website address: www.cirrus.com. Our home page
provides you access to product, marketing and financial data, job listings, and an online version of
this proxy statement, our Annual Report on Form 10-K, and other filings with the SEC.

If you would like to write to us, please send your correspondence to the following address:

Cirrus Logic, Inc.
Attention: Investor Relations
800 W. 6th Street
Austin, TX 78701

If you would like to inquire about stock transfer requirements, lost certificates, and change of
stockholder address, please contact our transfer agent, Computershare Investor Services, at
(877) 373-6374 (toll free) or (781) 575-2879 or by visiting their website at www.investorcentre.com
(see “contact us” section and other online features).

If you would like to report any inappropriate, illegal, or criminal conduct by any employee, agent, or
representative of the Company; any violation of the Company’s Code of Conduct; or any complaint or
concern regarding accounting, internal accounting controls or auditing matters, you may file an
anonymous and confidential report by contacting EthicsPoint, an independent reporting system
provider, by telephone at 1-866-384-4277 (1-866-ETHICSP), or through its website at
cirruslogic.ethicspoint.com.

ANNUAL REPORT

On May 21, 2021, we filed with the SEC an Annual Report on Form 10-K for the fiscal year ended
March 27, 2021. The Annual Report on Form 10-K has been provided concurrently with this proxy
statement to all stockholders entitled to notice of, and to vote at, the Annual Meeting.

Stockholders may also obtain a copy of the Annual Report on Form 10-K and any of our other SEC
reports, free of charge, (1) from the SEC’s website at www.sec.gov , (2) from our website at
investor.cirrus.com, or (3) by writing to Investor Relations, Cirrus Logic, Inc., 800 W. 6th Street,
Austin, TX 78701. The Annual Report on Form 10-K is not incorporated into this proxy statement and
is not considered proxy solicitation material.

BY ORDER OF THE BOARD OF DIRECTORS

John M. Forsyth
President and Chief Executive Officer
Austin, Texas
June 3, 2021

ANNEX

INCENTIVE PLAN RECONCILIATION

Net Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $779,332 $589,898
Cost of Sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $379,713 $282,216
Gross Profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $399,619 $307,682
Total Operating Expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $245,265 $224,854
Total Operating Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $154,354 $ 82,828

Operating Income Percentage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20%

14%

6 Months Ended
1H’21
2H’21

Operating Income Reconciliation
GAAP Operating Income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $154,354 $ 82,828
Amortization of acquisition intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
5,996
Stock compensation expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 27,981 $ 28,782
352
Other adjustments ** . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $
Bonus VCP, Executive, Leadership Plan Exclusion . . . . . . . . . . . . . . . . . . . . . . . $ 22,817 $ 10,872
Non GAAP Operating Income Used for Bonus Plans . . . . . . . . . . . . . . . . . . . $211,148 $128,830
Non GAAP Operating Income Percentage Used for Bonus Plans . . . . . . . . . . . .

5,996 $

— $

27%

22%

** Other adjustments may include certain acquisition expenses, litigation expenses, patent

agreements, restructuring items, sales reorganizations, asset gains, impairments, or other.

[THIS PAGE INTENTIONALLY LEFT BLANK]

CORPORATE
HEADQUARTERS

800 West Sixth Street
Austin, Texas 78701
United States
T +1-512-851-4000

cirrus.com